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The behavior of biological cells is governed by a multitude of pathways which coordinate
processes including metabolism, gene regulation and signaling. The list of elements and
their connections are often identified but less is known about the temporal dynamics
of pathways. Many important functions including the cell cycle and programmed cell
death can only be understood through dynamics. Due to the size and complexity of the
networks and their non-linear dynamics, quantitative models are essential in represent-
ing pathways and making predictions. When modeling pathway dynamics, one has to
capture and make predictions with respect to several sources of uncertainty including
molecular noise, cell-to-cell variability, and the fact that typically only noisy and partial
measurements are available.
The first part of this thesis focuses on parameter uncertainty in ordinary differen-
tial equation models. Due to the sparsity of measurement data, model parameters are
commonly under-constrained, and choosing a single best estimate is inadequate for fur-
ther analysis. We pose the parameter estimation problem as that of Bayesian inference,
where the uncertainty of the parameter values is characterized by a posterior proba-
bility distribution. Particle filters can sequentially approximate posterior probability
distributions, however, they suffer from practical issues such as sample impoverishment.
We provide an enhanced particle filter that improves sample diversity while preserving
the parameter posterior. Our case studies show that this method is more efficient and
accurate compared to particle filters used previously in this context.
It is important to know that qualitative and quantitative properties of pathway
models hold under parameter uncertainty. Using statistical model checking (SMC) it is
possible to verify whether a system meets a behavior specified in temporal logic with
at least a given probability. Standard SMC approaches rely on simulating independent
realizations of the dynamics, but this is not possible when dealing with a Bayesian
posterior distribution. We propose a method for performing model checking in this
setting based on a sequence of dependent samples obtained from a Markov chain. A
case study on a large model of extrinsic apoptosis demonstrates the practical usefulness
of the approach.
If elements of interest don’t directly interact with each other, building mechanistic
pathway models is not a realistic option. Probabilistic graphical models can represent
influences among elements of pathways and capture the uncertainty arising from unmod-
eled elements. We propose a method for learning the parameters of a dynamic Bayesian
network (DBN) model using a linear programming approach. The method scales well
vii
for large pathways due to the local nature of parametrization. Having learned a DBN
model, we use probabilistic inference to make predictions about dynamics. We monitor
if a specified behavior is met using model checking, allowing us to identify combinations
of perturbations that result in desired behavior. We model novel experimental data for
the phosphorylation of 12 key proteins involved in liver cancer progression on 4 relevant
cell lines. The model allows us to predict the response of diseased cells to perturbation
combinations and identify ones that modify the dynamics of certain proteins to mimic
their dynamics in healthy cells.
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Biology studies life from the level of molecules up to whole organisms and beyond. More
than a century of research on the cell, the basic unit of life, has shed light on many of
the fundamental processes governing living organisms.
Much of the recent progress has been driven by novel experimental technologies.
Methods such as the polymerase chain reaction, microarray technology, flow cytometry
and fluorescence microscopy have all contributed significantly to our understanding of
cellular components. These technologies have enabled the collection of vast amounts of
data and induced a change towards a systems approach in biology.
Classical approaches in biology have focused on the precise characterization of indi-
vidual components. One problem with this approach is that the same molecular entity
may be simultaneously involved in several higher level functional roles through interac-
tions with other elements. Therefore it is unlikely that higher level cellular processes
can be understood only through studying elements in isolation. This, coupled with the
availability of experimental technologies to measure several components simultaneously,
has lead to the emergence of the systems approach in biological research.
Systems biology concentrates on the network level understanding of cellular compo-
nents including genes, RNA molecules and proteins [1]. Networks of interacting compo-
nents which are responsible for some cellular function are often called pathways. While
the connectivity structure of several canonical and disease specific pathways has been
studied, less is understood about the temporal dynamics of the associated processes.
There are many examples, where a list of components or even the structure of interac-
tions between them is not enough to explain important cellular processes. For instance,
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upon DNA damage, the decision between cell survival and cell death depends on the
pulsating or prolonged activation of the protein p53 [2].
Due to the size and complexity of the pathways and the non-linearity of the dynam-
ics, computational models are essential for the understanding of biology at the systems
level. Models have predictive power and offer a coherent basis for depositing and shar-
ing biological knowledge. They can also be used to generate hypotheses and design
useful experiments, thereby reducing the need for costly and time consuming wet-lab
experiments.
The ability to predict behavior under targeted perturbations using computational
models could have an enormous impact. The cost of developing new drugs is grow-
ing dramatically and many proposed compounds fail at later stages of approval, often
because they do not work as expected. Modeling could be the missing link from tra-
ditional drug design to a pathway-level, systemic understanding of drug effects. This
could make developing new drugs cheaper and more reliable, and would help to identify
which treatment is most likely to result in a good outcome for patients with a specific
instance of a disease.
To achieve these goals, new computational methods are needed to efficiently con-
struct and use quantitative pathway models. The research described in this thesis is
meant to contribute to this goal.
1.1 Context and motivation
One of the key challenges faced by modeling efforts is to capture uncertainty in biological
systems. It is increasingly accepted that noise and variability is an inherent and fun-
damental aspect of biological systems rather than an additive nuisance [3]. In addition
to this, we are often limited to partial, inaccurate and often indirect observation about
biological systems. These effects result in uncertainty in model based predictions.
Quantitative computational models of pathway dynamics play an increasingly im-
portant role in modern biology. Biological pathways are often modeled using ordinary
differential equations (ODEs) [4]. The initial conditions and kinetic rate constants (to-
gether called model parameters) are commonly unknown and therefore the model is
subject to considerable uncertainty. A standard approach involves using an optimiza-
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tion procedure to find a single nominal set of parameter values. Models along with
the nominal parameter set are often published and deposited in repositories such as the
BioModels database [5]. However, this approach has important limitations because there
are often several points or regions of parameter space which explain the experimental
data equally well. These parameter values could otherwise correspond to very different
model behaviors.
One explanation for the under-constrained nature of ODE model parameters is that
parameters are often functionally related and there is a large amount of parametric
redundancy due to the evolved nature of the underlying networks. Further, the system
can only be observed partially and at a low time resolution. Observations are invariably
subject to noise due to cellular variability and the measurement process itself. These all
contribute to pathway model parameters being unidentifiable [6]. There is also evidence
that even large amounts of ideal time-series data can leave parameters poorly constrained
[7, 8]. These factors lead to model uncertainty (Figure 1.1), and one primary motivation
of our work is to develop methods to deal with this.
By adopting a probabilistic framework and posing the ODE parameter estimation
problem as one of Bayesian inference, we can embrace model uncertainty by (i) explicitly
modeling it and (ii) making predictions with respect to it. Prior knowledge can also be
exploited in a straightforward manner [9]. However, designing efficient inference methods
is a major challenge in the context of pathway models with high-dimensional parameter
spaces motivating novel computational methods.
When the modeling goal is to capture overall characteristics in signaling for a certain
cell type or in a given disease condition, it is useful to only measure and model a limited
but representative subset of elements. The existence of missing components results
in a special instance of model uncertainty, and detailed kinetic models (such as ones
based on ODEs) are of limited usefulness in this context. Graphical models can capture
indirect effects between elements, and account for missing components and other sources
of uncertainty through assuming probabilistic relationships between them. The use of
graphical models in systems biology (including Bayesian networks and dynamic Bayesian
networks) has mostly been limited to structure learning, both in the context of gene
regulatory networks [10] and signaling pathways [11, 12]. There is great potential in
using dynamic Bayesian networks as predictive dynamical models.
3
Figure 1.1: Sources of uncertainty in biological pathway models.
1.2 Research contributions
1.2.1 Efficient Bayesian inference of pathway parameters
Dynamical pathway models contain a number of parameters including kinetic rate con-
stants and initial conditions. Since these parameters generally cannot be measured
directly, their values have to be inferred from noisy measurement data. Optimization
based parameter estimation approaches cannot account for overall parameter uncer-
tainty. Conversely, in a Bayesian probabilistic framework the quantification of the pa-
rameter uncertainty becomes possible. However, the reconstruction of the Bayesian
posterior distribution is a highly challenging task.
We propose an enhanced particle filtering method to address some of the practical
issues encountered in this process (Chapter 3). Particle filters propagate parameter
samples forward in time and assimilate experimental data sequentially as weights on the
particles. In order to concentrate samples in high-probability areas, resampling is done,
but this often leads to sample impoverishment [13]. The solution proposed here involves
designing particle transitions on the parameter space using Markov kernels. Applying
the Markov transition kernel on a (possibly collapsed) set of samples introduces diversity
and results in a more faithful posterior representation. The quality of the posterior is
assessed through the accuracy of predictions made using it, and is compared against
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other, previously proposed particle filters. The methods are evaluated on a model of
the JAK-STAT signaling pathway, and show that kernel-enhanced filters can reach high
accuracy with significantly reduced sample size.
1.2.2 Verification of pathway dynamics under Bayesian uncertainty
Model checking is a widely used technique for automatically verifying properties of
biological pathways. ODE models with a component of uncertainty are difficult to verify
using model checking due to the continuity of the state space and the fact that their
solutions are not available in closed form. This has motivated the use of statistical model
checking techniques, which rely on sampling independent realizations of the dynamics.
The assumption that samples need to be independent has thus far prevented the use of
statistical model checking schemes on Bayesian parameter posteriors, since in this case,
independent sampling is not possible.
We propose a novel methodology and the theoretical foundations for performing
statistical model checking on ODE models characterized by a Bayesian parameter pos-
terior (Chapter 4). The key idea is to construct a Markov chain on the parameter
space of the model, which produces a sequence of dependent parameter samples from
the posterior. Each sample corresponds to a realization of the system, which is then
verified using a model checker. Due to the dependency of samples, it is challenging
to decide how many samples are needed to complete the model checking task with a
given precision. In our previous work [14], we proposed practically applicable sample
size bounds for Markov chain Monte Carlo estimates. Here we derive a form of these
bounds applicable to statistical model checking. This allows us to design a fix sample
size and an adaptive sample size (sequential) algorithm for performing statistical model
checking. We first verify properties on a model of the JAK-STAT signaling pathway.
We then consider the EARM model of apoptosis with 71 unknown parameters and very
limited experimental data, and show that some important qualitative properties of the
model are preserved, while others cannot be verified to hold with high probability due
to substantial parameter uncertainty.
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1.2.3 Learning dynamic Bayesian network models of pathway dynam-
ics
Probabilistic graphical models provide a succinct representation of stochastic pathway
dynamics. They are especially well suited in case an exact physical interaction between
elements does not exist or is unknown. Dynamic Bayesian networks (DBNs) have the
capability of dealing with temporal data and (in contrast with static Bayesian networks)
can model feedback loops. Previous research in using dynamic Bayesian networks in
biology has concentrated on inferring the structure of pathways. Less attention has
been given to learning and predicting dynamics. Learning pathway dynamics using
discrete DBN models has been proposed before but it requires an existing ODE model
to fill conditional probability parameters [15]. Here we propose a method to learn the
DBN parameters directly from experimental data. We incorporate prior knowledge
about the nature of interactions (activation or inhibition) in the form of constraints.
We then solve a series of linear programming problems, one for each time point, to learn
the conditional probability parameters from data. The method is scalable in the sense
that the size of the optimization problem is locally exponential but scales linearly with
the total number of nodes. The learned DBN model can be used to make predictions
under previously unseen conditions. We learn DBN models based on experimental data
collected for 4 cell lines covering stages from healthy to late stage liver cancer. Using
approximate inference on the learned DBN models, we can predict time course behavior
under various treatments including signaling ligands and small molecule drugs. We are
able to find promising combinations of kinase inhibitors that transform some dynamical
properties of diseased cells to mimic those of healthy cells.
1.3 Outline
The rest of this thesis is organized as follows. In Chapter 2 we provide an overview
of relevant concepts and methods used in modeling biological pathways. This includes
modeling formalisms, parameter estimation techniques and model checking methods.
Chapter 3 discusses the kernel-enhanced particle filtering method. We show that the
method outperforms previously proposed particle filters for the Bayesian inference of
pathway parameters. In Chapter 4 we present our method to perform statistical model
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checking on biological pathways whose parameters are characterized by a Bayesian pos-
terior distribution. We present both fix sample size and adaptive sample size algorithms
and provide sample size bounds for both. Chapter 5 presents a method to learn dynamic
Bayesian network models of pathway dynamics. Using inference on the learned model
we are able to predict behavior under various stimuli and perturbations. We learn cell
type specific models for four cell lines from different stages of liver cancer and obtain
insights about their behavior under previously unseen perturbations using the proposed
method. Chapter 6 summarizes the contributions of the thesis and discusses promising
directions for future research.
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The immense complexity present in biochemical networks, along with the rapid de-
velopment of experimental techniques has sparked interest in quantitative modeling
approaches in biology. In this chapter we briefly review the biological foundations of
pathways and the relevant concepts behind modeling them.
2.1 Biological pathways
2.1.1 Genes to proteins and cellular function
The genetic code is stored in the DNA which is built up of a sequence of nucleotide
bases. Through the process of transcription, portions of the DNA sequence called genes
are read and copied to a messenger RNA (mRNA) molecule. Transcription starts at a
special segment of the DNA called a promoter and ends when a terminator sequence
is met. Each mRNA molecule contains one or more protein coding regions which is
translated to a sequence of complementary tRNA (transfer RNA) molecules. Finally,
the amino acids carried by tRNA are linked to form a protein. The primary structure
of proteins is defined by the sequence in which the amino acid molecules are linked.
However, it is only after folding into a dedicated three dimensional structure that the
protein can properly fulfill its function inside the cell.
Proteins play a principal role in executing the cellular behavior specified by the ge-
netic code. Structural proteins form the cytoskeleton, which maintains the shape and
size of the cell. Proteins contain special binding sites which allow them to form com-
plexes with other proteins or bind small molecules. Enzymes catalyze specific chemical
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reactions by binding substrate molecules and transforming them into products. With-
out enzymes, most chemical reactions would occur at a very slow rate, making the cell
dysfunctional. Protein molecules are also involved in relaying external or internal sig-
nals, essential in reacting to environmental cues. DNA binding proteins, referred to as
transcription factors can bind to the promoter region of a gene to influence the speed
at which the gene is transcribed.
As we see from these examples, an understanding of how proteins work and interact
is of crucial importance towards discovering how cells function.
2.1.2 Pathway types
Cellular behavior is attained through a complex system of chemical reactions. Molecules
constantly collide, bind and are transformed into other molecules. We will call molecules
of the same type as a molecular species. Due to their structure and physical proper-
ties, certain species are likely to interact only with a limited set of other species. The
interactions between species can be thought of as links in a large network. Current
biological knowledge is far from completely mapping out interactions in this network.
It is more reasonable to concentrate investigations on sub-networks of restricted scope
which can be linked to a specific function. These sub-networks are commonly referred
to as pathways.
Biological pathways are generally classified in three distinct groups. In reality, these
pathways coexist and interact, however, for purposes of biological understanding, it
is useful to discuss them separately. While the main focus of this thesis is signaling
pathways, the methods and results will be applicable in a straightforward manner to
metabolic and gene regulatory networks as well.
Signal transduction pathways
Signal transduction enables cells to sense environmental cues and respond to them.
Signal transduction pathways are activated in response to internal or external stimuli.
External signals can reach the cell in the form of molecules but can also be caused
by other environmental factors. Signaling molecules, also called ligands can bind to
receptors extending from the cell membrane. The receptor changes its spatial structure,
thereby setting off a cascade of signal transduction inside the cell. Signaling cascades
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typically involve a series of protein modifications such as phosphorylation, dimerization,
complex formation and cleavage. Since proteins can act as transcription factors and bind
to promoters, if the signal reaches the nucleus, the cell can change its gene expression
profile in reaction to the received signal.
Signaling ligands include growth factors such as EGF, TGF, and VEGF, which
promote cell cycle progression, cell growth and cell differentiation. Members of the
interleukin-1 family regulate inflammatory responses and are important in the immune
response of cells. Other important signaling molecules include TNFα, TRAIL and Fas,
which induce caspase activation and apoptosis.
The most important process by which signals are propagated in signaling pathways
is through phosphorylation. Phosphorylation is a post-translational modification, which
happens when a phosphate group is attached to a specific amino acid site (usually serine,
tyrosine or threonine) of a protein. Phosphorylation often results in the activation of a
protein through a change in its spatial conformation. For instance the tumor suppressor
p53 is in an inactive form but is phosphorylated by ATM in response to DNA damage.
It is only in its active, phosphorylated state that p53 can fulfill its role as a transcription
factor. A typical signal transduction pathway representing externally triggered apoptosis
is shown in Figure 2.1.
Figure 2.1: Signal transduction pathway governing externally triggered apoptosis, in-
cluding reaction schemes. Figure is from [16] under the CC BY-NC-SA license.
Gene regulatory pathways
Gene regulatory pathways represent interactions between genes. Genes do not directly
interact with each other, however they can influence each other through transcriptional
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regulation. An example of such a process is a gene which expresses a protein that in
turn binds to another gene’s promoter region and changes the speed of transcription.
Gene regulatory pathways comprise a network of genetic interactions as direct positive
or negative regulation between genes.
The gene regulatory pathway for the circadian oscillator is shown in Figure 2.2. Each
node corresponds to a gene and the positive (+), negative (-) and neutral (0) effects are
shown along edges.
Figure 2.2: Gene regulatory pathway for the circadian oscillator. Figure is from the
Science Database of Cell Signaling [17].
Metabolic pathways
Metabolic pathways are networks of reactions that transform metabolites and various
other molecules. Cells require energy to function and energy in cells is used to build
necessary compounds, maintain structure, and grow. Catabolic processes break down
organic matter and store the released energy in form of adenosine triphosphate (ATP)
molecules. Anabolic processes use these energy carrying molecules to construct further
metabolites or cellular components such as nucleic acids and proteins. Enzymes play a
crucial role in metabolic reactions. Enzymes allow certain reactions to happen at a fast
rate - and thereby link species in the network - but they are not modified or consumed
in the process. Metabolic pathway models therefore often concentrate on links between
enzymes and the genes encoding them.
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2.2 Modeling formalisms
Biological models have traditionally been represented through informal graphical dia-
grams. These diagrams can give a qualitative, structural overview of the system. How-
ever, diagrams do not specify the concentration of species or the dynamics of different
reactions. As the size of a model grows, it is increasingly difficult to understand the
complex network of non-linear effects based on informal diagrams alone.
Building quantitative models of pathways are useful in several ways. First of all,
quantitative models let us untangle the strength of effects in a network of interactions
[18]. They allow a clear and consistent analysis to which extent each component con-
tributes to certain processes. Quantitative models are easily represented and simulated
on a computer. In fact, it is the power to execute pathway models and make predic-
tions that truly revolutionizes the way systems are understood [19]. Models also allow
us to analyze biological pathways through systems theory and elucidate fundamental
properties of biological systems such as modularity or robustness [20, 21].
Several formalisms have been introduced in the pathway modeling context. These
can be classified according to many different characteristics, including whether they are
mechanistic or abstract, deterministic or stochastic, static or dynamic and qualitative
or quantitative. Some of the widely used formalisms are classified in Table 2.1. It is
important to note that various extensions to the basic form of these models have been
proposed in the literature (for instance qualitative differential equations) that make these
distinctions less crisp.
Mech Abs Qual Quant Det Stoch Stat Dyn
ODE x x x x
CTMC/SDE x x x x
Boolean/Logic x x x x
BN x x x x
DBN x x x x
Table 2.1: Classification of widely used pathway modeling formalisms depending on
whether they are mechanistic or abstract, qualitative or quantitative, deterministic or
stochastic and static or dynamic.
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2.2.1 Mechanistic models
Building mechanistic models of biological pathways relies on chemical reaction kinetics.
We first look at the kinetic laws that mechanistic models are built of and then dis-
cuss ordinary differential equation based deterministic models and Markov chain based
stochastic models.
Reactions kinetics








where Ri are reactants, Pj are products, and ai, bj are the stoichiometric coefficients as-
sociated with them. In general, chemical reactions are reversible, however one direction
may be negligibly slow compared to the other, in which case the reaction is considered
irreversible.
The most basic concept in the quantitative modeling of chemical reactions is the
law of mass action [22]. According to mass action kinetics, the speed of a reaction is
proportional to the concentration of the reactants raised to the power of their stoichio-
metric coefficients. In what follows, we denote concentration with square brackets, for
instance, the concentration of Ri is denoted [Ri]. The forward reaction speed of (2.1) is










Here kr and kp are kinetic rate constants.
A specific example, often encountered as a component of pathway models is an
enzyme-substrate reaction. In this process, a substrate (S) is converted into a product
(P) by binding to an enzyme (E) and forming an enzyme substrate complex (ES). The






k3→ E + P. (2.3)
The assumption in these reactions is that complex formation is a reversible process but
product creation and release is irreversible. According to the law of mass action the
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reaction rates for this system are
f1 =k1[S][E]− k2[ES] (2.4)
f2 =k3[ES],
where k1, k2 and k3 are reaction rate parameters.
Mass action kinetics provides a faithful model of the reaction dynamics in case it
models elementary, physical interactions (such as binding and release in (2.3)). But it
is often only the dynamics of the substrate and the product that is of interest, and this
transformation cannot directly be modeled by mass action kinetics. This has resulted
in the derivation of kinetic laws that summarize the dynamics of a series of elemen-
tary interactions. We now look at two of the most widely used such kinetic laws, the
Michaelis-Menten equation and the Hill equation.
Michaelis-Menten kinetics relies on the assumption that the concentration of the
substrate is much larger than that of the enzyme, and therefore the enzyme-substrate
complex reaches a steady state and is not explicitly modeled. The speed of reaction





The parameters Vmax and K can be derived from the mass action parameters, and have
easily interpretable physical meanings. In addition, they can be measured more easily,
therefore Michaelis-Menten kinetics are popular when building quantitative pathway
models [23, 24].
The Hill equation can be used to model processes in which a substrate (S) can bind
to several different sites of a macromolecule, and bound substrates can influence the rate






Here V and K are kinetic rate constants and the parameter n quantifies substrate
cooperativity, and can represent positive or negative cooperativity depending on its
value.
Several other rate laws have been derived [26] and are used for modeling purposes.
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Ordinary differential equation models
Given a model structure and reaction kinetics, it is straightforward to obtain an ordinary
differential equations (ODE) model of the dynamics. We construct an equation for each
modeled species xi, 1 ≤ i ≤ n, which describes its immediate concentration change at
any given time. The reaction rate producing the species will appear with positive sign
and the reactions consuming it with negative sign (ri,k > 0 and ri,k < 0 respectively, for







where fk is the kinetic rate of reaction k. The state of the system at time t is described
by the vector x(t) := (x1(t), . . . , xn(t)). The kinetic rate constants will be summarized
in a vector θ, which we will refer to as model parameters. We also define the vector
valued function F , which describes the right hand side of the equations in (2.7) as
x˙(t) = F (x, θ). (2.8)
Given a value assignment to θ and initial conditions x(0), the solution of the ODE system
is the state trajectory x(t) for some time range t ∈ [0, T ]. Additionally, given that the
right hand side of the equations are C1 functions, there is a unique solution to the
equations [27]. Analytical solutions only exist for a restricted class of ODE systems, for
example ones whose right hand side is linear. In the case of large and non-linear systems
typically encountered in the pathway modeling context, closed form solutions will not
be available. Therefore, numerical integration methods are used to obtain approximate
solutions to the dynamics. Fix step-size solvers such as the fourth order Runge-Kutta
method (RK4) are fast and easy to implement [28]. However, due to a fix step-size
parameter, they are unsuitable for solving stiff problems, which are often encountered
in kinetic models due to different time-scales in the system [29]. Simulators for pathway
models therefore rely on more sophisticated solver packages which are efficient in a stiff
setting, such as LSODA [30] and CVODE [31].
As an example, we show the ODE description of the enzyme kinetic model described
by (2.3) in Figure 2.3. The individual equations are obtained by using (2.4) and (2.7).
Simulation is performed for t ∈ [0, 10] with initial conditions x(0) = (15, 10, 0, 0) and







=(k2 + k3)[ES]− k1[E][S]
d[ES]
dt






















Figure 2.3: ODE equations and time course solutions for a simple enzyme-substrate
system.
ODE models are an adequate description of pathway dynamics when the molecule
numbers are high enough to be treated as continuous values [32]. ODEs provide a
deterministic description of the dynamics. However, by allowing variability in initial
conditions and model parameters, it is possible to endow the model with a probability
distribution, as we do in Chapters 3 and 4 of this work. In case the quantity of con-
stituents is low, a continuous description of the dynamics may not be suitable. Stochastic
models which address this issue are introduced in the following section.
A further assumption in ODE models is that the contents of the cell are well-mixed
and the location of the components is not relevant. If representing spatial position is
necessary (for instance in pattern formation during development), partial differential
equation (PDE) models can be used. Compared to ODE models, PDEs are significantly
harder to calibrate and simulate [33].
Stochastic mechanistic models
Chemical reactions inside the cell often happen at low molecule numbers in a stochastic
manner. In this case it is reasonable to represent the quantity of species in terms of
molecule numbers instead of concentrations [34]. Stochastic models provide a way to
describe the discrete change in molecule numbers over time. Reaction events are assumed
to be distinct, and each reaction event changes the molecule numbers according to the
stoichiometric coefficients. The random occurrence of reaction events in time results in a
discrete state space stochastic process governing the species. A rigorous derivation of this
stochastic process (also referred to as the chemical master equation) based on statistical
physical considerations is described in [35]. The chemical master equation implicitly
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defines a continuous time Markov chain (CTMC) which can be exactly simulated using
the Gillespie algorithm [36]. The CTMC model also includes transition rate parameters,
and in fact, these parameters are even more challenging to learn than ones in ODE
models.
There are several ways of relating CTMCs and ODEs. First of all, the expectation
of the stochastic Markov process can be modeled using deterministic ODEs [37]. This
formally results in the same equations as the deterministic representation of the sys-
tem, however the species are measured in molecule numbers and the rate constants have
different meaning and numeric value. A more appropriate approximation to a CTMC,
which retains the stochasticity of the system, is one based on stochastic differential
equations (SDE) [38]. SDEs model the change in molecular quantities as diffusion pro-
cesses. SDEs can speed up the simulation process and are amenable to useful analysis
techniques known from other fields, most notably finance [39].
When a pathway contains species, some of which exist at low and others at high
molecule numbers, using a purely deterministic or purely stochastic model is impractical.
Hybrid simulation methods have been developed to deal with this problem. In this
context, species and reactions are partitioned, and a single simulation algorithm is given
which contains discrete and continuous state updates [40, 41].
2.2.2 Abstract models
It is often the case that a the species of interest which need to be included in a pathway
model do not directly interact with each other. Further, one may be interested in
modeling the activity level of each species rather than its molecular amount [42]. In such
cases standard kinetic laws are not applicable, and a more abstract description of the
influences among species is needed. Conceptually simple methods such as multilinear
regression [43] and principal component analysis [44] can reveal influences in a data-
driven manner. Models based on logic rules such as Boolean models [45] and fuzzy logic
models [46, 47] have also been proposed in this context.
Here we introduce Bayesian and dynamic Bayesian networks, which model influences
in a probabilistic framework.
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Bayesian networks
Bayesian networks are probabilistic graphical models represented as a directed acyclic
graph (DAG) [48, 49]. The graph consists of a finite set of nodes X and a set of edges
E ⊂ X ×X. The set of nodes X = {X1, X2, . . . , Xn} correspond to random variables
and the edges encode the independence structure of the joint distribution of X. Here
Xi ∈ X represents a finite valued random variable taking its value from the set V .
The Markov property induced by the edges states that a node is independent of its
non-descendants given its parents. A Bayesian network structure is faithful to the un-
derlying joint distribution when an independence relationship is implied by the Markov
property if and only if the same independence relationship exists on the corresponding
set of random variables.
The main advantage of the graph representation is that it allows a succinct parametriza-
tion of the joint distribution. Namely, it is enough to parametrize the distribution of
each node conditioned on its parents. We associate a conditional probability table
Θi = P (Xi|PA(Xi)) with each node. Here PA(Xi) is the set of parents of Xi de-
fined as PA(Xi) = {Xi1 , . . . , Xi`} with (Xik , Xi) ∈ E for 1 ≤ k ≤ `. Each entry
Θi(xi|xj1 , xj2 , . . . , xj`) encodes the probability of Xi taking a value xi ∈ V given the
value assignment (xi1 , xi2 , . . . , xi`) ∈ V ` to its parents. Using this parametrization, and
exploiting the Markov property, we can express the factorized joint distribution as




The conditional probability table entries can be used directly to calculate the probability
of a joint assignment.
Dynamic Bayesian networks
Dynamic Bayesian networks (DBNs) represent a set of random variables over time [50,
49]. In the DBN, a set of system variables X = X1, X2, . . . , Xn are modeled at a discrete
set of time steps t ∈ {0, 1, . . . , T}. The model consist of a node for each variable at each
time point, for instance, Xti denotes the random variable representing the value of Xi at
time t. Similar to general Bayesian networks, edges encode an independence structure
among the set of nodes. However, edges are restricted such that they are (i) directed
forward in time and (ii) only span a single time step. With these assumptions, for
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t > 0, we have the parenthood relationship PA(Xti ) ⊆ {Xt−11 , Xt−12 , . . . , Xt−1n }, and
for the initial time point PA(X0i ) = ∅. From here the set of edges E is defined as
(Xt−1j , X
t
i ) ∈ E if and only if Xt−1j ∈ PA(Xti ).
This implies a set of first-order Markov assumptions in time, namely, that given the
current state, the next state is independent of the previous state, or
(Xt−11 , X
t−1
2 , . . . , X
t−1
n ) |= (Xt+11 , Xt+12 , . . . , Xt+1n )|(Xt1, Xt2, . . . , Xtn). (2.10)
The parametrization of a discrete DBN model is through a set of conditional prob-
ability tables, one for each variable at each time point. The CPT for variable Xi at




i|xt−1i1 , xt−1i2 , . . . , xt−1i` ), rep-
resenting the probability of Xti taking the value x
t




, . . . , xt−1i` ) ∈ V ` to PA(Xti ).
A BN and DBN model of a small signaling network is shown in 2.4. Each node
represents the activity of a molecular species, in this case, a protein. The example
illustrates the difference in the way static BNs and DBNs are used in biology. BNs do
not have a time component and can only represent static (steady state or equilibrium)
influences among molecular species. In contrast, DBNs model the temporal influence
among species and can be learned based on time-course experimental data. Another
important difference is that BNs require acyclicity and therefore cannot model feedback
loops. Due to the fact that DBN variables are present across multiple time steps, the
forward directed edges can model feedback loops. For example, the edges RAF→ ERK
and ERK→ RAF constitute a feedback loop in the DBN in Figure 2.4. Note also, that
we have included edges in the DBN from each species to itself in the next time point.
This is intended to model forms of persistence, for instance the fact that a protein is
more likely to stay active once it has been activated.
2.2.3 Summary
We introduced both mechanistic and abstract pathway modeling formalisms. In the rest
of this thesis we will focus on ODE models to represent dynamics based on molecular
level interactions in a continuous time, deterministic manner. Our choice of ODEs
relies on the assumption that they provide an accurate description of dynamics when






P (NFκB = 1|TNFα = 0,PI3K = 0) = 0.1
P (NFκB = 1|TNFα = 0,PI3K = 1) = 0.3
P (NFκB = 1|TNFα = 1,PI3K = 0) = 0.4














= 1|NFκBt = 0,TNFαt = 0,PI3Kt = 0) = 0
P (NFκB
t+1




= 1|NFκBt = 1,TNFαt = 1,PI3Kt = 1) = 0.9
Figure 2.4: Bayesian network and dynamic Bayesian network representation of a small
signaling pathway model. The model is adapted and simplified from [51]. The dotted
edge from ERK ro RAF in the DBN forms a feedback loop. The same feedback cannot
be modeled on the static BN.
abstract, probabilistic interactions between molecular species when the modeling goals
require a larger scale but less detailed description.
2.3 Model calibration
Focusing on ODE models, we now discuss how unknown model parameters can be
estimated or inferred given experimental data. Dynamical pathway models typically
contain a number of unknown kinetic rate parameters. The initial concentration of some
species, if they are unknown, can also be considered parameters. Getting quantitatively
consistent values for these parameters is a significant challenge in current systems biology
efforts and is an active area of research [52].
Some parameters can be measured experimentally. For instance, the parameters of a
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reaction with Michaelis-Menten kinetic rate may be measured in vitro. This approach,
however, is impractical since experiments are very time consuming and expensive. Re-
sources would be better allocated making measurements on the system instead of its
elements in isolation. In addition, reaction rates measured in isolation may not be con-
sistent with those present in the studied system. For the above reasons, the estimation
of model parameters is carried out using computational methods.
We introduce two conceptually different ways of formulating the model calibration
problem. Parameter estimation poses an optimization problem for finding the single
best parameter vector. The underlying assumption is that parameters are constants
which have an unknown but exact value. Parameter inference relies on representing pa-
rameters are random variables. The parameters possess a prior probability distribution,
which is then updated by experimental data using probabilistic inference. The resulting
probability distribution is commonly referred to as the posterior distribution. Note that
the latter formalism still maintains that there is an underlying exact parameter value.
It is rather our limited knowledge or belief about the parameter value which is modeled
as a probability distribution.
2.3.1 Parameter estimation
Assume that we are given a set of experimental data Y , which contains measurements
for some of the variables at a few discrete time points. Our goal will be to find model
parameters θˆ such that the simulated output of the model provides a good fit to the
data. The experimental data is structured as follows. Yi,j denotes the measured value
for species i at time point tj , where i ∈ {1, . . . , n} and j ∈ {1, . . . ,m}. In practice, data
is often available for a set of different experimental conditions and Y can be expanded
in the obvious way to show this.
Parameter estimation is formulated as an optimization problem with respect to an
objective function J . The objective function takes a vector of proposed model param-
eters as an argument and quantifies the difference between data and simulated model







wi,j(xi(tj)|θ − Yi,j)2. (2.13)
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Here xi(tj)|θ is the result of simulation when using parameter θ and wi,j is a weight
corresponding to each data point. Weights are used in practice to account for the
differences in magnitude of species concentrations.
Given the objective function, parameter estimation is an optimization problem with




The error function itself is quadratic, but since simulated curves depend on parameters
in a highly non-linear way, finding the minimum is a challenging non-linear optimization
problem. Parameter estimation methods use a search algorithm to find the optimum in
the (usually high-dimensional) space of parameters.
Several methods have been proposed to solve the optimization problem in the con-
text of pathway models [53]. Local methods such as Hooke-Jeeves pattern search [54]
or Levenberg-Marquardt method [55] are useful when the optimum is in near the initial
point that the search starts from. Often the range of parameters is wide and the pa-
rameter space contains numerous local minima. In this setting, global search methods
are needed, which implement ways of avoiding local minima. Stochastic ranking evolu-
tionary strategies [56] and genetic algorithms [57] are some of the popular methods that
have proved to work well in practice [58].
Global optimization methods often work well in practice but are based on heuristics
and are not proven to converge to the global optimum in a finite number of steps. It
is not possible to theoretically characterize the set of samples at any specific iteration
of the search. Most importantly, these methods only provide a single output to the
optimization problem. It is not known whether that is an optimal value and whether
there are any other “good” values.
2.3.2 Parameter inference
Parameter inference [59, 60] defines parameters as random variables in a Bayesian prob-
abilistic framework. This is both conceptually and also in methodology, fundamentally
different from parameter estimation. Even if the underlying parameter (such as a ki-
netic rate constant) does have a well defined and exact value, the probabilistic approach
allows us to model our belief or uncertainty about its value based on limited data. The
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parameter vector θ is endowed with a prior distribution p0(θ), in the simplest case, uni-
form over a bounded interval for each parameter. The experimental data Y is related to
the parameters through the likelihood function p(Y |θ), which expresses the probability
of observing Y given parameters θ. The form of the likelihood function is assumed to
be known, and can be evaluated using simulation.
Our goal is to constrain the distribution of the parameters by conditioning on ex-
perimental data. This conditioning is expressed in the posterior distribution, which we
denote pi(θ|Y ). Using the Bayes theorem, we can express the posterior as




p(Y |θ)p0(θ)dθ . (2.15)
Note that in (2.15) the denominator is not a function of θ, and hence pi(θ|Y ) ∝ p(Y |θ)p0(θ).
The posterior probability of the parameter is determined by how likely the parameter
is inherently (its prior), and its compatibility with the observed data (its likelihood).
The Bayesian framework allows several ways to determine model parameters:
argmax
θ
p(Y |θ) Maximum likelihood (ML),
argmax
θ
pi(θ|Y ) Maximum aposteriori probability (MAP),
pi(θ|Y ) Bayesian posterior.
While ML and MAP estimates recover a single parameter value, the goal of parameter
inference is to construct the full Bayesian posterior. Projections of the (usually high-
dimensional) parameter posterior can reveal the histograms of individual parameters
and the correlation between pairs of parameters. However, recovering the posterior
distribution is not the only goal of parameter inference. Namely, it can be useful to
evaluate the expected value of a function of θ with respect to the posterior. For instance,




Several methods have been proposed for calculating integrals of this form including
Markov chain Monte Carlo [61], sequential Bayesian filtering (including Kalman filters
and particle filters) [62], variational Bayesian methods [63] and approximate Bayesian
computation [64]. More details on these methods will be discussed in Chapters 3 and 4.
There is an important connection between parameter estimation and parameter in-
ference. More specifically, there is a correspondence between the sum of squared errors
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and a special case of the likelihood function. Constructing the likelihood function usu-
ally involves integrating out the possible realizations of the system given a parameter
value. In the context of ODE models we can exploit the properties that (i) the system
state trajectory is a unique and deterministic function of θ; (ii) Y is available at a finite
discrete number of time points; and (iii) the measurements are uncorrelated given the
current system state. With these properties, the general form of the likelihood simplifies





p(Yi,j | xi(tj)|θ). Here again xi(tj)|θ is the result of simulation when
using parameters θ. It is often reasonable to assume that p(· | xi(tj)|θ), that is, the
distribution of a data sample conditioned on the system state, is Gaussian. It can then
be written as p(· | xi(tj)|θ) = N (xi(tj)|θ, σ2i,j), where N (µ, σ2) is the normal distribution
with mean µ and variance σ2. The log-likelihood is then expressed as













with C being a positive constant. We can now establish a connection between the





log p(Y |θ) =: θˆML, (2.18)
with the choice of wij := 1/σ
2
i,j .
2.4 Model analysis and verification
It is possible to generate hypotheses and gain insights about biological systems using
analysis techniques on the model representing it. In the context of ODE models, steady
state analysis concentrates on the behavior of the dynamics in the limit, including stable
states and limit cycles [65]. Bifurcation analysis reveals how the steady state landscape
changes as a function of changing parameters or initial conditions, and concentrates on
abrupt qualitative changes in limit behavior (for instance transition from limit cycle to
stable state) during a smooth change in parameters [66]. Sensitivity analysis provides a
quantitative measure of how the time-course dynamics or the steady state of the system
changes when varying parameters or initial conditions. Both local and global sensitivity
analysis methods are widely used and provide insights about variability and robustness
[67].
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Having constructed and calibrated a quantitative model, it is important to verify
that it is consistent with knowledge about the underlying system. Manually verifying
properties of interest based on simulation output is difficult and prone to interpretation
bias, especially if the pathway being modeled is large. Models are often constructed in
an iterative manner, and verification may need to be performed many times during this
process. This motivates us to choose a language to make statements about dynamics,
and use algorithms to automatically verify whether these properties are met by the
model. Temporal logics coupled with model checking algorithms have been applied for
this purpose in fields including program analysis [68] and circuit design verification [69],
and are recently also adopted for pathway models.
Model checking, in general terms, is used to verify state transition models with
respect to properties expressed in formal logic [70]. Model checking has found many
applications in systems biology. For instance, it has been used to verify properties of a
stochastic model of the mitogen activated protein kinase (MAPK) cascade [71], a model
of fibroblast growth factor signaling [72] and to analyze the network controlling the
nutritional stress response in E. coli using piecewise linear ODEs [73].
Properties about realizations of dynamical models can be expressed using temporal
logic. There are many choices for an appropriate logic depending on the modeling
formalism and the goals of verification. Here we focus on linear temporal logic (LTL),
which has proven to be particularly useful in systems biology as it can be interpreted
on a broad class of model types and can intuitively express properties of interest. An
LTL formula is interpreted on a single execution path and is therefore well suited for
deterministic ODE models. Using temporal operators in LTL it is possible to make
statements about reachability (F), stability (G) and ordering (U) of events, and these
statements can be combined using standard logic operators such as AND (∧), OR (∨),
and implies (⇒).
For instance, recall the small enzyme-substrate system from Figure 2.3. The property
FG[0 ≤[S]≤ 5] is interpreted as: at some time the substrate concentration will be in
the interval [0, 5], and from then on it will stay in the same interval. The formula [5 ≤
[E] ≤ 10]U[5 ≤ [ES] ≤ 10] states that the enzyme concentration is between [5, 10] until
the concentration of the enzyme-substrate complex reaches the interval [5, 10]. From
Figure 2.3, we easily see that both these properties are true. We will give a more precise
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definition of the syntax and semantics of LTL formulas in Chapter 4.
In the context of ODEs, since one must rely on numerical solutions, a bounded
LTL (BLTL), interpreted on finite time intervals is usually necessary. Further, when
the realizations of the system are stochastic, PBLTL, a probabilistic extension of BLTL
can be used. PBLTL is applicable on CTMCs and other stochastic models, but also
in a setting where an ODE system is endowed with a probability distribution due to
model uncertainty. A formula in PBLTL has the general form P≥rϕ, where ϕ is a BLTL
formula, and the intended meaning is, ϕ holds with at least probability r. Solving this
probabilistic model checking problem exactly is intractable for large models due to state
space explosion. However, statistical model checking provides an approximate solution,
and its efficiency does not depend on the size of the state space.
Statistical model checking (SMC) involves repeatedly simulating the system, veri-
fying the property for each realization and deciding whether P (S |= ϕ) > r that is,
whether the dynamical model S satisfies ϕ with at least probability r. The decision
can be made once sufficiently many samples have been evaluated [74]. The usual for-
mulation of SMC is based on a hypothesis test between H0: P (S |= ϕ) > r + δ and H1:
P (S |= ϕ) < r − δ [75]. The parameter δ defines an indifference region around r, in
which choosing either H0 or H1 is acceptable. The standard SMC scheme relies on the
sequential-probability ratio test (SPRT) as a stopping criterion [76]. After drawing m













Here zi is 1 if the ith simulated trajectory satisfies the formula and 0 otherwise. Hy-
pothesis H1 is accepted if qm ≥ 1−βα , and hypothesis H0 is accepted if qm ≤ β1−α . If
neither is the case then another sample is drawn. The constants α and β are chosen
by the user and signify the upper limit on false positive and false negative decisions.
Statistical model checking has been applied, for instance, to verify a large stochastic
model of T-cell receptor signaling [77].
There are many other works that aim to make model checking methods more appli-
cable for pathway modeling tasks. The method proposed in [78] makes the construction
of temporal logic formulas easier for practitioners by allowing biologically relevant, high-
level query templates to be pieced together and automatically translated into temporal
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logic. Model checking has also been used to search for parameters with which the model
fits specified dynamical properties [79, 80]. In [81] we proposed statistical model check-
ing coupled with global optimization to find parameters of ODEs with variability in
initial conditions, and used the approach to calibrate large pathway models.
There are a number of tools that are available for model checking biological pathway
models including BioCham [82], BioDiVinE [83] and MIRACH [84]. There are also
several general purpose tools that have been used for pathway models such as PRISM
[85], UPPAAL [86] and Breach [87]. For further details, we refer to a comprehensive







Quantitative models are essential for better understanding the dynamics of biological
pathways, and ordinary differential equations (ODEs) are the most often used modeling
formalism in systems biology. However, calibrating model parameters to be consistent
with prior knowledge and experimental data remains a significant challenge. The limited
nature of experimental data, coupled with the common unidentifiability of parameters
has motivated the representation of the model parameters as a probability distribution,
rather than a single value. This allows the representation of a finite or infinite set of
model parameters, each possible parameter vector weighted according to its support
from prior knowledge and experimental evidence. The advantages of a probabilistic ap-
proach include the coherent treatment of measurement noise, prior knowledge and also,
possibly, the stochasticity of dynamics, in a single quantitative framework. Further, the
uncertainty in the predictions made by the model can be quantified. The main difficulty
with this approach is that large-scale Bayesian inference is required for reproducing
the posterior distribution of model parameters. Designing efficient parameter inference
algorithms for ODE based pathway models is a difficult and open problem [59].
A class of algorithms which can approximate the distribution of parameters is sequen-
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tial Bayesian inference, also called Bayesian filtering and data assimilation [62]. These
methods were originally developed for inferring the hidden state of a system based on
noisy observations. However, by taking parameters as static state variables, they can
be extended to recover a distribution over parameters. Sequential inference methods
start with a prior distribution and iteratively update it by stepping forward in time
and incorporating the measurement data available at the current time point into the
distribution. The sequential nature of these methods increases efficiency by breaking up
inference into a series of simpler problems, and also enables the use of the methods in
settings where observations are received in real time [89].
Particle filters are especially well suited for sequential inference, since they approx-
imate the sequence of distributions by samples (called particles), which has proven
numerical advantages in high-dimensional settings [90]. Such high-dimensional settings
are very common when dealing with pathway models, as each model parameter corre-
sponds to an additional dimension in the parameter space. The particle filter starts
by generating a set of samples according to the prior distribution. These samples are
propagated forward in time using the model dynamics. When a new observation is
available, the samples are reweighted by the likelihood of the observation. The particles
are then resampled proportional to their weights to concentrate them in regions of high
probability. This method has been shown to result in samples distributed according to
the true posterior distribution [90].
A useful graphical tool called DA1.0 [13] has recently been released, which imple-
ments the particle filter algorithm for pathway parameter estimation, following the meth-
ods used in [91]. However, the estimation often fails in practice due to particle collapse.
Namely, since parameters are static, once they have been sampled initially, their value
cannot change. Resampling then results in the multiplication of only a few high-weight
particles, leading to a loss of diversity among samples, and, ultimately, to a collapsed
representation of the posterior. This phenomenon often appears when using particle
filters, and is also called particle degeneracy and sample impoverishment [92].
There have been two approaches proposed in the systems biology literature to deal
with this problem. A pragmatic, brute-force approach advocates using very high sample
sizes and peta-scale parallel computing to get satisfactory results [93]. However, this
approach does not address the root cause of particle collapse, the fact that parameters
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are static. Another possible approach to avoid particle collapse is to add random noise
to the particles at each step of the filter. This can help in introducing diversity since the
resulting particles will be spread to different positions randomly. In the context of ODE
pathway models, injecting noise was recently proposed in [94], adopting a method origi-
nally proposed in [95]. However, this method disrupts the estimate, since the randomly
generated noisy particles are no longer distributed according to the posterior. This can
lead to biased and inaccurate estimates.
To overcome these limitations we propose to use an improved particle filter, which
relies on applying a Markov transition kernel on the particles at each step [96]. The
method works by iterating over the (potentially collapsed) particles and proposing a
randomly generated new position. Then, the posterior probability of the current and
the proposed particle are compared, and the proposal is either accepted or rejected
according to an acceptance probability. The kernel (the combination of proposal and
acceptance) is designed in a way that the new samples are still distributed according to
the true posterior distribution.
We use case studies to show that the kernel-enhanced particle filter approach gives
more accurate estimates under parameter uncertainty than other methods previously
used for ODE based pathway models. A limitation of previous results on particle filters
for pathway parameter inference was that their performance was evaluated based on
tight convergence to the nominal model parameters. Arguably, this is not an adequate
basis of evaluation, since the goal of the inference task is finding the posterior distribution
representing the uncertainty in parameter values, rather than finding a single best value.
We address this by using the accuracy in making predictions according to the parameter
posterior as a valid basis of comparison between particle filters. Intuitively, a better
particle filter will provide estimates with smaller bias and lower variance with a given
sample size.
In our case studies, we first construct a small synthetic example to illustrate the
limitations of previously used particle filters in pathway parameter inference, and show
that the kernel-enhanced particle filters are more robust due to their ability to recover
from particle collapse. Next we use a model of the JAK-STAT signaling pathway (a
commonly used benchmark model for Bayesian inference) and evaluate Bayesian pre-
dictions about quantities of interest. We show that using an equal number of particles,
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predictions are made with much higher accuracy using kernel-enhanced filters than with
other particle filters. The significantly increased efficiency holds even when factoring
in the additional computational cost of performing kernel steps. Due to their accuracy
and efficiency, using kernel-enhanced particle filters will make parameter inference more
realistic for ODE based pathway models, and could lead to a wider adoption of Bayesian
inference in this context.
In the next section we define the basis of sequential Bayesian estimation and particle
filters and discuss how they have previously been used in the pathway modeling con-
text. Section 3.3 introduces the kernel-enhanced particle filter and proposes schemes for
implementing it on pathway models. We then evaluate the performance of our particle
filters and compare it to previously proposed ones in Section 3.4.
3.2 Background and previous work
In this section we establish the basis of using particle filtering for inferring the distribu-
tion of pathway model parameters. We first give a state space formulation of the ODE
model, and then introduce sequential inference methods for recovering the parameter
posterior. We also introduce previous works using sequential Bayesian inference, and
specifically particle filters, in the setting of pathway models.
3.2.1 Pathways as state space models
We introduced ODE models of biological pathways in Section 2.2.1. The basis for
performing sequential Bayesian estimation on ODEs is formulating the equations as a
discrete time state space model [97]. In a standard ODE model only the state evolution
is described. Measurements are regarded as external data, to which some model outputs
can be fit through distance measures, such as squared error distance. As opposed to
this, the state space model includes both the state evolution and observations as part
of a single probabilistic model. Since information about the state is only available
through observations, the state transitions are modeled between the available discrete
observation times, resulting in a discrete time description of the dynamics. Assume that
observations are available at time points t1, t2, . . . , tT . We will use the discrete time
index n ∈ {1, 2, . . . , T} to denote the observation at time tn as yn := y(tn). The same
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discrete indexing is used for the system state, that is, xn := x(tn).
The state space model is formally stated as
x0 ∼ p0(x) (3.1)
xn ∼ p(x|xn−1, θ)
yn ∼ g(y|xn).
Here, xn and yn are random variables representing states and observations, θ ∈ Rd is
a vector of d model parameters, p0 is a prior distribution, p(x|xn−1, θ) is the transition
model and g(y|xn) is the observation model.
The state space model will be able to represent a general class of deterministic and
stochastic dynamical models including ODEs, DTMCs, CTMCs and SDEs. ODE models
constitute a special case, since their dynamics are deterministic, and the transition model
p(x|xn−1, θ) needs to be expressed using the ODE equations. We will make use of Fθ,
the flow of the ODEs [27] to construct the state transition between successive time
points under the parameter vector θ. Fθ is a function R× Rdx → Rdx , where dx is the
number of state variables of the ODE, and is defined as
Fθ(t,x) = x +
t∫
0
F (x(τ), θ)dτ, (3.2)
where F is the right hand side of the ODE. With this choice, we have
xn := Fθ(tn − tn−1,xn−1). (3.3)
As a consequence of the discrete-time nature of this model, there are several in-
dependence assumptions that hold. First, the state xn is independent of all previous
states given the state xn−1. The states, therefore, form a Markov chain. Further, the
observation yn is independent of all other observations and states given the current
state xn. The independence assumptions in this description are intuitively captured by
a probabilistic graphical model, in particular, a hidden Markov model. We note that
HMMs have traditionally been used in a discrete state space setting, however, here we
follow the sequential state estimation literature, where the name is used for both dis-
crete and general state spaces [89]. Algorithms on the HMM allow us to reconstruct the
distribution of the hidden sequence of states given observations. Here our goal will be
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to use such algorithms to infer the value of the model parameters. This motivates us to
formally treat model parameters as part of the system state. We augment the system
state x with θ and introduce the notation s = (x, θ) to refer to the joint state-parameter
vector.
Using this formalism, even though the model parameters are static, they are formally
endowed with temporal dynamics. We introduce a time index on θ to represent its value
at time n as θn. We can extend (3.1) to include the process describing the parameter
dynamics as
θ0 ∼ p0,θ(θ) (3.4)
θn = θn−1.
The ODE flow F and the observation model g can be extended to the joint state s in
the obvious way. This formulation is shown as a graphical model in Figure 3.1.
θ0 θ1 · · · θn−1 θn · · ·
x0 x1 · · · xn−1 xn · · ·
y1 yn−1 yn
Figure 3.1: State space model with dynamic parameters.
This model structure is crucial since it allows us to infer the value of the parameters
sequentially. In the following section, we show how to infer the hidden states and
parameters of the system.
3.2.2 Sequential filtering
In this section we introduce filtering, a method to infer the hidden state of the model
conditioned on the observations up to time n. We use the notation y1:n to represent the
set of observations from time 1 to time n. The goal of sequential inference is to recover
the posterior distribution of the state at time n, written as pi(sn|y1:n), for n ∈ {1, . . . , T}.
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Here the first equation is the prediction step which constructs the distribution of the
state at time n based on the previous posterior and the transition model. The new
observation yn is only introduced in the second, update step, where the likelihood of
the new measurement based on the predicted state is taken into account to construct
the posterior at time n.
In general, the equations (3.5) cannot be solved analytically. This is due to the fact
that the state transition is usually non-linear and the likelihood may not be Gaussian.
Several algorithms have been developed to solve the filtering problem [62]. Each one
has different assumptions about the transition and observation model.
The Kalman filter [98] assumes linear dynamics, and a linear observation model with
Gaussian noise. In this case the posterior is guaranteed to be Gaussian, and there is a
closed form solution to the filtering equations. The extended Kalman filter (EKF) [99]
was proposed to deal with non-linear dynamics. It relies on first-order linearization at
each discrete time point where an observation is available, and the propagation of the
Gaussian approximation via the linearized dynamics. The EKF can work well in prac-
tice, but only when the observation frequency is very high, and therefore the estimate
converges despite linearization. The unscented Kalman filter (UKF) [100] further relaxes
the assumptions by representing the Gaussian posterior using a deterministically placed
set of points (called sigma points) around a mean value. These points are propagated
using the true system dynamics, and the mean and covariance of the next posterior is
calculated from the empirical moments of the points.
Particle filters (PF) assume a fully sample based representation of the posterior,
and implement sampling schemes to directly approximate (3.5). Importantly, they work
without restrictions on the transition or observation model. Further, (as a general
property of Monte Carlo methods) the accuracy of particle filter estimates does not
directly depend on the dimensionality of the posterior.
Several sequential Bayesian inference methods have been used in the context of
pathway models. The extended Kalman filter [101, 102] and unscented Kalman filter
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Name Transition model/noise Observation model/noise Posterior
Kalman Filter (KF) Linear/Gaussian Linear/Gaussian Gaussian
Extended KF (EKF) Differentiable/Gaussian Linear/Gaussian Gaussian
Unscented KF (UKF) Non-linear/Gaussian Non-linear/Gaussian Unimodal
Particle Filter (PF) Non-linear/Arbitrary Non-linear/Arbitrary Non-parametric
Table 3.1: Recursive Bayesian inference methods on hidden Markov Models
[103] have been applied to parameter estimation in non-linear pathway models. The
local linearization employed in the EKF can cause the filter to diverge [101], thereby
making it necessary to use traditional parameter estimation methods in addition to
filtering. While the UKF is more robust to nonlinearity in the transition model, there is
still no guarantee against divergence, as shown, for instance, in [94]. In addition, both
EKF and UKF produce a unimodal posterior, uniquely characterized by a mean and
covariance matrix, which is not more informative than maximum likelihood parameter
estimates with local sensitivities. As we will also see from case studies in Section 3.4, the
parameter posteriors will often be far from Gaussian. The covariance-based posterior
representation of EKF and UKF can also degrade in high dimensions, since it requires
a matrix of size d2θ for dθ parameters. We therefore focus on particle filters for the
parameter inference task.
The introduced sequential inference techniques are summarized in Table 3.1. The
next section introduces particle filters in more detail and discusses how they have been
applied in pathway modeling.
3.2.3 Particle filters
Particle filters approximate a sequence of probability distributions using sampling tech-
niques. Their flexibility, efficiency in high-dimensions, and applicability in on-line tem-
poral settings made particle filters essential in fields including finance, [104] robotics
[105] and geophysical science [106].
The main idea behind particle filtering is to represent a sequence of probability
distributions by a set of N random samples called particles. Each particle si has an
associated weight wi, i ∈ {1, 2, . . . , N}. These samples can be used as a discrete support





where δ denotes the Dirac-delta function. Perhaps the most important feature of this
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representation is that the particles need not conform to a grid or be spaced according to
a parametric rule. This allows particles to concentrate in the most important regions of
the distribution they represent. Therefore all resources can be allocated to those parts
of a distribution that matter most and parts that contribute less to the probability
mass are ignored. This sparsity is an especially important trait when representing high-
dimensional distributions.
The objective of particle filtering will be to solve the predict-update equations in
(3.5) without explicitly having to compute the integrals involved therein. In order to do
this, a sampling procedure is given, which ensures that particles in the posterior at time
point n will be approximately distributed according to pi(sn|y1:n), that is, the posterior
with observations up to n.
The filter starts by sampling N particles from the prior, and the weights are initial-
ized uniformly. The particles are each propagated according to the model dynamics to
the next time point, where their weight is updated based on the likelihood of the current
observation. As the filter progresses in time, some of the particles can gradually accu-
mulate very low weights. This means that those samples are not in the high-probability
regions of the posterior density. Weight degeneracy can be assessed by quantifying how
far the distribution of weights is from being uniform. A commonly used measure is the















n is the normalized weight. A low effective sample size means
that most of the samples are located in low-probability areas. This motivates us to
eliminate the low-weight particles, and instead, allocate more resources to the promising
high-weight particles. Resampling achieves just this goal by taking N samples from the
multinomial distribution defined by the weights. More precisely, we resample a new set
of particles skr , k ∈ {1, . . . , N} with replacement where the probability of skr taking the
value of si is P (skr = s




n. Several resampling schemes have been
proposed in the literature that have better variance properties than simple multinomial
resampling. These include residual, stratified and systematic resampling [92]. We found
that the choice of resampling algorithm has little effect on the quality of the results in
our case studies, and therefore do not discuss these in more detail.
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Algorithm 1 shows the basic, most commonly used form of the particle filter, which
is also called the bootstrap filter [108].
Algorithm 1 Basic particle filter
Input: Number of particles N , measurements Y = y1:T , resample threshold κ
Output: Set of particles siT , i ∈ {1, . . . , N}
1: Sample initial particles from prior si0 ∼ p0(s), and set wi0 := 1/N , i ∈ {1, . . . , N}
2: for n=1. . . T do
3: for i=1. . . N do
4: Propagate particle sin := F(tn − tn−1, sin−1)




7: if Neff < κN then





9: Set win := 1/N , i ∈ {1, . . . , N}
10: end if
11: end for
Using this basic particle filter for parameter inference in state space models has first
been introduced in time series analysis [109]. The same idea has been applied for hy-
brid functional Petri-net (HFPN) models of biological pathways in [91] and [110]. This
method has been implemented in the graphical tool DA1.0 with many useful functional-
ities [13]. However, these methods suffer from sample impoverishment due to repeated
resampling, resulting in a collapsed representation of the parameter posterior. Since
resampling involves duplicating particles exactly, in the worst case, the particle filter
can end up with N particles all being the exact copy of a single one. This is especially
severe when the state evolves with degenerate dynamics, as in the case of static param-
eters. One pragmatic solution offered in [93] is to simply increase the sample size and
use massive parallelization to avoid particle collapse. A better solution to this problem
would be crucial for getting a good approximation to the posterior with limited sample
size.
In the context of ODE parameter inference, [94] proposes injecting noise as a way to
spread particles at each step of the filter. Following [95], a multivariate Gaussian random
vector θ′ ∼ N (θin,Σ) is picked around each particle thereby diversifying the otherwise
static parameters carried by the particles. The main problem with this approach is that
the perturbed parameters will generally not be distributed according to the posterior
pi(sn|y1:n). This can lead to biased and inaccurate estimates. Our goal in Section 3.3
will be to use a method of particle diversification, which overcomes these limitations.
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3.2.4 Making predictions and evaluating particle filters
The goal of particle filtering is to construct a representation of a complicated posterior
distribution such that accurate predictions can be made with respect to it. A prediction
can be formalized as the expected value of a measurable function f : Θ→ R with respect
to the parameter posterior pi, where Θ is the space of parameters. This expectation can





Having a set of particles si = (xi, θi) with associated weights wi, i ∈ {1, . . . , N}, the
expectation can be approximated by a simple weighted average over predictions made
by each particle [92] as







Here f is only a function of the parameters θ since the model is deterministic. This can
also be understood as an instance of Bayesian model averaging, where each particular
choice of parameters is a possible hypothesis, and we are averaging over predictions
made by each choice.
The theoretical convergence results that exist for particle filters are also understood
in terms of such predictions. It is shown in [90] that limN→∞ ÊN = Epif with probability
1 for any bounded function f .
There is a wide variety of predictions we can make in this context. One obvious
choice is f(θ) := θ, in which case the mean of the parameter vector is calculated. The
prediction can also be on any of the state variables, based on the result of simulating
the system with θ. For instance, the peak level of activity of a protein, or the level it
settles at after a certain period of time may be of interest. We can also construct f to
express whether the system, when simulated with θ, satisfies a property expressed in
temporal logic (similar to the method in Chapter 4).
In the systems biology literature, the performance of particle filters [13, 94] and
other sequential Bayesian parameter inference methods [103, 102] has been studied with
a criterion other than the above. Namely, the criterion for showing that these methods
work in [94, 103, 102] was by assuming a nominal parameter vector θ∗, generating
synthetic measurement data with respect to θ∗, and showing that the mean or mode
of the distribution of particles is close to θ∗. In [13], evaluation is done based on the
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match of the maximum aposteriori parameter to the measurement data. These are
both criteria appropriate when the goal is parameter estimation rather than parameter
inference. The performance criteria have not revealed how accurately predictions are
made with respect to the Bayesian posterior which is being approximated. In our case
studies (see Section 3.4), we will use measures that quantify the prediction accuracy of
particle filters for parameter inference.
3.2.5 Summary
We reviewed a state space model formulation of ODE based pathway models. The state
space formulation allows us to infer hidden states and parameters sequentially by as-
similating observations iteratively in time, using the recursive predict-update equations.
We then discussed existing sequential inference methods including KF, EKF, UKF and
particle filters, and argued that particle filters are the appropriate method in this set-
ting. Particle filtering in its basic form (Algorithm 1) can be used to infer a parameter
distribution, but sample impoverishment often leads to degenerate estimates in practice.
The methods previously proposed to alleviate this problem when performing ODE path-
way parameter inference have important limitations. Finally, we showed how Bayesian
predictions can be made using particle filters, and argued that the accuracy of these
predictions is an appropriate basis of comparison between different methods.
In the next section we propose methods for inferring pathway parameters based on
the application of Markov transition kernels on the particles. The transition kernel is
designed to be consistent with the underlying posterior, and will achieve diversification
without adding disruptive noise.
3.3 Kernel-enhanced particle filter algorithms
In what follows, we introduce methods for dealing with sample impoverishment in par-
ticle filters. The goal is to diversify samples by spreading them randomly, but in a way
that the posterior distribution (which we want to approximate) is preserved. This is
possible by applying, to each particle, a Markov transition kernel, which is invariant to
the posterior. The use of Markov transition kernels on particles was first proposed in
the context of target tracking [96] and signal processing [111], and later extended to
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static variables in [112]. Here we adapt the idea of using kernel steps to the setting of
parameter inference in ODE based pathway models.
Generating a new particle s′ according to kernel K is expressed as s′ ∼ K(·|s),
where s is the original particle. The key is to design K as a Markov transition kernel
with stationary distribution identical to the target posterior pi. Since it is hard to
directly sample from such a kernel, we design the kernel in two steps, a proposal and an
acceptance step.





the ith particle representing the joint state-parameter vector at time n. Since our
model is deterministic, xin is a deterministic function of θ
i
n, through the ODE solution:
xin = Fθin(tn,x(0)) =
∫ tn
0 F (x(τ), θ
i
n)dτ . Therefore, when proposing a new position for
the particle, s′, we will design a kernel move for the parameters only, and then set the
states accordingly as a function of the parameters. Denote the proposal distribution by
q(s→ s′), meaning the probability of proposing s′ when the current particle is s. Then,




n), we propose s






θ′ ∼ q(θin → θ′)
x′ := Fθ′(tn,x(0))
−→ s′ = (x′, θ′).
Here the notation q(θin → θ′) for the proposal is meant to highlight that q is only applied
on θ. However, from now on we will denote the proposal as q(s → s′), and understand
that only the parameter is newly proposed by the kernel, and the associated state is set
accordingly using simulation.
The acceptance step has to account for the fact that the proposed particle was picked
from q, but our goal is to sample from pi. We can achieve this by either accepting or
rejecting the new particle. Denote the probability of accepting the new particle as
α(sin → s′). We need to find α such that the detailed balance holds with respect to pi
[113]. The detailed balance ensures the symmetry of transition between s′ and sin with
respect to pi, and is written as
pi(s′|y1:n)q(s′ → sin)α(s′ → sin) = pi(sin|y1:n)q(sin → s′)α(sin → s′). (3.10)
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One choice of α, which trivially satisfies (3.11) was introduced by Metropolis and Hast-
ings [114], and is written as



















There are several important properties to note in (3.12). Due to the fact that only the
ratio of the posterior probabilities is needed, we can ignore the normalization constant
and directly write the ratios of the prior times the likelihood (second equation). It is
clear that to evaluate the acceptance rate the likelihood of both s′ and sni needs to be
calculated up to time n. To avoid simulating sni multiple times, it is possible to save
the likelihood values up to n during the filtering process. In case of the new particle
s′, the proposal itself involves simulating x′ based on the proposed θ′, and allows us to






where the likelihood of the particle only depends on the state, that is, g(yk|s′k) =
g(yk|x′k), and x′k = Fθ′(tk,x(0)) is the state at time k simulated using θ′.
3.3.1 Particle filter algorithm with kernel steps
We now present the main algorithm of this section, the particle filter with kernel steps.
Algorithm 2 uses the proposal q in a generic form. There are many different choices for
a proposal distribution, and the choice can have a significant effect on the performance
of the algorithm. In the next section, we suggest choices that are expected to work well
for pathway models.
3.3.2 Sampling strategies
Here we look at possible ways of proposing new particles based on the current ones.
Due to weighting and resampling, the existing particles (even if collapsed) will generally
42
Algorithm 2 Kernel-enhanced particle filter
Input: Number of particles N , measurements Y = y1:T , resample threshold κ
Output: Set of particles siT , i ∈ {1, . . . , N}
1: Sample initial particles from prior si0 ∼ p0(s), and set wi0 := 1/N , i ∈ {1, . . . , N}
2: for n=1. . . T do
3: for i=1. . . N do
4: Propagate particle sin := F(tn − tn−1, sin−1)




7: if Neff < κN then





9: Set win := 1/N , i ∈ {1, . . . , N}
10: end if
11: for i=1. . . N do
12: Propose θ′ ∼ q(θin → θ′) and simulate with θ′ to get x′
13: Set s′ := (x′, θ′)
14: Evaluate acceptance rate α(sin → s′)
15: Generate η ∼ Uniform[0, 1]
16: if η < α(sin → s′) then





be concentrated in higher probability regions. Therefore it makes sense to propose the
kernel moves based on the current set of particles. In each case, we need to derive an
appropriate acceptance rate to account for the fact that the proposal distribution is not
equal to the posterior.
Particle based fixed proposal
The first kernel we consider involves a Gaussian proposal of predetermined width around




n), the proposal would
be θ′ ∼ N (θni ,Σ). Here Σ is the covariance matrix of the proposal. The entries of
the covariance matrix can greatly affect its efficiency. Namely, for a covariance matrix
with small entries, the random proposal will be close to the original particle. This will
typically result in high acceptance rates, but the resulting particles will still cluster
around the original ones. Larger variance terms will imply lower acceptance rates but
potentially more diversification. In our case studies we set the diagonal values of Σ
proportional to the prior range of each unknown parameter (in case of normal and
log-normal priors it can be set proportional to the prior variance of each unknown
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parameter).
The proposal in this case is clearly symmetric, that is, q(s → s′) = q(s′ → s) and
therefore the acceptance rate simplifies to the ratios of priors and likelihoods as








We will refer to this method as PF-KGAUSS.
Adaptive proposal towards population mean
The previous method could have the disadvantage that proposed moves are clustered
around the existing individual particles. Further, the variance entries in the proposals
need to be set based on prior knowledge or tuned manually. It is possible to exploit
the population of particles to build adequate proposals. Namely, we can calculate the
population mean and variance of the particles, and use this information in the proposal.
This idea appeared in [95] and [94], but there it was used as a method to inject random
noise, rather than as a proposal step for a Markov kernel.
























The idea is to propose new parameters such that the mean of the proposal is shifted
towards the population mean, and the variance of the proposal is scaled according to




n + (1− a)µˆn (3.17)
θ′ ∼ N (µin, h2Σˆn), (3.18)
where a = (3δ − 1)/2δ, h2 = 1 − a2, and δ ∈ (1/3, 1) is a discount factor [95]. This
construction is appealing, since it preserves the original empirical mean and variance
(µˆn and Σˆn) [115]. Further, δ is the only parameter which needs to be chosen by the
user. Generally the value of δ, as recommended by [95], is chosen around 0.95− 0.99.
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To adapt this proposal for our kernel based setting we need to derive an acceptance
rate, which guarantees the preservation of the posterior. In this case the proposal around
the original parameter is not symmetric, since it is shifted towards the population mean.
Consequently the ratio of proposal probabilities in (3.12) cannot be eliminated. The





′ + (1− a)µˆn, h2Σˆn)
φ(θ′; aθin + (1− a)µˆn, h2Σˆn)
, (3.19)
where φ(x;µ,Σ) is the value of the multivariate normal density function with mean
µ and covariance Σ, evaluated at x. This ratio will need to be used in (3.12) when
calculating the acceptance rate.
We will refer to this method as PF-KSHIFT.
Adaptive population based proposal
It is also possible to build a proposal only based on the population mean and variance.
The only way the proposed particles will depend on the original ones (and guaranteed to
still be distributed according to the posterior) is through the acceptance rate. Recall the
population mean and variance from (3.15) and (3.16). A new particle can be proposed
as
θ′ ∼ N (µˆn, Σˆn). (3.20)
Each proposed particle will still be accepted or rejected with respect to its corresponding
θin. Here, again, the proposal is not symmetric, and the proposal ratio appearing in the







where, again, φ(x;µ,Σ) is the value of the multivariate normal density function with
mean µ and covariance Σ, evaluated at x.
We will refer to this method as PF-KPOP.
3.3.3 Computational cost
Performing kernel steps requires additional computation since the acceptance rate cal-
culation involves simulating the newly proposed particle. The basic particle filter does
not use this step, and is, therefore faster.
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Assume that the total number of particles is N , and that data is available at T uni-
formly spaced time points. The dominating computational cost of running the particle
filter is the numerical simulation of ODEs. We will assume that the ODE solver has a
linear time complexity, that is, solving the ODE equations for n time steps takes O(n)
time. The basic particle filter propagates particles sequentially from time n to n + 1,
for n = 0, 1, 2 . . . T , meaning that each particle is simulated once up to T , resulting in a
computational cost of O(NT ).
The kernel-enhanced filter, on top of the cost of the basic filter, will perform ad-
ditional steps. At each time step n, one needs to simulate the N newly proposed
particles from the initial time up n. For one iteration this is an additional cost of




2), resulting in a total cost of O(NT 2) to run the filter. This
implies that the kernel-enhanced methods will have increased computational cost if mea-
surements are available at many time points. However, there are several other arguments
to consider.
First, as the number of measurement points increases, the additional information
gain from each data point will generally decrease. From the perspective of particles,
this means that the effective sample size will change slowly across time steps. This
implies that one could also decrease the frequency of kernel steps without degrading
performance. In particular, if the frequency of kernel steps is set proportional to the
simulation time rather than the number of measurement time points, then the original
O(NT ) cost is preserved.
Second, the accuracy of making predictions with a fixed number of particles is more
important than the time needed to run the particle filter. This is because generally,
the particle filter is ran once, and the particles are saved as a representation of the
parameter posterior for later use. Any prediction, which involves simulation, that is
made subsequently with the particles, will have a cost linear in N . Therefore we argue
that it is better to run the particle filter once, with higher computational cost, if the
stored particles will subsequently give more accurate predictions.
A more practical argument, also made in [13], is that increasing the number of
particles is limited by the available memory. There is more flexibility in increasing
processing time with a fix particle number, especially if a multi-threaded architecture is
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available. Accuracy with a limited number of particles will be even more important when
considering a GPU implementation of the particle filter [116], which is a memory-limited
environment.
Finally, as our case studies in the next section show, kernel-enhanced filters can reach
the same accuracy as the basic particle filter with significantly reduced sample size, and
this makes up for the additional time needed to run the filter.
3.4 Case studies
First we construct a small, synthetic example to show the robustness of kernel-enhanced
methods compared to other particle filters. Then we use a model of the JAK-STAT
pathway to compare different particle filters in making predictions with respect to the
Bayesian posterior. This model has been used in several works related to Bayesian infer-
ence including evaluating unscented Kalman filters [103], as well as Bayesian uncertainty
analysis and experimental design [117, 118]. Its use in the Bayesian inference context as
a benchmark is due to the fact that there is considerable parameter uncertainty given
the available experimental data. It is also relevant since wet-lab experimental data has
been published for the model, allowing computational methods to be evaluated in a
realistic setting.
We evaluate the three proposed kernel-enhanced particle filters, PF-KGAUSS (Gaus-
sian proposal around each particle), PF-KSHIFT (proposal shift towards population
mean) and PF-KPOP (proposal from population distribution), and compare these meth-
ods with ones previously used for pathway parameter inference. PF-BASIC is the basic
particle filter shown in Algorithm 1. PF-NGAUSS injects noise into the parameters by
moving them randomly using a multivariate Gaussian (similarly to PF-KGAUSS, but
without the acceptance step). PF-NSHIFT implements the noise injection method pro-
posed by Liu and West [95], and is the basis of the kernel-enhanced PF-KSHIFT method
(see Section 3.3). For all particle filters, resampling was done only when the effective
sample size was below N/3, where N is the number of particles. We implemented PF-
NGAUSS and PF-KGAUSS with an uncorrelated Gaussian around each particle whose
standard deviation along each parameter dimension was equal to 0.2 times the range of
the parameter. For the PF-NSHIFT and PF-KSHIFT methods, we set the parameter δ
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to 0.95. The CVODE stiff solver was used to numerically solve ODEs [31]. We exploited
the property that particles can be propagated in parallel, and ran all experiments on 12
cores with 2.27GHz Intel Xeon CPUs.
3.4.1 Enzyme-substrate process
An important limitation of the basic particle filter is that the parameters, sampled
initially, only get resampled, but their value does not change over time. Once a particle
is eliminated due to resampling it cannot be recovered, even if subsequent measurements
would assign higher probabilities to it. Noise injection based methods do have the
potential to recover from such a situation, but the random nature of perturbing particles
will decrease their efficiency. We expect that the kernel-enhanced methods, through the
principled diversification of particles according to the posterior, will show much better
robustness.
We illustrate this on a small, synthetic example of an enzyme catalyzed reaction
consisting of 4 species and 3 parameters. The model represents an enzyme which binds
to a substrate reversibly, and then releases a product, which accumulates over time. The
ODE equations are given in Figure 2.3 (Section 2.2.1). We set the parameters k1 = 0.1,
k2 = 0.1 and k3 = 0.35, and set the initial conditions of substrate to 15 and enzyme
to 10 units. A uniform prior distribution was assumed over the parameters, with the
ranges for parameters being k1, k2, k3 ∈ [0, 1]. We generated synthetic experimental data
with the nominal parameters for the product concentration [P ] at the equally spaced
time points 1, 2, . . . , 10, and added zero-mean Gaussian observation noise with standard
deviation of 0.5.
We then perturbed the measurement of the product at time 1 by adding a uniform
random number to it between 4 and 5. This perturbation has little effect on the overall
likelihood landscape. However, it can have a huge effect on the performance of particle
filters. This is because the filters progress forward in time and resample particles based
on the likelihood of the current measurements. Hence the first measurement point could
result in particles being early on resampled in a region which is not representative of the
overall posterior. This leads to particle collapse from which the particle filter should,
ideally, recover.
We ran each type of particle filter 200 times, independently, with 100, 1000 and 10000
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particles. We quantified how well the resulting particles fit the measurements through
the trajectory likelihood p(y1:T |si), where y are the measurements, T = 10 and si is the
ith particle. We calculated the logarithm of the mean of the trajectory likelihoods for
each run and plotted these values across 200 runs in Figure 3.2 (top). Here the interval
between the 5% and 95% quantile of log-likelihood values is shown.
To categorize which particle filter runs could “recover” after particle collapse and
converge to the high-probability region of parameter space, we set a threshold on the
trajectory log-likelihoods at −50 and calculated the percentage of runs which ended
above this threshold. We show the percentage of runs in which the particle filter could
recover and converge in Figure 3.2 (bottom).
The basic particle filter performs poorly, and even with 10000 particles, the log-
likelihoods are below −100. This is not surprising since the basic filter can only initially
sample and then resample particles; there is no mechanism to move them towards bet-
ter regions of parameter space upon particle collapse. Conversely, PF-KGAUSS and
PF-KPOP consistently achieve a log-likelihood above −25, and PF-KSHIFT behaves
similarly for larger particle numbers.
The noise injection based methods could in some cases converge to the correct region,
but not as consistently as kernel based methods. Investigating the relatively weaker
performance of PF-KSHIFT compared to the other two kernel based methods revealed
that after resampling in the first time step, the kernel proposal had very low variance,
and resulted in slower diversification. PF-KGAUSS and PF-KPOP had wider variability
in the proposal steps, which resulted in a faster and more consistent recovery.
In Figure 3.3, simulations are shown based on the result of different particle filter
methods (with 1000 particles). The gray shading shows the 5% to 95% quantile of
simulation trajectories. It is clear that PF-BASIC produces a collapsed estimate, that
is, only very few distinct particles remain due to resampling. PF-NSHIFT shows more
diversity but does not converge to the high-probability region, and while PF-NGAUSS
does converge, it has larger variability than the level of measurement noise would suggest.
The kernel based methods show good convergence and their spread is consistent with
the noise level of measurements. The spread of particles at each time step of the basic





























































Figure 3.2: Performance of particle filters on the model of an enzyme-substrate process.






















































Figure 3.3: Fit of 1000 particles to measurements of an enzyme-substrate process with
different particle filter methods. Gray shading corresponds to the 5% to 95% quantile
covered by particle trajectories, according to particle weights. Circles with error bars
show the measurement data. Dashed lines correspond to weighted mean and median
trajectories.
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3.4.2 The JAK-STAT pathway
In this section we compare the performance of particle filters on a model of the JAK-
STAT signaling pathway.
The JAK-STAT signaling cascade is initiated by erythropoietin (Epo), which, when
bound to a receptor, induces the phosphorylation of STAT protein in the cytoplasm.
Phosphoylated STAT dimerizes and enters the nucleus where it alters gene expression.
Subsequently the nuclear STAT goes through dissociation and dephosphorylation and
is transported back into the cytoplasm (see also [118]). The species in the model are




Epo Erythropoietin, input stimulus 2.0
STAT Unphosphorylated STAT monomer in cytoplasm 0
STATp Phosphorylated STAT monomer in cytoplasm 0
STATpd Phosphorylated STAT dimer in cytoplasm 0
STATn Total STAT in nucleus 0
X1 . . . XK Represent delay in STAT exiting nucleus (we use K = 10) 0




























= k4[Xi−1]− k4[Xi] , j = 2 . . .K
d[STATn]
dt
= k3[STATpd]− k4[XK ]
Figure 3.4: ODE model of the JAK-STAT pathway under Epo stimulation.
The variables in the model and the 4 kinetic rate constants (θ = (k1, k2, k3, k4))
cannot be directly measured. However, experimental data for two indirect quantities
(total phosphorylated STAT, and total STAT in cytoplasm) has been published in [119].
The experiments report the mean and standard deviations of these two quantities at
17 time points. Figure 3.5 shows the experimental data. We use Gaussian likelihood
(based on the measurement means and standard deviations) when comparing the data to
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simulated trajectories. A uniform prior distribution over a range of possible parameter
values is chosen as p0 : k1 ∼ U [0, 5], k2 ∼ U [0, 30], k3 ∼ U [0, 1], k4 ∼ U [0, 5].






















Total STAT in cytopl.
Figure 3.5: Experimental data for the JAK-STAT pathway [119]. The Gaussian likeli-
hood is evaluated using the shown data points and standard deviations.
Prediction accuracy
In order to compare how accurately the different particle filters make predictions, we
needed to establish a reference, “ground truth” estimate. We chose a simple, impor-
tance sampling based estimate with very high sample size as reference. This method
involves first sampling independently from the prior as si ∼ p0(s), and then calculating








where f is the function being predicted. By the strong law of large numbers, this estimate
will be consistent, that is Epif = limN→∞ ÊN . Naturally, this method of estimation is
not efficient in general since many samples will come from low-probability regions. But
we found that with a sample size of at least 106, the estimate has small enough variance
around its mean to serve as a good reference. To this end, we ran importance sampling
100 times with a total of 106 samples, and averaged out the ÊN values across runs to
obtain the reference value.
We then ran each particle filter repeatedly, with a range of particle numbers and
stored the resulting particles in order to evaluate multiple predictions. As an illustra-
tion of the result of the particle filter algorithm, we plot particles obtained in a single
execution for each considered method. Figure 3.6 shows the positions of 1000 particles in
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parameter space obtained using the different particle filters. The kernel-based methods
show good diversity among samples and indicate that the high-probability regions are
clearly represented. The basic particle filter degenerates and only 3 distinct particles
remain. The noise injection methods show significantly more diversity, while weights
are closer to uniform, indicating that predictions will be disrupted by samples that are
spread to lower probability regions. Similar properties are seen when plotting the sim-
ulation trajectories corresponding to the 1000 particles against the experimental data,




































































































































































































































































































































































































































−9 −8 −7 −6 −5 −4 −3 −2 −1 0
Figure 3.6: Scatter plots and histograms of 1000 particles with different particle filter
methods. The plot in row i and column j shows either the 2-dimensional projection of
particles on the parameters ki and kj if i 6= j, or the weighted histogram of a parameter
ki if i = j.
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Figure 3.7: Fit to experimental data with 1000 particles with different particle filter
methods. The plots for PF-KGAUSS and PF-KSHIFT are similar to PF-KPOP and
are given in the Appendix (Figure A.2).
In what follows, for each particle number (10 values between 100 and 100000), we
calculated statistics for 200 independent runs of each particle filter. We wanted to take
into account both the variance and the bias of our estimates, and therefore chose the
mean squared error (MSE) with respect to the reference as the measure of prediction
accuracy. We found that PF-NGAUSS gave very poor predictions compared to other
filters and therefore we chose to exclude it from the remaining results.
The first task we considered was estimating the mean of parameters k1, k2, k3 and
k4, whose reference values were estimated as 1.8213, 17.6235, 0.1531, and 2.4480, respec-
tively. The results in Figure 3.8 show the average MSE across 200 runs for PF-BASIC,
PF-NSHIFT and three kernel enhanced methods. We see that PF-NSHIFT, which in-
jects noise at each step of the filter results in a lack of convergence to the reference in
two cases (k1, k4). The PF-BASIC method has decreasing MSE as particle numbers
grow, however, the variance across runs is much higher than in the case of the kernel-
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enhanced methods (PF-KSHIFT, PF-KGAUSS and PF-KPOP), and hence its MSE is
consistently above the other methods.




































































































Figure 3.8: Estimating the mean of parameters k1, k2, k3, k4, showing the mean squared
error of estimates.
Similar differences in performance are found when considering the behavior of the
unobserved species in the pathway, as predicted by the particles. We made predic-
tions about the behavior of nuclear STAT, specifically, we were interested in the peak
amount of nuclear STAT reached within 60 minutes. The reference value, estimated
using importances sampling was 1.1895. The results in Figure 3.9 show that the kernel-
enhanced particle filters made accurate predictions even with very low sample sizes. The
PF-NSHIFT method did not converge to the true value as the number of particles was
increased. PF-BASIC showed decreasing MSE with growing sample size, but produced
predictions with around 2 orders of magnitude higher MSE compared to PF-KPOP.
Next we looked at how much STAT monomer remains in the cytoplasm, once Epo
stimulation has ended, at the 60 minute time point. The reference value for this estimate
was 1.5387. The results are shown in Figure 3.10. Again we found that PF-BASIC had
much higher MSE compared to the kernel-enhanced methods. PF-NSHIFT showed
decreasing MSE up to 20000 particles, but the MSE failed to decrease further with
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higher sample sizes.



























Figure 3.9: Estimating the peak amount of nuclear STAT, showing mean squared error
of estimates.


























Figure 3.10: Estimating the amount of cytoplasmic STAT monomer at the last time
point, showing mean squared error of estimates.
Sample size and runtime efficiency
In all cases we found that PF-KPOP provided the lowest MSE for a given number
of particles. We therefore compared the relative efficiency of particle filters with PF-
KPOP as a baseline. Specifically we looked at how many particles are needed with
a given method to reach the same MSE as PF-KPOP with 1000 particles. We used
interpolation on the mean square errors for each particle filter method to arrive at the
approximate number of particles needed to match the MSE of PF-KPOP. The results
are shown in Table 3.3. We see that PF-BASIC needs between 49.6 and 101.5 times as
many particles as PF-KPOP to reach the same accuracy. PF-NSHIFT is comparable to
56
PF-KGAUSS and PF-KSHIFT in 2 out of 6 predictions, but performs much worse on
predicting k3, and fails to converge in 3 our of 6 cases. In summary, the noise injection
method shows good performance in some cases but is not reliable for making predictions
in general.
Prediction PF-KPOP PF-KGAUSS PF-KSHIFT PF-NSHIFT PF-BASIC
k1 1000 8850 9671 * 101503
k2 1000 14585 8312 12532 95612
k3 1000 6285 5500 17274 49558
k4 1000 7880 4758 * 74438
Max. STATn 1000 6824 2986 * 82480
Final STAT 1000 4538 3744 5946 91006
Table 3.3: Estimated number of particles needed to reach same accuracy (MSE) as
PF-KPOP with 1000 particles. (*estimate not reliable since MSE does not converge)
The results in Table 3.3 mean that the kernel-enhanced methods, and in particu-
lar PF-KPOP have much better sample size efficiency than both PF-BASIC and PF-
NSHIFT, and PF-BASIC will need, on average 82.4 times the number of samples to
reach the same accuracy as PF-KPOP.
We have seen that the sample size efficiency of kernel based methods are much better
than other particle filters. This is important, since we are usually interested in finding
the best possible set of particles, for a chosen sample size, to represent the parameter
posterior. However, it is also important to consider the time taken to run the filter,
and as discussed in Section 3.3.3, kernel-enhanced methods will generally be slower due
to the additional cost of kernel steps. In Figure 3.11 we show the runtime of the PF-
BASIC and PF-KPOP methods for different particle numbers. The other methods are
not plotted, since the kernel based methods closely resemble PF-KPOP and the noise
injection methods are similar to PF-BASIC in terms of runtime. Clearly, the basic
particle filter is faster, and the ratio of runtimes for kernel based methods stabilizes at
around 5 times that of the basic particle filter.
To quantify the relationship between runtime and prediction accuracy, we calculated
how much time it takes to run each particle filter to reach the same accuracy as that of
PF-KPOP for 1000 particles. To do this, we referred to the estimated particle numbers
in Table 3.3, and then used these sample sizes to estimate the time needed to run each
particle filter. The results are shown in Table 3.4. The PF-KPOP method takes, on
average, 8.74 seconds with 1000 particles, and to reach the same accuracy, the PF-
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Figure 3.11: Particle filter average runtimes depending on the number of particles used.
The runtime of PF-NSHIFT matches PF-BASIC, and the runtime of PF-KGAUSS and
PF-KSHIFT are closely overlapped with PF-KPOP, hence they are not shown.
BASIC method will need 56.12 seconds on average. This means that, even though the
basic particle filter is faster, it needs 6.4 times the runtime to reach the same accuracy
as PF-KPOP due to the need for a much higher number of particles. The other kernel-
enhanced methods outperform the basic particle filter in all cases, but the results are
close, with PF-KSHIFT being somewhat better than PF-KGAUSS. Interestingly, the
noise injection method PF-NSHIFT performs only worse than PF-KPOP by a small
margin in 3 out of 6 cases, but in the other 3 cases it does not converge, and therefore
cannot reach the reference accuracy, even with very high sample size and runtime.
Prediction PF-KPOP PF-KGAUSS PF-KSHIFT PF-NSHIFT PF-BASIC
k1 8.74 39.6 38.3 * 70.6
k2 8.74 62.6 34.0 11.5 66.1
k3 8.74 28.2 25.0 13.3 31.3
k4 8.74 35.3 22.4 * 50.0
Max. STATn 8.74 30.6 14.4 * 56.1
Final STAT 8.74 20.8 17.8 9.0 62.6
Table 3.4: Estimated time needed (in seconds) to reach same accuracy (MSE) as PF-
KPOP with 1000 particles. (*estimate not reliable since MSE does not converge)
We finally summarize the overall sample size efficiency and runtime efficiency of each
particle filter compared to PF-KPOP. The sample size and runtime required by each


































































Figure 3.12: The relative number of particles (sample size) and runtime needed to match
the accuracy of PF-KPOP with 1000 particles. Sample sizes and runtimes are shown
relative to that of PF-KPOP, which is normalized to 1 to serve as reference. (* For
PF-NSHIFT, the cases where convergence did not occur are not included.)
3.5 Summary
In this chapter we proposed improvements on previously used particle filters for pa-
rameter inference in ODE based pathway models. The main issue with particle filters
is that the set of particles can collapse into a few distinct samples resulting in inaccu-
rate estimates. We proposed three variants of kernel-enhancement, in which, at every
time point, a Markov transition kernel is applied on each particle. This resolves the
problem of particle collapse while still guaranteeing that the true parameter posterior is
preserved. The kernel steps consist of a proposal, in which new particles are proposed
in random (but usually guided) directions. Then the ratio of posterior probabilities of
the old and new particles are compared to accept or reject each proposal. The accep-
tance or rejection is based on a formula that guarantees new samples to be distributed
according to the posterior. Hence diversification is achieved while preserving the target
distribution of the filter.
A small synthetic case study demonstrated that contrary to other particle filters, the
kernel-enhanced methods can robustly recover from a collapsed particle state. Our case
study on the JAK-STAT pathway has shown that predictions with the kernel-enhanced
particle filters result in significantly reduced mean squared error compared to the basic
particle filter, and particle filters relying on random noise injection. In particular, our
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case study showed that the kernel-enhanced particle filter relying on proposals from the
particle population statistics (PF-KPOP) was around 60 to 100 times more sample-size
efficient than the basic particle filter. Even when factoring in the additional runtime
cost to perform kernel-steps, the kernel-enhanced method achieved the same accuracy
around 4 to 8 times faster than the basic filter.
Representing the parameter posterior in terms of particles opens up several interest-
ing possibilities. For instance, it is possible to update the particles with new measure-
ment data, simply by running the filter up to the time point of the new measurement
and updating particle weights based on the corresponding likelihood value. This method
can also be used in experimental design since it allows us to test how the parameter
landscape (and, as a consequence, the uncertainty in predictions) changes when new
data points are introduced. Finally, particles could be used to select between multiple
alternative models based on Bayesian scores. Some of these tasks have been proposed in
the context of Bayesian inference [117, 118, 102, 9] but using methods other than par-
ticle filters. Using kernel-enhanced particle filters could make these tasks more realistic
in practice, since, as our case studies have shown, they give an accurate representation
of the parameter posterior with limited sample size.
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Chapter 4
Verification of pathway dynamics
under Bayesian uncertainty
4.1 Introduction
Analysis and verification is crucial for building reliable models of biological pathways.
Verifying a pathway model involves making statements about the intended behavior of
the pathway expressed in temporal logic. Model checking algorithms can then be used
to verify whether the model satisfies the specified properties [88]. Verifying properties
of a pathway model is especially challenging when the model has a component of uncer-
tainty. In this case manually examining simulation traces will not reveal properties of
the system. Statistically valid techniques are needed to formulate properties and check
whether they are satisfied with sufficiently high probability.
In this chapter we propose a novel method to verify properties of a model under
parameter uncertainty. We focus on ordinary differential equations (ODE) based mod-
els whose parameters are not exactly known and cannot be directly measured. Their
value can only be partially inferred from noisy and limited experimental data. As also
argued in Chapter 3, treating model parameters as random variables is reasonable in
this context. Using a Bayesian approach one can incorporate previous knowledge about
the parameter values through a prior distribution. The prior is then updated using the
likelihood of the observations to obtain a posterior distribution over the parameters.
The main contribution of this chapter is providing a framework for verifying properties
of a model characterized by such a Bayesian posterior distribution.
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The method proposed here provides an important link between two areas of systems
biology research. There is a growing body of work on Bayesian inference in systems
biology [59], meanwhile, there is strong interest in the formal verification of pathway
models [88]. However, the interface of the two areas has been largely unexplored. The
method proposed here is important in this context since it enables the verification of
an uncertain model with its possible realizations (corresponding to different parameter
values) weighted according to their support from prior knowledge and experimental data.
The approximate probabilistic verification of dynamical systems usually involves
simulating independent realizations of the system. However, under Bayesian parameter
uncertainty, sampling independently according to the posterior distribution is usually
not possible. Previously proposed statistical model checking methods [75, 74] require
that the samples are independent and are therefore not applicable in this context. Our
method provides a solution to perform statistical model checking when using dependent
samples from the parameter posterior distribution of an ODE model.
We propose a Markov chain Monte Carlo (MCMC) based statistical model checking
framework. The MCMC scheme produces a sequence of dependent random realizations
of the model dynamics over the parameter posterior. Using this sequence of samples, we
construct hypothesis tests to decide whether the model satisfies a temporal logic property
with at least a given probability. Two different hypothesis tests are introduced, with
one using an initially chosen fix sample size, and the other one making the decision
in a sequential and adaptive manner, based on the result of previous samples. Using
recent results from the theory of general state space Markov chains, we prove sample
size bounds for both hypothesis tests.
There is a strong connection between this chapter and Chapter 3 in that both address
parameter uncertainty in ODE based pathway models. In Chapter 3 we used particle
filter algorithms to obtain samples from the parameter posterior. Here we propose a
method to do model verification based on the posterior. In principle, one could use a
particle filter to obtain a representation of the parameter posterior and then use the
particles to perform model verification. Here, instead, we build on an MCMC method-
ology for several reasons. First, in the context of formal verification, an approximate
answer is only acceptable if it is based on strong statistical guarantees. We are able to
derive such statistical error bounds for MCMC estimates, but similar error bounds for
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finite sample size particle filter estimates have not yet been established. Second, here we
directly exploit the fact that MCMC collects samples in a sequence, and our sequential
hypothesis test can adaptively stop the sampling procedure once enough samples have
been collected. In contrast, particle filter sample sizes would need to be fixed in advance,
and the filter would need to be run up to the maximal time point before verification
could begin. For these reasons we build on an MCMC methodology, but view other
forms of Bayesian inference to perform model verification under parameter uncertainty
as an interesting direction for future research.
First, we apply our method on an ODE model of the JAK-STAT biochemical path-
way [119]. The empirical results show that the proposed method enables verification
with respect to the Bayesian parameter posterior with reliable error bounds. We also
find that sequential testing is often significantly more efficient than the fix sample size
test. Next, we use our method on a model of the extrinsically triggered apoptosis path-
way (EARM1.3) [120], a large model containing 69 dynamical species and 71 unknown
parameters. We find that some important qualitative properties are preserved, while
others cannot be verified under substantial parameter uncertainty arising from the lim-
ited nature of experimental data. In both case studies we use wet-lab experimental data
available from the literature, demonstrating the practical applicability of our method.
The rest of this chapter is organized as follows. In the next section, we review some
of the basic concepts behind our method and discuss previous work. In Section 4.3 we
introduce our method in detail. This includes defining the temporal logic for expressing
dynamical properties and our main algorithms for performing statistical model checking
using MCMC. Section 4.4 provides theoretical error bounds and sample size guarantees
of our algorithms, and compares the efficiency of the hypothesis tests. Section 4.5
addresses some of the important practical aspects of using this method. In Section 4.6
we apply the proposed method to perform verification on two pathway models. We
conclude with a summary of the main contributions and results.
4.2 Background and previous work
Properties about dynamical systems can be formally expressed as formulas in temporal
logic. Using temporal logic, one can conveniently describe both qualitative and quan-
63
titative dynamical properties of interest. The technique of model checking [70] is used
to automatically verify if a model satisfies these properties. Model checking has been
used for the analysis of dynamical embedded systems [121] and hybrid systems [122],
and is of significant interest in systems biology [123, 77, 124]. Both temporal logic and
model checking techniques have also been extended to analyze dynamical systems with
a component of stochasticity. In this context one verifies if a property is satisfied with
a certain probability.
When the state space of a stochastic model can be explicitly enumerated (for instance
in the case of discrete state space Markov chain models), the reachable states can be
traversed to find the probability of a dynamical property being satisfied [72]. However,
due to state space explosion this is intractable for large pathway models. It will also
be impossible in the case of non-linear ODE models where an explicit reconstruction of
the state transitions is not possible. In this case a statistical model checking approach
can be used to perform implicit verification based on repeated simulation of the model
dynamics.
Statistical model checking (see also Section 2.4) aims to verify whether a dynamical
system S satisfies a temporal logic property ψ with probability at least r, or more
formally, whether S |= P≥r(ψ). For a single realization (also called a trajectory) of the
system, ψ is either satisfied or not. By imposing a probability measure over the set
of trajectories, one can define the probability of satisfaction of ψ, denoted Pψ. This
probability is compared to a threshold r, and the verification problem is generally posed
as a hypothesis test between H0 : Pψ ≥ r+ δ and H1 : Pψ ≤ r− δ, with δ being a chosen
indifference region [75]. The hypothesis test is solved using statistical approximations
based on repeated simulation of the system [74]. Importantly, statistical model checking
assumes that each sampled realization of the system is statistically independent.
As we have discussed in Chapters 2 and 3, the dynamics of ODEs is governed by a
set of kinetic parameters whose value is often not known and not directly observable.
In a Bayesian framework, the uncertainty in the parameter values is represented by a
probability distribution. Following Chapters 2 and 3, we refer to the probability distri-
bution of parameters conditioned on a set of observations as the posterior distribution.
As the parameter values determine the system dynamics, the parameter distribution
also induces a probability measure over the possible realizations of the system dynam-
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ics. However, obtaining independent samples from a posterior distribution is impossible
in all but very special cases. Verification relying on independent samples cannot be
used in this setting, and we are not aware of any previous work that has addressed this
limitation.
Sampling independent system trajectories according to a prior distribution is usually
straightforward. In [81], we showed that when there is a uniform distribution on the
model parameters, one can use random sampling and a standard statistical model check-
ing scheme to verify if a property is satisfied with a given probability. This was used
with the motivation of modeling small, local variability in rate constants among individ-
ual cells. A more complete characterization of a pathway model’s parameter space with
respect to logic properties was addressed in [73], where piecewise-multiaffine differential
equations are considered, for which it is possible to identify regions of parameter space
where the model satisfies a temporal logic property. The above approaches deal with
parameter uncertainty as a prior property of the system, rather than its uncertainty
conditioned on data, which we address here. A recent work [125] considers the problem
of parameter learning in CTMC models. The goal is to find parameters such that the
probability of satisfaction of a set of temporal logic properties becomes most likely. Even
though parameters are treated in a Bayesian framework, there are important differences
from our setting, namely in [125] (i) the properties themselves are used as “data” with
respect to which parameters are tuned and (ii) Bayesian inference is not performed,
instead, a global optimization procedure is used to find the single maximum likelihood
or maximum aposteriori-probability parameter estimate.
In our approach we use a Markov chain Monte Carlo (MCMC) method to collect a
sequence of samples from the space of possible parameters. The chain is designed to en-
sure that the samples are distributed according to the parameter posterior. MCMC is a
general strategy to obtain samples from distributions that are hard to sample from [126].
These samples can then be used to analyze properties of interest. The MCMC method
has been used in systems biology to explore the parameter posterior of ODE models
[127, 128, 16]. These works, however, have not addressed the problem of probabilistic
verification. Further, these works do not use error estimates for the results obtained
using MCMC. Claims for the correctness of the approach rely on methods such as the
Gelman-Rubin diagnostic [129, 130] to qualitatively assess convergence, rather than pro-
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vide quantitative confidence intervals. In contrast, here we build on recent results in
statistical theory to explicitly bound the error in our MCMC estimates. In fact, the
efficiency and accuracy of our statistical model checking algorithms crucially depend on
MCMC error bounds for finite sample sizes.
4.3 Statistical model checking under Bayesian uncertainty
In this section we develop the methodology for performing statistical model checking
under Bayesian uncertainty. We first define our temporal logic to express dynamical
properties. Then we show how hypotheses can be posed to express whether the model
satisfies a property with at least a given probability. Then a Markov chain Monte Carlo
method is presented to collect samples from the parameter posterior, and our two main
algorithms, a fix sample size test and a sequential test is proposed to decide between
the hypotheses.
4.3.1 ODE models with Bayesian parameter uncertainty
An ODE model describes the time-derivative of a set of variables x(t) ∈ Rdx through
a system of (possibly non-linear) equations (see also Section 2.2.1). The equations are
stated as
x˙(t) = F (x(t), θ).
Here θ ∈ Rdθ is a vector of model parameters. To simulate the model, initial conditions
x(0) need to be set, and throughout the rest of the chapter we assume that these are
given. However, if this is not the case, initial conditions could also be treated as part of
the set of unknown model parameters.
We constrain model parameters (whose values are not exactly known) to be in a
bounded set Θ ⊂ Rdθ , and for simplicity define this set as the hypercube arising by
constraining parameter θi to the interval [ai, bi], where ai < bi ∈ R, 1 ≤ i ≤ dθ. The set
of possible parameter values will thus be Θ = [a1, b1]× [a2, b2]× . . .× [adθ , bdθ ].
Importantly, we assume that a prior probability density p0(θ) is given over Θ. One
can use the prior to encode existing knowledge about the joint distribution of parameters.
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In the simplest case, p0(θ) will be uniform over Θ, defined as
p0(θ) =








is a constant ensuring that p0 integrates to 1.
When more is known about the value of the parameters, a Gaussian or a log-normal
distribution is used as a prior. For instance, an uncorrelated Gaussian prior would have
the form p0(θ) =
dθ∏
i=1
N (µθi , σ2θi). In principle, truncation may be needed in these cases
to integrate to 1 over the bounded Θ, but in practice the tail probabilities will decay
fast enough that this effect is negligible.
Now assume that we have a set of observations Y , and recall from Section 2.3 that
Yi,j denotes the measured value for species i at time point tj . We will use the Gaussian
likelihood to assess how well a particular set of parameters explains the experimental
data. The form of the likelihood is











where C is a constant ensuring a unit integral, xi(tj)|θ is the value of species i at time
tj when using parameters θ, and σi,j are the standard deviations of each data point. In
case not all variables are observed or if the state is observed through a function g of the
state, as y(tj) = g(x(tj)), the likelihood can be modified in the obvious way.
Using the prior and the likelihood, we can express the posterior distribution of pa-
rameters as




p(Y |θ)p0(θ)dθ . (4.3)
The parameter posterior will introduce a component of uncertainty in the ODE
model. Intuitively, it will “weight” realizations of the model based on their support
from prior knowledge and observations. In the following sections, we provide methods
to verify whether properties expressed in probabilistic temporal logic are met with a
given probability, with respect to the posterior.
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4.3.2 Probabilistic properties and verification
In this section we first define a temporal logic on trajectories of the ODE model. The
logic will be able to express dynamical properties on the system variables such as “the
concentration of STAT starts in the interval [0,0.1], after which it reaches the interval
[1,2] and stays in the interval [1,2]”. We then extend the logic to a probabilistic setting
where there is a probability distribution over the set of trajectories. Finally, we show
how deciding whether a property holds with at least a given probability can be posed
as a hypothesis test.
Properties on a single trajectory
To specify the dynamical properties of a single realization of the system, we first encode
them as formulas in a specification logic. We assume that analyzing the dynamics of
the system is of interest only up to a maximal time point T . Accordingly, we use a
bounded version of linear time temporal logic (BLTL)[70]. The formulas in this logic
are interpreted at a finite set of time points T = {0, 1, . . . , T} corresponding to all the
relevant time points of interest. With a slight abuse of notation, we will directly use
these integer time indices to specify the state at the corresponding time point. For
instance x(1) will denote the state at time point 1.
In our setting a trajectory is represented by ςθ, which (given fix initial conditions)
is fully defined by the choice of parameters θ since the ODE system is deterministic. A
trajectory will be defined by the set of states ςθ = (x(0)|θ, x(1)|θ,. . . , x(T )|θ), where
x(i)|θ is the value of system variables at time point i when the corresponding ODEs are
simulated with the parameter set θ. ςθ(t) = x(t)|θ for t ∈ T . The transitions from x(i)|θ
to x(i+ 1)|θ is ensured by the fact that once we fix the parameters values, the systems
of ODEs has a unique solution and is characterized by a continuous function (for more
details, see [81]).
Atomic propositions in BLTL will be of the form (i, L, U) with L ≤ U . This is
interpreted as “the value of xi falls in the interval [L,U ]”. When describing the case
study, for easier readability, we will use the [L ≤ xi ≤ U ] notation with the same
intended meaning.
The syntax of formulas in BLTL are defined as follows:
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• Every atomic proposition is a BLTL formula.
• The constants true and false are BLTL formulas.
• If ψ and ψ′ are BLTL formulas then ¬ψ and ψ ∨ ψ′ are also BLTL formulas.
• If ψ is a BLTL formula then G≤tψ and F≤tψ are also BLTL formulas, where t ≤ T
is a positive integer.
• If ψ and ψ′ are BLTL formulas then ψU≤tψ′ is a BLTL formula, where t ≤ T is a
positive integer.
Logic operators such as ∧, ∨ and ⇒ are defined in the standard way and allow the
construction of complex combinations of statements.
Properties of the system dynamics defined by the ODEs can be efficiently expressed
using BLTL. The semantics of BLTL will be defined by ςθ, t |= ψ (expressing that the
trajectory ςθ satisfies the property ψ are time t), as follows.
• ςθ, t |= (i, L, U) iff L ≤ ςθ,i(t) ≤ U where ςθ,i(t) is the ith component of ςθ(t).
• ςθ, t |= ψ ∨ ψ′ iff ςθ, t |= ψ or ςθ, t |= ψ′.
• ςθ, t |= ¬ψ iff ςθ, t 6|= ψ.
• ςθ, t |= ψU≤kψ′ iff there exists k′ such that k′ ≤ k, t+ k′ ≤ T , ς, t+ k′ |= ψ′ and
ςθ, t+ k
′′ |= ψ for every 0 ≤ k′′ < k′.
Finally, we say that ςθ |= ψ (that is, the trajectory ςθ satisfies ψ) iff ςθ, 0 |= ψ. The
derived temporal operators G≤t and F≤t are defined as follows.
F≤tψ ≡trueU≤tψ,
G≤tψ ≡¬F≤t¬ψ.
This provides the basis for verifying a single trajectory of the ODE system. We next
introduce a probabilistic extension of BLTL which applies to sets of trajectories.
Statistical model checking as a hypothesis test
Under assumptions of continuity and measurability on the ODE equations, we can assign
a probability to the trajectories satisfying a given formula ψ with respect to the distri-
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bution of parameters (for a detailed discussion, see [81]). We can define the probability




pi(θ|Y )I(ςθ |= ψ)dθ, (4.4)
where I is the indicator function taking value 1 if ςθ |= ψ, and 0 otherwise.
To express properties of this nature, we will encode them in a formalism called
PBLTL[131], which is a probabilistic extension of BLTL. Formulas in PBLTL are of the
form P≥r(ψ) (or P≤r(ψ) ), where ψ is a BLTL formula and r is a real number in (0, 1).
The PBLTL formula P≥r(ψ) expresses that we want to verify whether the probability
measure of the trajectories satisfying ψ (or Pψ) is at least r.
Deciding whether P≥r(ψ), can be posed as a hypothesis test [132, 75, 74]. Our goal
is to decide between the following two hypotheses.
H0 : Pψ ≥ r + δ, (4.5)
H1 : Pψ ≤ r − δ,
where P≥r(ψ) is a PBLTL formula and δ is a parameter defining an indifference region.
We refer to an algorithm that chooses between the two hypotheses as a hypothesis test.
The hypothesis test makes an error, if it chooses H0 when H1 holds (Type-I error), or
if it chooses H1 when H0 holds (Type-II error). If neither hypothesis holds (that is,
Pψ ∈ (r − δ, r + δ)), either decision is considered correct. For simplicity, we will just
consider the overall error rate (denoted by ) covering either error type. It is important
that the desired error rate , along with δ and r can be chosen by the user.
Due to the difficulty of sampling independently from the posterior, we will use a
Markov chain Monte Carlo method, which produces a sequence of dependent samples
from the posterior, to decide between the hypotheses.
4.3.3 MCMC for statistical model checking
Our goal in this section is to design a Markov chain in a way that its stationary dis-
tribution matches the parameter posterior pi(θ|Y ). Then, if the chain is stationary, it
will provide a sequence of samples from the posterior. The chain starts at an initial
parameter sampled from the prior. In each subsequent step of the chain, one first uses
a proposal distribution to pick the next candidate parameter, and then applies the ac-
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ceptance ratio to accept or reject the proposed candidate. At each step of the Markov
chain, the trajectory corresponding to the current parameter vector is verified, and these
samples are used to decide whether P≥rψ.
There are many possible ways to construct an adequate proposal distribution and
acceptance rate. The only requirement is that the resulting Markov chain have a unique
stationary distribution, and that the stationary distribution is identical to the posterior
pi(θ|Y ). A sufficient condition for the existence of a stationary distribution is detailed
balance, which states that the probability of being in state θn and move to the state θm
is equal to the probability of moving from θm to θn, or more formally,
pi(θn|Y )P (θn → θm) = pi(θm|Y )P (θm → θn). (4.6)
Here P is the overall probability of the transition, which is a combination of the proposal
and the acceptance rate. The uniqueness of the stationary distribution holds if the
Markov chain is ergodic. A simple sufficient condition of ergodicity is that there exists
a finite integer k such that any state can be reached from any other state in exactly k
steps.
It is important to point out that our statistical model checking scheme, and the-
oretical analysis in Section 4.4 will hold for any Markov chain that fulfills the above
properties. The design of an efficient Markov chain is often problem-specific and is an
orthogonal problem to our main contribution (for more details on constructing efficient
chains, we refer to [133]). Here we introduce a standard MCMC scheme based on the
Metropolis-Hastings algorithm [114].
We denote the proposal by q(θn → θ), which represents the probability of proposing
θ if the current parameter value is θn. A good choice for the proposal is q(θn → θ) =
N (θn,ΣMH), a dθ-dimensional multivariate Gaussian with mean identical to the current
parameter vector, and covariance matrix ΣMH. Here ΣMH can be diagonal with entries





. . . 0
0 0 σ2MH,dθ

In practice it is important to choose the entries of the covariance matrix carefully,
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since it affects the mixing properties of the chain. In the case of pathway models,
prior knowledge about individual parameters, or initial test runs will provide sufficient
information to choose the diagonal entries.
The acceptance rate needs to be chosen in a way that the detailed balance is kept
with respect to the posterior. The acceptance rate follows from the Metropolis-Hasting
scheme, where the candidate is accepted with probability α, determined by the proposal



















Note that the normalization constant p(Y ) appearing in the posterior is eliminated, and
one only needs to evaluate the prior and the likelihood at the original and at the proposed










This choice of acceptance rate will ensure detailed balance, and imply reversibility.
It also is easy to see that the resulting chain will be ergodic. This simply follows from
the fact that the proposal Gaussian will propose any parameter in Θ with nonzero
probability, and the acceptance rate is also always positive in Θ. Therefore any state
can be reached from any other state within one step, implying ergodicity.
The above conditions ensure that the Markov chain will converge to the true poste-
rior. To ensure that the chain has sufficiently converged, we take an initial t0 number
of steps in the Markov chain, called the burn-in time. The estimation done with respect
to the samples (in our case the verification task) is only started after the burn-in phase.
We now introduce the function getMCMCsample, which takes as input the current
parameter values, takes a single step in the Markov chain, and returns the new parameter
values.
We are now ready to present two tests between the hypotheses in (4.5). These tests
use getMCMCsample as a subroutine. The main idea is that at each step of the Markov
chain, the trajectory corresponding to the current parameter value is simulated and
verified with respect to a given property ψ. Once a sufficient number of samples have
been verified, we can stop the Markov chain and decide between hypotheses H0 and H1.
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Function getMCMCsample
Input: parameter vector θin. Output: parameter vector θout
1: Sample a new parameter vector based on proposal: θ′ ∼ q(θin → θ)






3: Generate η ∼ Uniform[0, 1]
4: if η < α then
5: return θout := θ
′
6: else
7: return θout := θin
8: end if
4.3.4 Fix sample size hypothesis test
A fix sample size hypothesis test is shown in Algorithm 1. This test assumes that we
have fixed N , the total number of samples to collect, and thus a choice of either H0
or H1 is returned after exactly N steps. The algorithm first takes t0 burn-in steps to
ensure convergence to the posterior. Then in each of N steps, a property ψ is verified.
If the number of times it is verified to be true is at least rN then H0, otherwise, H1 is







where γ is the spectral gap of the Markov chain, and is discussed in detail in Section
4.5.1. We will prove in Section 4.4 that this choice of N achieves an error rate of  in
deciding the hypothesis test.
Algorithm 1 Fixed sample size hypothesis test
Input: BLTL property ψ, threshold probability r, observations Y , number of samples N , number
of burn-in steps t0, prior p0, proposal q.
Output: Choice of H0 or H1.
1: Sample initial parameter vector from the prior ϑ0 ∼ p0(θ)
2: for i := 1 . . . t0 do
3: ϑi := getMCMCsample(ϑi−1)
4: end for
5: Set S := 0 and θ0 := ϑt0
6: for n := 1 . . . N do
7: θn := getMCMCsample(θn−1)
8: Simulate the trajectory ςθn
9: if ςθn |= ψ then
10: S := S + 1
11: end if
12: end for






4.3.5 Sequential hypothesis test
A sequential sample size hypothesis test is shown in Algorithm 2. This test uses sequen-
tial hypothesis testing to adaptively set the number of steps before stopping (based on
the result of verification on samples gathered so far). The stopping condition is governed
by a threshold M . At each step, a property ψ is verified. The number of times up to
step number n when ψ was verified to be true is counted by S. If S crosses the upper
threshold nr + M then H0 is chosen, if it crosses the lower threshold nr −M then H1
is chosen, otherwise we continue taking samples.
Figure 4.1 shows the lower and upper stopping conditions and an example trace of







Figure 4.1: Sequential hypothesis test with an example running sum crossing the upper
stopping condition.
It is important to note that the sequential hypothesis test will always stop within a
finite number of iterations with probability 1, as shown in Section 4.4.
4.4 Theoretical analysis
In this section we present bounds on the error of the hypothesis tests introduced in the
previous section. In what follows, we state results in more general terms. Namely, results
hold for any reversible Markov chain on state space Ω ⊂ Rd with a unique stationary
distribution pi. The Markov chain described in the previous section is an instance of such
a chain. In our dynamical systems verification context, Ω will correspond to Θ ⊂ Rdθ ,
the set of possible model parameters, and pi corresponds to the posterior pi(θ|Y ). For
the general discussion, we assume that a square-integrable function f (in other words
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Algorithm 2 Sequential hypothesis test
Input: BLTL property ψ, threshold probability r, observations Y , stopping condition M , number
of burn-in steps t0, prior p0, proposal q.
Output: Choice of H0 or H1.
1: Sample initial parameter vector from the prior ϑ0 ∼ p0(θ)
2: for i := 1 . . . t0 do
3: ϑi := getMCMCsample(ϑi−1)
4: end for
5: Set n := 1, S := 0 and θ0 := ϑt0
6: loop
7: θn := getMCMCsample(θn−1).
8: Simulate the trajectory ςθn
9: if ςθn |= ψ then
10: S := S + 1
11: end if
12: if S ≥ nr +M then
13: return H0
14: else if S ≤ nr −M then
15: return H1
16: else
17: Set n := n+ 1 and continue
18: end if
19: end loop
f ∈ L2(pi)), with 0 ≤ f(x) ≤ 1 for x ∈ Ω is evaluated at each step of the Markov
chain. The function f corresponds to evaluating I(ςθ |= ψ), taking 1 or 0, depending on
whether the property of interest is satisfied with the current parameters. Consequently,
the expectation Epif will correspond to Pψ in our setting.
4.4.1 Concentration of the Markov chain estimate
In this section we show a Hoeffding-type concentration inequality for estimates made
using dependent samples obtained from a Markov chain. It provides an upper bound
on the probability that the sum of f(Xi) deviates from its expected value. This will be
the basis of the stopping conditions for our hypothesis tests. This result was proven for
Markov chains on finite state spaces in [134]. The result has only recently been extended
to general state spaces in [135]. This form of the result follows from [134] and [135] with
rescaling to exploit the fact that the values of f are bounded between 0 nd 1.
Theorem 4.1 (Hoeffding inequality for reversible Markov chains). Let X1, . . . , Xn be a
stationary reversible Markov chain with spectral gap γ, and unique stationary distribu-




then for any t ≥ 0,







Note that the requirement that the chain be stationary is ensured by choosing a
sufficiently long t0 initial burn-in time.
4.4.2 Sample sizes and error bounds for the tests
Suppose that X1, X2, . . . is a reversible Markov chain on Ω ⊂ Rd, with unique stationary
distribution pi, and f : Ω → [0, 1] is a bounded function. Our objective is to do a test
between the following two hypotheses, given r ∈ (0, 1) and δ ∈ (0,min(r, 1− r)), (this is
a more general form of (4.5)).
H0 : Epif ≥ r + δ,
H1 : Epif ≤ r − δ.
In the following sections, we discuss two tests to choose between these hypotheses. The
first one is a fixed sample size test (a generalized form of Algorithm 1), while the second
one is a sequential test (a generalized form of Algorithm 2).
Fixed length hypothesis test
Suppose that we have a sample of length n consisting of the values f(X1), . . . , f(Xn).
Let Sn := f(X1) + . . .+ f(Xn). We will use the following hypothesis test.
• If Sn ≥ nr, accept hypothesis H0,
• otherwise accept hypothesis H1.
The next theorem bounds the Type-I and Type-II errors of the test, which correspond
to accepting hypothesis H1 when in fact hypothesis H0 holds, and vice-versa.
Theorem 4.2 (Error bound for fixed length hypothesis test). For the fixed length hy-




Proof. Suppose that H1 holds, implying that Epif ≤ r− δ. A false decision is made (H0
is chosen) if Sn ≥ nr. From here
Sn − nEpif ≥ nr − (nr + nδ) = nδ
Applying the Hoeffding inequality (Theorem 4.1), we get
P (Sn − nEpif ≥ nδ) ≤ exp
(−γδ2n) .
The same holds under the opposite hypothesis.
This result is directly applicable to Algorithm 1, and implies that in order for the






We now turn to establishing a stopping condition for the sequential hypothesis test. The
sequential test is as follows. We fix a threshold M > 0. Denote Sn := f(X1)+. . .+f(Xn)
as before. First, set n = 1, then
• if Sn ≥ nr +M , accept hypothesis H0,
• if Sn ≤ nr −M , then accept hypothesis H1,
• otherwise, set n := n+ 1 and repeat.
In contrast to the fix length hypothesis test where n was chosen in advance, here, n
is variable and M is the parameter chosen in advance to guarantee an error rate of .
The following proposition bounds the errors of the test with a particular choice of M .
Theorem 4.3 (Error bound for sequential hypothesis test). For the sequential hypoth-
esis test, both the Type-I and Type-II errors are bounded by
exp (−2γδM) · exp
(
− M






Proof. Suppose that H1 holds, and thus Epif ≤ r − δ. A false decision occurs (H0 is
chosen) when, for any n ≥ 1, Sn ≥ nr+M . From here Sn−Epif ≥ nr+M−(nr−nδ) =
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M + nδ. Applying the Hoeffding inequality (Theorem 4.1), we get






≤ exp (−2γδM) · exp (−nγδ2) .
It is easy to see that the probability of a false decision is then bounded by the sum
of these terms over all possible n. We also exploit the fact that since Sn ≤ n, when
n ≤M/(1−r), it always holds that Sn ≤ nr+M . Therefore the first bM/(1−r)c terms
of the sum will be 0.
∞∑
n=bM/(1−r)c












≤ exp (−2γδM) · exp
(
− M






The same holds under the opposite hypothesis.
This result is directly applicable to Algorithm 2, and implies that in order for the




2γδ + γδ2/(1− r) . (4.14)
4.4.3 Efficiency of fix length and sequential tests
We have already shown that having chosen r, δ and , the fix sample size test will take
n = log(1/)
γδ2
steps. The number of steps before the sequential test stops (either H0 or
H1 is chosen) is a random variable. We now examine the expected number of steps (we
refer to this as the stopping time T ) of the sequential test. In what follows, we will be
able to show the following important properties
• With the same choice of r, δ and , the expected stopping time of the sequential
test is around half that of the fix sample size test if either H0 or H1 holds, that is,
Epif 6∈ [r − δ, r + δ].
• If Epif is “further” from the edges of the indifference region. the stopping time of
the sequential test decreases even more.
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• Even if neither hypothesis holds, that is, Epif ∈ [r−δ, r+δ], the test will stop with
probability 1, and “forcing” a decision after a 2M/δ steps will have only marginal
effect on error.
First we derive an upper bound for the expected stopping time of the sequential test.
Theorem 4.4. For the sequential test, with M chosen as in (4.14), the expected stopping
time satisfies









Proof. Under hypothesis H1, the probability of the event that T ≥M/δ+ t is less than
equal to the event that Sn > nr −M at step n := bM/δ + tc. Under H1, Ef ≤ r − δ,
thus,
P (Sn > nr −M) = P (Sn > nEpif + nδ −M)
= P (Sn > nEpif + (t− 1)δ).
Using the Hoeffding inequatiy we see that for any t > 0
P (T ≥M/δ + t) ≤ exp
(





To arrive at the expected stopping time, we use the fact that for any real valued random




































where the second step comes from an upper bound for the exponential integral. We now
substitute M as in (4.14) to get








The same holds under the opposite hypothesis.
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By comparing (4.12) with (4.15), we can see that the sequential test typically requires
less than half of the samples of the fix length test.
Our bound in (4.15) is based on the worst case, when Epif is exactly on the border of
either hypothesis region. In practice Epif will often be further from r, and |Epif − r| > δ
will hold. It is easy to show that in this case the denominator of (4.15) can be changed
from 2γδ2 to 2γδ(|r − Epif |), resulting in earlier expected stopping.
It is also clear that the test will stop in a finite amount of time almost surely, even
if none of the two hypotheses is satisfied (that is, if Epif ∈ [r − δ, r + δ]). In practice,
however, we do not know whether this is the case, and one may need to stop the run after
a certain number of steps, depending on available resources. By (4.16), the probability
that the chain runs for more than 2M/δ steps is less than
exp
(





under both hypotheses, which is very small in practice. Therefore, if this happens, one
can stop and choose H0 if S2M/δ ≥ (2M/δ)r and H1 otherwise. This modification of the
original test only changes the Type-I and Type-II errors at most by the amount (4.18).
4.5 Practical considerations
4.5.1 Estimating the speed of mixing
The sample size bounds assume that we know the spectral gap of the Markov chain,
denoted γ. The spectral gap is a quantity describing the mixing properties of the Markov
chain. Intuitively, a small value of γ corresponds to a slowly mixing chain, meaning
that many steps have to be taken before samples become approximately independent.
Conversely, a fast mixing chain (with large γ) will produce a sequence of samples that
become close to independent within a few steps. As seen from the sample size bounds in
Section 4.4, a slowly mixing chain will require a larger sample size to carry out hypothesis
testing.
The spectral gap is a property defined on reversible Markov chains. For Markov
chains on finite, discrete state spaces, the spectral gap is simply the difference between
the two largest eigenvalues of the transition matrix. In the general state space case,
which applies in our setting, the spectral gap is somewhat more difficult to define, and
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the precise definition is given in Appendix B. Here we focus on how to estimate γ in
practice.
In practice, the spectral gap has to be estimated from the output of the Markov
chain. In general the output of the Markov chain is a function f : Ω → R, where Ω is
the state space of the chain. In our case, f denotes the model checker verifying a single
trajectory based on a chosen parameter, and therefore f : Θ → {0, 1}. The main issue
is that the spectral gap is an inherent property of the Markov chain, independent of f ,
but we can only monitor the output of f to estimate the spectral gap. If the output
of the chain is computed for several functions f , then we recommend to compute γˆ for
each of them and use the minimum of those estimates. Once a reliable estimate for γ
has been obtained, the same value holds for any f used in later runs.
At each step Xi ∈ Ω of the chain we have access to f(Xi), and we need to estimate
γ from the sequence of values f(X1), . . . , f(XN ). In [14], we have shown that a good
estimator for γ can be derived by estimating two related values: (1) Vf := V arpif , the
variance of f with respect to pi, and (2) σ2, the asymptotic variance of the mean of f






























Estimating σ2 is more difficult, and several methods have been proposed in the litera-
ture [136]. The estimation typically relies on the lagged autocovariance of the output
sequence f(Xi). In [14] we have proposed such an estimator, and showed that it has good
theoretical properties and is reliable in practice. Let ρˆk denote the empirical k-lagged



























(N − t0 − η)2 . (4.22)
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As for the choice of t0 and η, in [14], we show that setting t0 := 0.1N and η := 10N
1/3
will result in a consistent estimate for σ2. It is important to note that N and t0 chosen
for estimating σ2 and Vf is not necessarily the same as ones used in subsequent runs of
the Markov chain.
Having obtained σˆ2 and Vˆf , we can now calculate the estimated spectral gap as
γˆ := 2Vˆf/σˆ
2. (4.23)
4.5.2 Decoupling sampling and model checking
Typically, one will be interested in verifying several different properties of a model. It is
impractical to re-run the full MCMC procedure for each property independently. We can
exploit the fact that the Markov chain based sample collection is essentially independent
from the model checking task. The sequence of parameter samples collected by the
Markov chain only depends on the model and the experimental data, and not on the
property that is being verified.
Running the Markov chain and performing model checking both involve simulating
the system. Namely, the Markov chain simulates the system with each proposed param-
eter value, and evaluates the likelihood with respect to experimental data. Independent
from this, the model checker needs to simulate the system (possibly under different ini-
tial conditions) to verify against a given temporal logic property. For these reasons, in
practice, it is better to first run the Markov chain for a large number of steps “off-line”,
and store the collected parameter samples for later use in verification.
Assuming that a sufficiently long sequence of parameter samples has been stored, it
is possible to run the same fix sample size or sequential hypothesis tests on this stored set
of samples. In fact, there are two important optimizations that this enables in practice.
First, many of the parameters that the Markov chain generates are identical. This
is because each time a proposed parameter is rejected, the previous parameter is kept
(the Markov chain stays in its original state). Depending on the design, the Markov
chain will typically have an acceptance rate between 10−40%. Naturally, it is enough to
perform verification with each distinct parameter, and take into account the multiplicity
of the parameter in the hypothesis test. For instance, assume parameter θi is kept for
m steps before another parameter is accepted, then one would add m · I(ςθi |= ψ) to the
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sum tracking the number of samples satisfying the property ψ in the hypothesis tests
(see Algorithms 1 and 2 in Section 4.3).
Second, it is possible to parallelize the decoupled verification phase. For the fix
sample size test, massive parallelization is possible, since each stored parameter can be
verified independently. For the sequential test, it is possible to introduce batches of
samples that are verified in parallel. After verifying a batch of samples, the stopping
condition of the sequential test is checked, and the procedure either stops and makes a
decision, or another batch of samples is simulated and verified.
4.6 Case studies
The proposed method was implemented in C++, and runtimes were measured on a
2.83 GHz computer with 8GB of RAM. We first apply our method on a model of the
JAK-STAT pathway and then on a larger model of extrinsic apoptosis.
4.6.1 The JAK-STAT pathway
A model of the JAK-STAT signaling pathway was introduced in Section 3.4.2. Here
we use the same ODE model and experimental data, which have been presented. The
model contains 4 unknown parameters. We use a Markov chain as introduced in Section
4.3 to collect samples from the space of parameters according to the posterior distribu-
tion, while evaluating the corresponding trajectories against properties of interest. The
parameter ranges and the square root of the covariance matrix diagonal entries (σMH)
used to define the MCMC proposal distribution are provided in Table 4.1.
Parameter Limits σMH
k1 [0, 5] 0.02
k2 [0, 30] 0.5
k3 [0, 1] 0.01
k4 [0, 5] 0.02
Table 4.1: Parameter ranges and entries in the proposal covariance matrix
We chose 16 discrete time points between 0 and 60 minutes to represent trajectories
with respect to BLTL formulas (in the formulas below we will use the absolute time
rather than the discrete time index).
We are mainly interested in the dynamics of nuclear STAT (STATn), since it is
involved in gene expression [119]. Specifically, we verify dynamical properties of STATn
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under various types of Epo stimulation (Epo is an input set externally and does not
appear in the formulas).
Property 1 STATn reaches a high level and then settles at a low level under transient
Epo stimulation
ψ1 = F
≤60([1 ≤ STATn ≤ 2] ∧ F≤60(G≤60([0 ≤ STATn ≤ 0.5]))). (4.24)
Experimental analysis of algorithms
We use the verification of P≥r(ψ1) to empirically analyze different aspects of our ap-
proach. We ran m = 2000 independent instances of the MCMC sampler for a total of
2 ·105 steps each (with t0 = 104 burn-in steps). We use the output of the m independent
chains as a basis for constructing empirical results.
To get a reliable estimate of the true underlying probability of satisfaction Pψ1 , we
took the overall average of the estimates from all m chains, and treated the obtained
value Pψ1 ≈ P̂ψ1 = 0.888 as the reference for Pψ1 . The method described Section 4.5.1
was used to estimate the value of the spectral gap to obtain γ = 0.0127.
We first examine the empirical error rate of the fixed sample size hypothesis test.
For a fixed sample size n, we define the empirical error rate En as the ratio of chains
choosing H0 if H1 holds (or the ratio choosing H1 if H0 holds). If neither H0 nor H1
holds (when r − δ < Pψ < r + δ), then En := 0. We set r = P̂ψ1 − δ and calculated
En for a range of sample sizes up to n = 2 · 105. For the same set of sample sizes, we
calculated the error rate bound derived from equation (4.12) as n = exp(−nγδ).
Figure 4.2 shows En and n as a function of n for different values of δ. It is apparent
that En decreases monotonically with increasing sample size n, and that En is higher for
lower values of δ. Importantly, Figure 4.2 demonstrates that the theoretical bounds on
the error rate are reliable in practice, since the empirical false negative rate is consistently
below this upper bound (En ≤ n for all examined n, δ).
We next look at results for sequential hypothesis testing. The sequential hypothesis
test method enables the early termination of the sampling chain if the running estimate
crosses a threshold. We refer to the number of samples collected in the Markov chain
before a decision is made as the stopping time (see also Section 4.4). In Figure 4.3, the























Figure 4.2: Empirical error rates for the fixed sample size test for a range of sample sizes.
Dashed lines show the theoretical upper bounds derived from (4.12). Here r = P̂ψ1 − δ
and  = 0.01 are fixed, and 3 distinct δ values are shown.
Pψ1 for a set of r values in (0, 1). Here the value of δ = 0.05 and  = 0.01 is fixed. As
a reference, we note that the corresponding fixed sample size test would take 1.45 · 105
samples. The plot shows that for values of r distant from the true probability, sequential
sampling consistently terminates with small variability at low sample sizes. When r is
close to the true probability, the stopping times show significantly higher variability.
Figures 4.4 and 4.5 show the mean empirical stopping times for a range of r values for
different values of δ, and different values of , respectively. For values of r close to P̂ψ1 ,
some chains did not stop within 2 · 105 samples, and the corresponding mean values
are therefore not determined. These empirical results are consistent with sequential
hypothesis testing in the independent sample setting [132].
We also evaluated the empirical error rate in the sequential hypothesis test, and found
that out of the m = 2000 parallel runs, no error was made under all examined choices
of r, , δ. This, on one hand shows that the specified error bound (4.13) was indeed met.
On the other hand, it suggests that the bound (4.13) might not be sharp and M could
be chosen even smaller than described by (4.14), resulting in earlier stopping.
Further properties
We now look at two further properties regarding STATn. Recall that property ψ1
specified the behavior of STATn under transient Epo stimulation. Here we specify
the behavior of STATn under two rounds of transient Epo stimulation (ψ2) and under
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Figure 4.3: Empirical distribution of stopping times with sequential hypothesis test for
different values of r. Here δ = 0.05 and  = 0.01 is used.
sustained Epo stimulation (ψ3), (again, Epo is set externally and thus does not appear
in the formulas). Figure 4.6 shows 3 different time courses for the externally set Epo
stimulation used when verifying with respect to ψ1, ψ2 and ψ3.
Property 2 STATn reaches a high level and then settles at a medium level under two
rounds of transient Epo stimulation
ψ2 = F
≤60([1 ≤ STATn ≤ 2] ∧ F≤60(G≤60([0.5 ≤ STATn ≤ 1]))). (4.25)
Property 3 STATn reaches a very high level and then settles at a very high level under
sustained Epo stimulation
ψ3 = F
≤60(G≤60([1.5 ≤ STATn ≤ 2])). (4.26)
Table 4.2 summarizes the results of the verification with properties ψ1 to ψ3.





P≥r(ψ1) 0.8 0.05 0.01 True 143384/315s 145045/319s
P≥r(ψ2) 0.8 0.05 0.01 True 54789/125s 145045/328s
P≥r(ψ3) 0.8 0.05 0.01 False 13698/36s 145045/317s
Table 4.2: Verification results on properties of the JAK-STAT pathway model. Out-
comes (true or false) were the same for fixed length and sequential tests.
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Figure 4.4: Mean empirical stopping times for sequential hypothesis test for different
values of δ, with  = 0.01. Dashed lines show constant sample sizes required for the
fixed sample size test.








































Figure 4.5: Mean empirical stopping times for sequential hypothesis test for different
values of , with δ = 0.05. Dashed lines show constant sample sizes required for the
fixed sample size test.
























































Figure 4.6: Epo stimulation dynamics. These time courses are used as (deterministic,
externally fixed) inputs when verifying ψ1, ψ2 and ψ3 respectively. Transient stimula-
tion [119] (left), two rounds of transient stimulation [119] (center), sustained stimulation
(right).
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4.6.2 Extrinsic apoptosis reaction model
The extrinsic apoptosis reaction model (EARM) is an ODE model of apoptosis in re-
sponse to the death ligand TRAIL. Several versions of the model were published in
recent years, and the model has been used to classify cell types based on the apoptotic
process, to study cell-cell variability due to varying initial conditions, and variability
due to stochastic dynamics [138, 139, 140, 141, 142]. The work in [139] is specifically
relevant, since there, model checking is used to characterize properties of the model
under a range of initial conditions. We will verify similar properties of the model here,
but under Bayesian parameter uncertainty. Here we use the version of the model called
EARM1.3, following [16, 140].
The EARM1.3 model is considerably large. It contains 69 dynamical variables rep-
resenting the active and inactive form of proteins and their complexes. We assume that
71 parameters are unknown, the set of unknown parameters being the ones representing



















Figure 4.7: Simplified diagram of the EARM1.3 extrinsic apoptosis model.
Measurement data is available for the effector caspase reporter protein (EC-RP),
which is a metric for the direct initiation of cell death. The EC-RP data is normalized
to arbitrary units, and is compared to the model variable cPARP (cleaved PAPR protein)
using a Gaussian likelihood function. There is significant uncertainty in many of the
parameters (as also observed in [16]), partly due to the fact that measurements are noisy,
and are only available for the single, most downstream species. Accordingly, there is also
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variation in the dynamics of the internal, unobserved species. It is important to verify
that certain characteristic properties hold, even under the model uncertainty arising from
the limited data. In our setting, the EARM1.3 model is set up to represent HeLa cancer
cells. We choose values for initial conditions, parameter prior distributions, degradation
and synthesis rates following [140]. The ligand amount was set to 3000 units, which
corresponds to 50ng/ml of TRAIL treatment in HeLa cells.
Name Initial amount Name Initial amount
Receptor 1000 PARP 1000000
Flip 2000 Bid 60000
Caspase-8 10000 Mcl-1 20000
Bar 1000 Bax 80000
Caspase-3 10000 Bcl-2 30000
Caspase-6 10000 Pore 500000
Caspase-9 100000 CytoC m 500000
Apaf 100000 Smac 100000
XIAP 100000
Table 4.3: Initial amounts in the EARM1.3 pathway model.
According to [16], we use independent log-normal prior distributions for the param-
eters. The prior mean and variance for each parameter is shown in Table 4.4.
Name (µ, σ2) Name (µ, σ2) Name (µ, σ2) Name (µ, σ2)
kf1 (−6.4, 2.0) kr1 (−6.0, 2.0) kc1 (−2.0, 1.2) kf2 (−6.0, 2.0)
kr2 (−3.0, 2.0) kf3 (−7.0, 2.0) kr3 (−3.0, 2.0) kc3 (0.0, 1.2)
kf4 (−6.0, 2.0) kr4 (−3.0, 2.0) kf5 (−7.0, 2.0) kr5 (−3.0, 2.0)
kc5 (0.0, 1.2) kf6 (−7.0, 2.0) kr6 (−3.0, 2.0) kc6 (0.0, 1.2)
kf7 (−7.0, 2.0) kr7 (−3.0, 2.0) kc7 (0.0, 1.2) kf8 (−5.7, 2.0)
kr8 (−3.0, 2.0) kc8 (−1.0, 1.2) kf9 (−6.0, 2.0) kr9 (−3.0, 2.0)
kc9 (1.3, 1.2) kf10 (−7.0, 2.0) kr10 (−3.0, 2.0) kc10 (0.0, 1.2)
kf11 (−6.0, 2.0) kr11 (−3.0, 2.0) kf12 (−7.0, 2.0) kr12 (−3.0, 2.0)
kc12 (0.0, 1.2) kf13 (−2.0, 2.0) kr13 (0.0, 2.0) kf14 (−4.0, 2.0)
kr14 (−3.0, 2.0) kf15 (−3.7, 2.0) kr15 (−3.0, 2.0) kf16 (−4.0, 2.0)
kr16 (−3.0, 2.0) kf17 (−3.7, 2.0) kr17 (−3.0, 2.0) kf18 (−4.0, 2.0)
kr18 (−3.0, 2.0) kf19 (−4.0, 2.0) kr19 (−3.0, 2.0) kc19 (0.0, 1.2)
kf20 (−3.7, 2.0) kr20 (−3.0, 2.0) kc20 (1.0, 1.2) kf21 (−3.7, 2.0)
kr21 (−3.0, 2.0) kc21 (1.0, 1.2) kf22 (0.0, 2.0) kr22 (−2.0, 2.0)
kf23 (−6.3, 2.0) kr23 (−3.0, 2.0) kc23 (0.0, 1.2) kf24 (−7.3, 2.0)
kr24 (−3.0, 2.0) kf25 (−8.3, 2.0) kr25 (−3.0, 2.0) kc25 (0.0, 1.2)
kf26 (0.0, 2.0) kr26 (−2.0, 2.0) kf27 (−5.7, 2.0) kr27 (−3.0, 2.0)
kf28 (−5.2, 2.0) kr28 (−3.0, 2.0) kf31 (−3.0, 2.0)
Table 4.4: Prior distributions for the parameters of the EARM model. The priors are
log-normal, with variance σ2 and mean chosen as µ := log10 knom, the logarithm of the
nominal parameter values.
When running MCMC on the space of parameters, we propose steps in the loga-
rithmic space with σMH := 0.1875. With this choice, an acceptance rate of 0.15 − 0.2
was reached resulting in good mixing. We estimated the spectral gap of the Markov
89
chain according to Section 4.5.1 and obtained γ = 0.002. We then used our fixed sample
size and sequential hypothesis testing methods (with parameters r = 0.9,  = 0.01 and
δ = 0.05) to verify properties of the model. Note that with these parameters the fix
sample size hypothesis test will always take 921035 samples, irrespective of the prop-
erty being verified and the choice of r. We therefore ran the MCMC procedure for a
total of 106 steps (with 10000 burn-in steps) and stored the sequence of parameters
for subsequent verification (see the decoupling method proposed in 4.5.2). The MCMC
procedure took less than 6 hours to run.
Time of apoptosis
First we were interested in verifying the timing of apoptosis. Apoptosis is marked by the
cleavage of PARP, and cells can be considered dead once the amount of cleaved PARP
(cPARP) reaches 50% of total PARP. With our initial conditions, this is at 5 · 105. The
property ϕ1a specifies that apoptosis will happen within 5 hours.
ϕ1a = F
≤5[cPARP > 5 · 105]. (4.27)
The property was verified to be true. We next verified whether all cells were alive
within the first 3 hours.
ϕ1b = G
≤3[cPARP < 5 · 105]. (4.28)
This, again, was verified to be true. From here we see that the time of apoptosis falls
between 3 and 5 hours after ligand treatment.
Effector caspase delay
In some cell lines the activity of the effector caspase almost immediately follows the
activity of the upstream initiator caspase. In other cases there is significant delay be-
tween the two, possibly due to the need for mitochondrial membrane permeabilization
(MOMP). We want to verify whether either the delayed effect or the immediate effect
is preserved under model uncertainty. We express the activity of the initiator caspase
through total cleaved Bid (tBid) reaching at least 10% of total Bid within 4 hours. Once
this happens, we specify that cPARP stays below 50% of total PARP for 1 hour, mean-




≤4([tBid > 6000] ∧G≤1[cPARP < 5 · 105]). (4.29)
The property is verified to be false. We tested the opposite property, namely that cells
die within 1 hour of initiator caspase activity, expressed as
ϕ2b = F
≤4([tBid > 6000] ∧ F≤1[cPARP > 5 · 105]). (4.30)
This property was also verified as false. Hence we find that neither the immediate,
nor the delayed effector caspase activity holds with high probability. In this case, our
limited information about parameter values (the model uncertainty) does not allow us
to conclude that either property holds motivating us to add more measurements to
constrain our parameters and predictions.
We added measurements available for IC-RP [120, 16], the initiator caspase reporter
protein. This reporter measures the activity of initiator caspases, and is a metric for the
formation of tBid. We then ran the MCMC procedure again, this time using both EC-RP
and IC-RP data. The results show that the new data was sufficient to reduce parameter
uncertainty in making predictions about effector caspase delay. The properties on the
time of apoptosis (ϕ1a and ϕ1b) still held true with at least 0.9 probability. Further,
property ϕ2a was now verified to be true. This indicates that there is, indeed, substantial
delay in effector caspase activity.
Next we were interested in whether the property of effector caspase delay holds
directly on the levels of the active caspases. This would require that EC-RP and IC-
RP data together are sufficient to constrain the uncertainty in caspase dynamics. We
formulated properties on the activity of Caspase-8 and Caspase-3 by assuming that the
caspases can be considered active once the active form (marked by asterisk) reaches 0.01
times the total amount of caspase. The property ϕ3 expresses that there is at least 1
hour of delay in Caspase-3 activation following Caspase-8 activation.
ϕ3 = F
≤4([Caspase-8∗ > 100] ∧G≤1[Caspase-3∗ < 100]). (4.31)
Interestingly, ϕ3 could not be verified to hold true with high probability. The opposite
property (stating that there is no delay) similarly, could not be verified to hold true
with sufficiently high probability.
In summary, we found that model predictions depend heavily on the amount and
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nature of experimental data used to constrain model parameters. We could reliably pre-
dict the timing of cell death given EC-RP data. Adding IC-RP data constrained cleaved
Bid dynamics sufficiently to find that, with high probability, there is substantial delay
between initiator and effector caspase activity. However, the uncertainty in parameters
prevented us from making reliable predictions using the model about caspase dynamics.
More details about the dynamics of species appearing in the specified properties is
given in Appendix B.
4.7 Summary
In this chapter we proposed a method for performing statistical model checking on
pathway models under Bayesian parameter uncertainty. This enabled us to verify if
properties of interest expressed in temporal logic hold with respect to the parameter
posterior distribution. This is important in systems biology since due to the large
number of model parameters and limited, noisy experimental data, parameter values
cannot usually be constrained to a single value. Despite parameter uncertainty, certain
important properties of the model dynamics may be preserved, and our method enables
the verification of these properties.
The main technical challenge in performing verification is that obtaining independent
samples from the posterior is not possible. We relied on dependent realizations of the
system collected using a Markov chain Monte Carlo method. Using error bounds on the
finite sample size estimates obtained with MCMC, we derived hypothesis tests to decide
whether a temporal logic property holds with at least a given probability.
Our first case study on the JAK-STAT pathway showed that even though parameter
values cannot be well constrained, predictions made using the model (specifically the
dynamics of nuclear STAT protein) are reliable. We also found that the empirical
false decision rates for both the fixed sample size and sequential hypothesis tests are
in all cases below our derived error bounds. Next we turned to a large ODE model
of extrinsically triggered apoptosis. Here a very wide region of parameters could fit
measurement data, and the dynamics of many species showed large variability. We
found that properties involving species directly constrained by experimental data are
verified to hold with high probability. However, certain important properties of the
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model could not be verified to hold due to variability in dynamics.
Here we considered dynamical systems described as systems of ODEs. It is possible
to generalize the methodology to continuous-time Markov chain (CTMC) and stochastic
differential equation (SDE) models [143, 60]. In these models the system state over time
is described by a stochastic process. By conditioning on observations, one can consider
the posterior distribution of the system state (and any unobserved parameters), and
verify the system’s behavior with respect to this distribution. MCMC methods have
been proposed for sampling the posterior in such models [144], and our probabilistic
verification methods could be adapted to this context. It will also be interesting to
examine the use of methods other than MCMC, such as particle filters or approximate
Bayesian computation [64], however, rigorous bounds on the required sample size in
these settings is still an open question.
Our case study on the extrinsic apoptosis model was set up to represent the typical
characteristics of HeLa cells. There are versions of the model for other cell lines such
as HCT115, SKW6.4 and T47D [139], and it would be interesting to verify properties
for these cell lines as well. More generally, the case study showed that our proposed
method works on large biochemical pathway models with real experimental data. This
motives us to apply the method on other pathway models where limited experimental





network models of pathway
dynamics
5.1 Introduction
Changes in signal transduction are a key component of many complex diseases including
cancer. These changes are systemic in that their ground cause cannot usually be reduced
to a single element or even a single pathway. Some of the acquired characteristics of
cancer cells, including the ability to evade apoptosis and the insensitivity to anti-growth
signals can be linked to simultaneous changes in multiple signaling pathways [145]. A
key challenge is to understand the changes involved in the transformation to a diseased
state, and to find treatments to reverse or mitigate the effect of these changes.
Computational models are essential in combining prior knowledge with experimen-
tal data, and making predictions in this context [4, 1]. The modeling formalism chosen
needs to capture the dynamics of representative elements (usually the phosphorylation
of proteins) across several relevant pathways. The commonly used ordinary differential
equations (ODEs) formalism, which we have studied in Chapters 3 and 4, requires de-
tailed information about the reactions and their kinetics. It is difficult to capture effects
between elements that do not directly interact with each other, or when the mechanism
of the interaction is not well understood. In addition, ODE models do not capture the
stochasticity inherent in the dynamics of the underlying system. An alternative is to
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work with stochastic models whose dynamics are described in terms of continuous time
Markov chains [146, 147, 148]. However, these models are also based on molecular level
interactions and due to many unknown rate constants, it is computationally challenging
to deal with realistic biochemical networks. Scaling up is therefore restricted in both
the number of elements that can be modeled, and also in the portion of overall cellular
signaling covered. These properties highlight the need for a more abstract formalism
that can overcome these limitations.
Probabilistic graphical models including Bayesian networks and dynamic Bayesian
networks have received much attention as pathway models [12, 149, 150], primarily in
the context of gene regulatory networks. Here random variables (nodes in the graphical
model) are associated with the activity of a molecular species. In contrast with ODEs
and CTMCs, these models capture the interactions between elements as conditional
probability distributions, and do not require explicit knowledge of the underlying bio-
chemical mechanisms. Boolean and logical models offer a similar, abstract description of
relationships, but they are built on fixed, deterministic logical rules [47, 51]. Probabilis-
tic models will be able to better handle and incorporate several sources of uncertainty.
These include the noisiness of experimental data, the uncertainty arising from stochastic
dynamics, the variability among a population of cells, and also the uncertainty induced
by missing (unmodeled) elements.
In this chapter we propose dynamic Bayesian networks (DBNs) [10] as an appropriate
model of signal transduction in this context. We develop a novel method for learning
the parameters of dynamic Bayesian networks from experimental data, and then show
how the model can be used to make predictions. Specifically, we use the learned DBN
models to find “treatment” conditions that achieve specified system behaviors.1
Via a separation of concerns, we assume the structure of the DBN is known. Specif-
ically, we assume that directed interactions between the species involved in the pathway
can be obtained using prior knowledge networks [151, 152]. We then tackle the problem
of learning the relevant parameters of the DBN that are induced by the conditional prob-
ability tables associated with the nodes of the DBN. Existing Bayesian network learning
algorithms [153, 49] rely on discretizing the data, and then counting the occurrence of
1This chapter is based on the joint work, in preparation, with Mingsheng Zhang, Tathagata Dasgupta,
Jeremy Gunawardena, Peter Sorger, David Hsu, and P.S. Thiagarajan.
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value combinations in the data to determine conditional probability parameters. This
approach will require a very large amount of data, and necessitates the discretization
of otherwise continuous data. Further, the conditional probabilities whose associated
value combination did not appear in the data set will be undefined.
To address these shortcomings, we propose to learn DBN parameters using a con-
strained optimization approach. Linear constraints are used to incorporate prior knowl-
edge about the nature of interactions, which can be typically classified as activations or
inhibitions. The match to experimental data is captured by an objective function, which
can be posed as a linear expression. Procedurally, the learning starts from an initial
time slice, where the marginal probability distribution of each model variable is known.
We formulate and solve a linear programming problem for each time slice by using the
marginal distributions at the previous time slice. Linear programming (LP) is often
tractable even for large problems and is guaranteed to find a globally optimal solution
when it exists [154]. Previous work has proposed LP based approaches to structure
learning [155, 156] for gene regulatory networks in a deterministic setting. In contrast,
our method learns the dynamics of a probabilistic system model.
The second component of our work is a framework for finding treatment conditions
to achieve specified dynamics. During disease progression cells undergo a transforma-
tion from a healthy to a diseased state. An important aspect of this transformation
is a change in the way cells respond to external stimuli including growth factors and
inflammatory signals. Using targeted perturbations (for instance with drugs that inhibit
specific kinases) it is possible to reduce the effect of some of these changes, and this is
the basis of several existing molecular drugs [157]. Using a DBN model it is possible
to simulate the effect of such perturbations on elements of (possibly multiple) signaling
pathways. An important challenge is that the state of the DBN is described by a com-
plicated probability distribution. Consequently, we need to provide a way to formulate
the biologically relevant properties which should be attained through perturbations, and
show how to evaluate them on a DBN model.
We propose a framework based on a probabilistic temporal logic adapted for DBNs
following [158]. The logic can be used to specify dynamical properties such as: “AKT
reaches a high level with high probability under insulin stimulation”. These types of
statements are straightforward to construct and can be algorithmically verified when
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written as a temporal logic formula. Model checking has been previously applied to
pathway models [71, 78] and also specifically to DBN models [158]. However, in these
studies the goal was to assert and verify the properties of a model. Here, instead,
we exploit model checking to monitor the system dynamics under various treatment
conditions, and determine which conditions will ensure the specified temporal patterns.
If the set of all possible treatment conditions is discrete and small, we can exhaustively
search through them and report the ones satisfying a property. Otherwise, we can use
an optimization procedure on the space of possible treatments, and find ones with which
the number of satisfied properties is maximized.
We used our approach to model a network of signaling proteins involved in the
progression of liver cancer. This part of the work is in collaboration with the Department
of Systems Biology, Harvard Medical School, where all experiments were performed.
Protein phosphorylation data was collected for 12 key proteins taken from major cancer
pathways in 4 cell types. The cell types comprise human primary hepatocytes (HPH),
an immortalized hepatocyte cell line (HHL5), an early stage transformed hepatocyte line
(HepG2), and a late stage transformed hepatocyte cell line (Focus). These cell types
cover a range of stages from a healthy to a diseased, cancerous state.
The experimental data consists of measurements under multiple perturbations. Each
perturbation involves stimulation with one of five ligands, combined with one of five
small molecule drugs (kinase inhibitors). We have constructed a prior knowledge network
(PKN) based on the signaling pathway database GeneGO (www.genego.com) from which
we derived a DBN structure. We then used our approach to learn the parameters of a
DBN model for each cell type. We validated our models by training with only a part of
the available data and comparing predictions with the remaining, unseen data. Further,
a limited number of additional treatment combinations (multiple ligands combined with
multiple inhibitors) were measured for the HepG2 cell line, and our DBN model could
accurately predict activity under these conditions.
Subsequently, using our probabilistic model checking method we searched for com-
binations of kinase inhibitors that modify certain properties of diseased cells to match
those of healthy cells. This component of our work is motivated by increasing evidence
that combinations of drugs can be significantly more effective than individual drugs for
complex diseases including cancer [159]. Our approach can be adopted to search for
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such treatments and guide experiments in promising directions.
We defined a set of 18 characteristic dynamical properties that are verified to hold on
the DBN representing healthy cells. For instance, in one of the properties, we specified
that the protein cJUN stays at a low level with high probability under TNFα stimulation.
This holds in healthy cells but does not hold in diseased cells, and in fact, none of the
single inhibitors can prevent sustained cJUN activation in Focus cells. We then searched
the set of possible combinations of kinase inhibitors and evaluated them with respect to
each of the 18 properties. Our analysis yielded interesting results, for instance, we found
that on the Focus cell line, with any single inhibitor at most 6 of the properties can be
satisfied. But when using the combination of 2 inhibitors, as much as 10 characteristic
properties of healthy cells can be met.
The rest of this chapter is organized as follows. In Section 5.2, we introduce dynamic
Bayesian networks as models of biological pathways and review previous work. We
show how parameters defining the dynamics of these models can be learned using linear
programming in Section 5.3. In Section 5.4, we propose a temporal logic and model
checking framework to evaluate treatment conditions using the DBN model. In Section
5.5 we present a case study of our approach on liver cancer cell lines, and conclude the
chapter with a summary.
5.2 Background and previous work
5.2.1 Bayesian and dynamic Bayesian networks
A technical introduction to Bayesian and dynamic Bayesian networks was given in Sec-
tion 2.2.2. Here we review their use in the context of modeling biological pathways.
Bayesian networks have been used extensively in computational biology [160], and
specifically in representing gene regulatory networks [149, 161, 10]. They are a natu-
ral choice in this context, since they allow the modeling of indirect and probabilistic
influences among genes of interest. The structure of the model gives an easy to inter-
pret, graphical representation of dependences (and conditional independences) between
genes, without the need to include elements related to the exact mechanism of the ef-
fect, including mRNA and proteins. BNs have also been used to capture the structure of
signaling pathways in [11]. Here phosphorylation was measured at a single cell level, on
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proteins involved in T-cell signaling. The single-cell data under multiple perturbation
conditions enabled the learning of a Bayesian network structure among the proteins.
One limitation of BNs is their static nature, that is, the fact they do not include a
time component. This precludes the modeling and prediction of time course dynamics.
Even though time-resolved data is often available, this information is not exploited, and
instead, activity or no activity is summarized by a single value (as in [11]). Another
important limitation of Bayesian networks is that their structure is limited to acyclic
graphs. It is not possible to model feedback loops – a very important characteristic
of biological pathways – using Bayesian networks. These limitations are resolved by
dynamic Bayesian networks, which we discuss next.
DBNs are a special class of Bayesian networks [50], which include an explicit time
component. Each variable is represented at multiple time points, and edges represent
dependencies among variables in time. A basic assumption about DBN structure when
modeling biological pathways is that edges point forward in time [162]. This is a natural
assumption when describing temporal physical processes. This implies that DBNs are
guaranteed to be acyclic, and therefore feedback effects can be modeled across time
points. The first work to propose using DBNs for learning gene regulatory pathways
was [162]. Here the structural expectation maximization (SEM) algorithm was used to
infer the topology of a synthetic network consisting of 5 genes. The ability to model
feedback loops and to use time-course data motivated many other works in which the
aim is to learn the structure of a gene regulatory network, including [163, 164, 165, 166]
and [167].
More recently, DBNs were applied in the context of protein signaling in [12]. Here
a conditional Gaussian parametrization of the variables is assumed, and with a specific
choice of priors, the posterior probability of possible network structures can be obtained
in a closed form. The method was used to learn the structure among signaling proteins in
a breast-cancer cell line using reverse-phase protein array data. The structure inference
revealed possible links among proteins that have not been known before.
In all the above works (both for BNs and DBNs), the goal was inferring the structure
of a pathway model. These studies can elucidate important topological information, but
do not consider DBNs as executable simulation models of pathway dynamics. A relevant
work in this context by Liu et al. [15] proposes learning a DBN as an approximate but
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more efficient representation of an ODE model. The structure of the DBN is directly
derived from the ODE equations, and repeated simulation of the ODEs is performed to
populate the conditional probability tables of the discrete DBN. Approximate inference
methods on the DBN can then be used to perform simulation, sensitivity analysis and
model checking [158]. An important limitation of this approach is that it requires an
existing ODE model, which is in itself a considerable effort to build. Further, even with
a very large set of generated ODE trajectories, many of the conditional probabilities in
the DBN will be undefined. Our approach differs from [15] in several aspects. First, here
we propose a method to learn conditional probabilities directly from experimental data
rather than from an existing dynamical model. Further, we do not rely on discretizing
and counting value combinations to determine conditional probability parameters. In-
stead we solve a constrained optimization problem in a way that the data is kept on its
original, continuous scale. A useful feature of the constrained optimization approach is
that through the imposed constraints, all entries in the conditional probability tables
will be set.
5.2.2 Identifying drug effects
Biological networks are redundant and key processes are often controlled by several
interacting pathways. Consequently, many diseases are difficult to treat using a drug
targeting a single protein or gene. One possible solution is to use multiple drugs tar-
geted at distinct pathway elements to achieve a coordinated effect [168]. However,
experimentally evaluating such combinations is an arduous and expensive process due
to the exponential blowup of possible combinations. Computational models of pathways
could play a very important role in predicting responses to combination treatments, and
several recent works have attempted to do this. A structure learning approach is con-
sidered in [169] and [170], where the effect of a set of cancer drugs is learned through the
removal of edges from a signaling network model. This reveals interesting differences
in the effect of each drug, however, does not provide a predictive, dynamical model of
combinatorial drug effects. In [171] and [172], a generic template of ODE based cou-
pling is proposed between proteins. In this model, the time derivative of a protein’s
concentration depends on a non-linear transfer function of the linear combination of its
parents’ concentration levels. The goal is to find an optimal model structure with respect
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to steady-state experimental data. The model is then used to predict the steady-state
response under multiple perturbations. However, predicting transient dynamics under
perturbations are not considered. Further, a systematic way of finding combinations
meeting given criteria is also missing. In Section 5.4 we will address these shortcomings.
5.3 Learning DBN parameters using linear programming
In this section we describe our method to learn the parameters of a DBN model from
experimental data.
5.3.1 Structure from prior knowledge
First we assume that a signed prior knowledge network (PKN) is available. The PKN is
defined on a set S = {S1, S2, . . . , SN} of N molecular species of interest. The PKN gives
a signed parenthood relationship between these species via the function PA : S → 2R,
where R = S × {+,−}. If (Sj ,+) (or (Sj ,−)) is in PA(Si) then this indicates that
Si acts directly as an activator (or inhibitor) on Si. Such structural information is
available from several free and commercial interaction network databases such as KEGG
[173], GeneGo (www.genego.com), Cell Signal Technology (www.cellsignal.com) Science
Database of Cell Signaling (www.stke.sciencemag.org), and the NCI Pathway Interaction
Database [174]. All of these databases also provide information on the qualitative nature
of connections, including labels for activation or inhibition.
The next step is constructing a DBN structure from the PKN. We assume that the
structure of the DBN does not change over time, that is, the parenthood relationship of
the PKN is kept through all time points of interest. This could be a strong assumption
when considering long-timescale processes such as gene expression during development
[175]. However, it is reasonable when modeling signal transduction due to the shorter
time scale of interest.
The DBN is constructed by representing the set of species S as random variables at a
finite, discrete set of time points 0, 1, . . . , T . At each time point t the node set will consist
of St = {Sti | 1 ≤ i ≤ N}. The edges of the DBN are defined through the parenthood
relationships, namely, (St−1j , S
t
i ) ∈ E iff (Sj ,−) ∈ PA(Si) or (Sj ,+) ∈ PA(Si). We also
include edges from a variable to itself, that is, (St−1i , S
t
i ) ∈ E, for all 1 ≤ i ≤ N . These
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edges (also called persistence edges in [162]) are used to express that once a species is
activated, it may remain active (or deactivate slowly) irrespective of its parents. We
always set persistence edges with a positive sign.
A key assumption made when constructing a DBN is that edges only span between
neighboring time points t − 1 to t. This is a first-order Markov assumption on the
dynamics of the underlying process. Namely, it implies St+1 |= St−1|St, which, with the
parenthood relationship, is equivalent to the assumption that for each node Sti ,
St+1i |= (St−1,St\PA(Sti )) | PA(Sti ). (5.1)
This will not hold if species other than the parents of Sti influence its value when going
from t − 1 to t. Therefore the accuracy of the DBN representation relies on choosing
time points sufficiently close to each other. If measurement times are far apart compared
to the speed of underlying dynamics, one solution is to use interpolation on the data
points, as described in Section 5.3.5.
Example We use a small running example to illustrate some aspects of our approach.
The model includes 4 proteins involved in epidermal growth factor (EGF) signaling. The
PKN for the model is shown in Figure 5.1(a), and the corresponding DBN in Figure
5.1(b). The set of species in the PKN are S = {EGF, SOS, MEK, ERK}, and the par-
enthood relationship describes, that, for instance, PA(SOS) = {(EGF,+), (ERK,−)}.
In the DBN representation, random variables are introduced at each time point, for in-
stance, at t = 1, we have nodes S1 = {EGF1,SOS1,MEK1,ERK1}. The parenthood re-
lationship is extended to the DBN as, for instance, PA(SOS2) = {SOS1,EGF1,ERK1}.
The first-order Markov assumption imposed by the DBN would imply that, for instance,
MEK1 |= EGF0, and MEK2 |= EGF0 | (SOS1,MEK1).
5.3.2 Parametrization and constraints
The concentration level of each species in the DBN is represented as a discrete value
taken from a finite set. For convenience we assume all species take values from V =
{v1, v2, . . . , vK}, where V is a set of non-negative numbers with v1 < v2 < . . . < vK .
However, our construction will naturally hold when variables take values from different









EGF0 EGF1 EGF2 · · · EGFT
SOS0 SOS1 SOS2 · · · SOST
MEK0 MEK1 MEK2 · · · MEKT
ERK0 ERK1 ERK2 · · · ERKT
0 1 2 · · · T
(a) PKN (b) DBN
Figure 5.1: The prior knowledge network (PKN) and the derived dynamic Bayesian
network (DBN) representation of a small pathway.
set of conditional probability tables (CPTs), one for each node.
The CPT for the node Sti is denoted Θ
t
i, 1 ≤ t ≤ T , and it describes the probability
of Sti taking a value in V , given a value assignment to its parents. As suggested by the
notation, CPTs are assumed to be time-variant, meaning that, in general, Θti will not
be equal to Θt
′
i if t 6= t′. This is important especially if the time steps between available
measurements are not uniform. The entries in the CPTs can be written as Θti = {θti,j,k},
where θti,j,k = P (S
t
i = vk | PA(Sti ) = pii,j). Here pii,j is the jth possible value assignment
to the parents of Si, and j ∈ {1, . . . ,K |PA(Si)|}, i ∈ {1, . . . , N} and k ∈ {1, . . . ,K}. We





For the variable Si, the number of parent value assignments (we will also refer to
these as parent configurations) is K |PA(Si)|, and for each parent configuration the CPT
contains the entries of a conditional probability distribution described by K values. The




The number of parameters in each CPT grows exponentially with the number of parents,
but does not depend on the overall number of variables or time steps. This highlights
the fact that a sparse DBN structure (in which a node has few parents compared to the
overall number of nodes) is a succinct representation of a large stochastic model.
A key idea in our approach is exploiting the labels in the PKN to impose constraints
on our DBN parameters. We call these constraints monotonicity constraints, and base
them on the following insights. A positive or activating relationship between a parent
species and its target implies that if the parent takes on a higher value, the target’s
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value should not decrease. Conversely, for a negative or inhibitory relationship, the
parent’s higher value implies that the target’s value should not increase. In the context
of the DBN, we impose these constraints on the expected value of each species at time
t conditioned on the value of its parents at time t− 1. For instance, suppose that Y is
a parent of X with a positive relationship, and suppose that V = {L,H}, with L < H.
Then we demand that
E(Xt|Y t−1 = L) ≤ E(Xt|Y t−1 = H), (5.2)
capturing the intuition that as the concentration level of Y increases the concentration
level of X ought to increase (or at least not decrease). The conditional expected values
are easy to derive from the CPT entries, since











More systematically, we can define a partial ordering relation on the set of parent
configurations via:
pii,j1 4 pii,j2 iff ∀Y ∈ PA(Si)

pii,j1(Y ) ≤ pii,j2(Y ) and Y is an activator, or
pii,j1(Y ) ≥ pii,j2(Y ) and Y is an inhibitor.
(5.4)
Here we use the notation pii,j(Y ) ∈ V to refer to the value which is assigned to Y by the
parent configuration pii,j .
Example (continued) We continue the running example from the previous section.
Assume that the set V contains two values, v1 = 0 and v2 = 1, and so K = 2. The CPT
of MEK1 (in generic notation S13) would consist of 8 entries of the form
θ1311 = P
(
MEK1 = 0|MEK0 = 0,SOS0 = 0)
θ1312 = P
(
MEK1 = 1|MEK0 = 0,SOS0 = 0)
θ1321 = P
(




MEK1 = 1|MEK0 = 1, SOS0 = 1) .
Here, for instance, parent configuration pi3,1 corresponds to
(





MEK0 = 1, SOS0 = 0
)
. MEK has a positive edge from both of its parents, and
the monotonicity constraints will give a partial ordering on the parent configurations as
pi3,1 4 pi3,2, pi3,1 4 pi3,3, pi3,2 4 pi3,4 and pi3,3 4 pi3,4. The relationship between pi3,2 and
pi3,3 is not constrained. The partial ordering is described by a total of 4 monotonicity
constraints. In terms of the CPT entries, for example, the relationship pi3,1 4 pi3,2 is
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expressed as the constraint
P
(
MEK1 = 0|MEK0 = 0,SOS0 = 0) · 0 + P (MEK1 = 1|MEK0 = 0, SOS0 = 0) · 1 ≤
P
(
MEK1 = 0|MEK0 = 1,SOS0 = 0) · 0 + P (MEK1 = 1|MEK0 = 1, SOS0 = 0) · 1.
5.3.3 Experimental data
Next, we assume that a set of measurement data D is available, containing measurements
for each modeled species Si ∈ S. The data set consists of observations of each species Si
at time points 1, . . . , T , under C ≥ 1 experimental conditions, henceD is a data matrix of
shape N×T×C. We denote by Dti,c the measurement of Si at time t under experimental
condition c ∈ {1, . . . , C}. Each experimental condition can be characterized by (i) a set
of initial conditions (marginals) and (ii) a set of clamped nodes. The initial conditions
describe the probability distribution of variables at the initial time point. The initial
joint distribution is usually uncorrelated, and can be simply represented as a product of
marginal distributions for each node. Clamped nodes have a fixed marginal distribution
through the whole duration of the experiment. For instance, an inhibited node may
be represented by a marginal distribution taking a low value with probability 1. We
also allow for repeats of the same experiment by simply considering each repeat as
an experimental condition, but with identical initial conditions and clamped nodes.
Importantly, we assume that the experimental data is normalized (or the set of discrete
value V is set) in a way that guarantees v1 ≤ Dti,c ≤ vK for all i, t, and c. Since the
data is on a continuous scale between v1 and vK , it makes sense to draw correspondence
between the expected value of Sti under experimental condition c and the data point
Dti,c. In the next section we describe an optimization problem that achieves this.
Example (continued) A dataset of our running example could consist of two exper-
imental conditions (C = 2), corresponding to the existence or lack of EGF stimulation.
This can be interpreted on the DBN by having the marginal of EGF clamped to a
high value (mt1,1(0) = 0,m
t
1,1(1) = 1, t ∈ {0, . . . , T}) in the first condition, and to a
low value (mt1,2(0) = 1,m
t
1,2(1) = 0, t ∈ {0, . . . , T}) in the second condition. In both
conditions, the initial distributions of the remaining three species could be set to a low
value: m0i,c(0) = 1,m
0
i,c(1) = 0, i ∈ {2, 3, 4}, c ∈ {1, 2}.
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5.3.4 Parameter optimization
Our goal is to find parameters for our DBN model such that the expected values of
species, as inferred from the DBN, match the experimental data. Taken together with
the monotonicity constraints, we can pose this as a constrained optimization problem.
The main idea behind our parameter optimization is to start from the initial marginals
defined by the experimental conditions, and iteratively (i) learn the parameters for the
next time point based on the data for that time point, and then (ii) infer the marginals
for each experimental condition at the next time point to be able to continue with step
(i). This is an iterative process, which, after T steps will give us the parameters at all
time steps.
Since both the monotonicity constraints and the fit to data will be defined in terms of
expected values, it makes sense to pose the optimization problem in terms of conditional
expectations rather than directly the CPT entries, which are conditional probabilities.
We denote the conditional expectations as θti,j = E(Sti | PA(Sti ) = pii,j), and draw the







Inductively assume we have marginals available at t− 1 with t ≥ 1. (Note that the
initial marginals (t = 0) are fully defined by the experimental conditions.) Each marginal
will be a vector describing the probability distribution of node Sti for each experimental
condition c, and is denoted as mt−1i,c := (m
t−1
i,c (v1), . . . ,m
t−1
i,c (vK)). Through the (yet
unknown) parameters θti,j , we can project these marginals, approximately, to expected














In the first equation Pc(PA(S
t
i ) = pii,j) expresses the joint probability of the parent
configuration pii,j under experimental condition c. The second equation then uses an as-
sumption of independence to approximate this joint probability by a product of marginal
probabilities, where mt−1`,c (pii,j(S`)) is the marginal probability assigned to S` ∈ PA(Si)
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at time t − 1 by the configuration pii,j . The approximation of joint probabilities by a
product of marginals also appears in the widely used factored frontier (FF) algorithm
[176], and is shown to often work well in practice. This approximation is necessary for
large models, since representing the joint distribution would be intractable.
We are now ready to formulate the constrained optimization problem for time t by
collecting what we have discussed so far, as follows:
Boundary constraints: ∀i, j : v1 ≤ θti,j ≤ vK ,
Monotonicity constraints: ∀i, j1, j2 for which pii,j1 4 pii,j2 : θti,j1 ≤ θti,j2 ,



























Here d is a distance measure between a data point and an expected value. Notice that the
constraints are linear, and the expected value is also a linear function of the parameters.
Therefore, if we choose d to be the L1 distance, the problem can be expressed as a linear
programming (LP) problem. It is also possible to choose the L2 distance, in which
case the problem becomes one of quadratic programming (QP), or more specifically, a
linearly constrained least-squares problem. Section 5.5.4 will show that the predictive
performance of using either method is similar. Therefore we focus on LP, since it can
be solved more efficiently.
The general form of linear programming is
minimize fTx
subject to Ax ≤ b,
(5.9)
where x is a vector of unknown variables (corresponding to the vector of parameters
θti,j in our case), the coefficients in f correspond to the objective function, and A and b
specify the constraints. The boundary and monotonicity constraints in (5.8) are trivially
expressed through A and b. We now show how the objective value can be expressed as
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∣∣Eti,c −Dti,c∣∣ . (5.10)
This can be expressed as a linear function by using slack variables yti,c (see also [154]).
Namely, we can add the constraints
yti,c ≥ Eti,c −Dti,c and (5.11)
yti,c ≥ Dti,c − Eti,c, (5.12)








The linear programming problem can be solved efficiently using standard algorithms
available in many free and commercial software packages (for more details, see Section
5.3.5). The solution of the optimization problem gives us the values of conditional
expected value parameters θti,j . We now need to reconstruct conditional distributions
from these values. This is an ill-posed problem for K ≥ 2, since the distribution will
have K entries, while the expected value is a single scalar. To resolve this, we use the
minimum variance criterion, which finds the distribution with minimum variance, whose











(vk − θti,j)2θti,j,k is minimized .
The minimum variance criterion is reasonable, since, lacking information about the exact
shape of the distribution, we are characterizing it by its first moment.
Having obtained θti,j,k, for all i, j, k, we can now infer marginals at time t from time








Since we now have available all the marginals at time t for experimental conditions
c ∈ {1, . . . , C}, we can proceed to the next time step to learn θt+1i,j,k, and continue
iteratively up to the last time T .
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5.3.5 Properties and extensions
Properties of the LP problems
We observe that in (5.8) the constraints on the parameters are independent for each
species. Further, the objective function is a summation of species-wise objective func-
tions. This is because the optimization is solved step by step in time, hence the pa-
rameters, and the marginals for each condition at the previous time point are fixed.
Therefore, in the present construction, the parameters can be learned locally for each
species. In fact, at each time point t, we can solve the N local LP problems in parallel.
This decomposability is also crucial, since it means that the size of each LP problem
is locally determined. Namely, for each node, the LP will be of exponential size in the
number of parents but independent of the overall number of nodes.
Proposition 1. (1) The number of variables (other than slack variables) solved for
by the decomposed LP problem for Sti is K
|PA(Si)|. (2) The number of monotonicity
constraints needed to fully specify the partial ordering is |PA(Si)|K |PA(Si)|−1(K − 1).
Proof. Part (1) holds since the variables in the LP problem are the set of conditional
expected values {θti,j}. There is one such expected value for each parent configuration,
the total number of which is K |PA(Si)|. For part (2), consider that with all other parents
fixed, a parent will have K − 1 monotonicity constraints between its value assignments
v1, v2, . . . , vK , and The number of possible fixed configurations for all other parents is
K |PA(Si)|−1.
In a pathway, the number of species that directly influence any particular species
is often limited and thus the graph of DBN will usually be sparsely connected. As
seen from Proposition 1 each individual LP problem will remain tractable even for large
pathways.
We can also easily see that the LP problem for each Sti will always have a solution.
Proposition 2. The LP problem posed at node Sti will always be feasible and have an
optimal solution.
Proof. The LP problem is feasible if there exists a value assignment to the unknown
variables which satisfy all the constraints. In our case, simply setting θti,j = ν, where
ν is a constant such that v1 ≤ ν ≤ vK , will trivially satisfy both the boundary and
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monotonicity constraints. The slack variables will also always be feasible simply by
yti,c ≥ |Dti,c − Eti,c|. Further, since the slack variables are bounded from below, and we
are solving a minimization problem on the sum of slack variables, an optimal solution
is guaranteed to exist.
Solving the LP problems
Any optimal solution to a feasible LP problem is also globally optimal, and can be
found in polynomial time [154]. Several algorithms including the simplex method and
interior point methods have been proposed and implemented in tools to solve large LP
problems efficiently in practice. It is often the case that more than one optimal solution
exists for the optimization problem. One shortcoming of LP solvers is that they only
return a single optimal solution. Therefore our learned DBN will be based on only one
of potentially many existing solutions.
The most important free LP solvers include lp solve [177] and the GNU Linear
Programming Kit (www.gnu.org). Several commercial solvers including IBM CPLEX
(www.ibm.com), and ones included with software such as MATLAB (www.mathworks.com)
are also available. Benchmarks show that current solvers can handle on the order of 106
variables and constraints [178].
Interpolation
Until now, we have taken the time slices of the DBN model to correspond to the time
points where measurement data is available. However, effects in the underlying system
could propagate at a speed which is not necessarily consistent with the time points when
measurement data is obtained. The first-order Markov assumption may be too restric-
tive to adequately represent the system dynamics. This can be resolved by introducing
additional, intermediate time slices in the DBN. By introducing these additional time
slices, variables that are correlated in the underlying system can be correlated in the
DBN as well. However, data is needed to formulate the objective function of the opti-
mization problem at each time step. Therefore we provide a simple interpolation method
by which the formulation of an objective function becomes possible at intermediate time
steps.
Based on the DBN structure we first compute Tcorr, the number of time steps after
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which all variables that can get correlated will be correlated. Between any two time
points t and t+ 1 at which we have data, we introduce Tcorr − 1 additional time points
and use linearly interpolated values as data for these time points using the actual data
values available at t and t+1. Suppose we introduce the time points (τ, τ+1, . . . , τ+Tcorr)






(Dt+1i,c −Dti,c) for 0 ≤ k ≤ Tcorr. (5.15)
Using these data points, we can formulate a sequence of LP problems to learn the
DBN parameters.
Example (continued) In our running example, Tcorr = 3, since EGF
0 will be first
correlated with ERK3 through the path EGF0 → SOS1 → MEK2 → ERK3.
5.4 Treatment evaluation using model checking
The second main contribution of this chapter is developing the means for identifying
treatment conditions using which the dynamics of the pathways under study can be
reshaped. Treatment conditions typically consist of the addition of ligands or inhibitors,
which stimulate or block certain pathway components. Under treatment conditions,
pathways will change their dynamics in response to internal or environmental cues. It is
important to predict these changes computationally, since the set of possible treatments
is usually combinatorial, and only a small subset can be studied experimentally. If we
are able to find possibly relevant treatments with the help of the model, experiments
can be focused towards verifying this limited set of conditions.
Treatments on a pathway can be translated to DBN models through imposing ini-
tial conditions and clamping nodes. Having learned a DBN model using the method
described in Section 5.4, we can use inference to recover the state distribution under
various treatments. However, characterizing the “behavior” of a DBN model is chal-
lenging since the system state is described by a sequence of probability distributions in
time. A language or formalism is needed to make statements about the state trajectory.
This formalism needs to be interpretable on a DBN, and needs to be able to express bi-
ologically relevant behavior types. Here we propose to use a probabilistic temporal logic
to make statements about the temporal evolutions of the probabilistic system state.
112
In a discrete DBN the marginal distribution of variables can be efficiently recovered
using inference. This motivates us to make temporal logic statements about the state
evolution of the system through its sequence of marginal distributions. An appropriate
temporal logic will therefore be interpreted on a sequence of probability distributions.
This is different from the logic used in Chapter 4 (PBLTL) in that here we will make
statements about the marginal distributions of variables, rather than individual realiza-
tions of the state dynamics. Such logics have been developed before in the literature
for Markov chains [179, 180], and also specifically for DBNs [158]. We adopt here a
probabilistic bounded linear temporal logic (PBL) from [158]. By making statements
explicitly on marginal distributions, PBL is well suited for performing model checking
on DBNs.
5.4.1 Probabilistic temporal logic for the DBN
The atomic propositions of PBL are defined as (i, v)#r, where i refers to the species
Si ∈ S, v ∈ V , # ∈ {≤,≥} and r is a probability threshold in (0, 1). The atomic
proposition (i, v) ≥ r is satisfied at time t if and only if mti(v) ≥ r (similarly for
(i, v) ≤ r), where mti(v) is the marginal probability of species Si being at level v at time
t.
The formulas of PBL are generated by the following syntax:
• The truth constants true and false are formulas.
• Every atomic proposition (i, v)#r is a formula.
• If ϕ and ϕ′ are formulas then so are ¬ϕ and ϕ ∨ ϕ′.
• If ϕ and ϕ′ are formulas then so is ϕUϕ′ .
The temporal operators G (always from now), F (some time from now) can be derived as
Fϕ = trueUϕ; Gϕ = ¬F(¬ϕ). The logical operators ∧,⇒ and⇔ are defined as follows.
ϕ∧ϕ′ = ¬(¬ϕ∨¬ϕ′), (ϕ⇒ ϕ′) = (¬ϕ∨ϕ′), and (ϕ⇔ ϕ′) = (ϕ⇒ ϕ′)∧ (ϕ′ ⇒ ϕ). This
syntax allow us to express a range of system dynamics patterns as illustrated in Table
5.1.
The formulas of PBL are interpreted on the sequence of marginal distribution vectors




2, . . . ,m
t
n) is a vector of marginal
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Required dynamics Formula Explanation
ERK is not activated G((ERK, vL) ≥ 0.8) ERK is always at a
low level with high
probability.
ERK is transiently acti-
vated
F((ERK, vH) ≥ 0.8)
∧F(G((ERK, vL) ≥ 0.8))
ERK reaches a high level
after which it remains at
a low level.
ERK is activated and sus-
tained
F(G((ERK, vH) ≥ 0.8)) ERK reaches a high level
and stays at a high level.
Table 5.1: Examples of PBL properties for the dynamics of the protein ERK. Here
V := {vL, vH}, and vL denotes a low value and vH a high value.
distribution for each variable in Sti ∈ St, 1 ≤ i ≤ N . We let σ(t) = st and st(i) = mti.
We let σ(t) |= ϕ denote that ϕ holds at t, and define its semantics as follows.
• σ(t) |= (i, v) ≥, r iff mti(v) ≥ r,
• σ(t) |= (i, v) ≤, r iff mti(v) ≤ r,
• σ(t) |= ¬φ iff σ(t) 6|= ϕ,
• σ(t) |= φ ∨ φ′ iff σ(t) |= ϕ or σ(t) |= ϕ′,
• σ(t) |= Oϕ iff σ(t+ 1) |= ϕ,
• σ(t) |= ϕUϕ′ iff ∃t′ : t ≤ t′ ≤ T and σ(t′) |= ϕ′, and ∀t′′ : t ≤ t′′ < t′, σ(t′′) |= ϕ.
Using the above inductive definition, we say that the DBN D meets the specifications
ϕ iff σ(0) |= ϕ, and we denote this as D |= ϕ.
The task of a model checker is to determine whether a specification ϕ is met. Given
a sequence of marginals σ and a specification ϕ the model checker returns either true
or false depending on whether σ(0) |= ϕ. We perform model checking in an on-line
fashion, in which it is possible to stop early if the truthhood of the property can already
be determined. Such an on-line model checker is presented in [158], which we refer to
for more details.
In our setting one performs inference on the DBN to reproduce the sequence of
marginals, which the model checker can verify. We now look at inference algorithms on
the DBN.
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5.4.2 Inference on the DBN
Inference on a DBN involves recovering the joint probability distribution of the set of
variables at each time point. The joint distribution at a given time point is called the
belief state. Exact inference on DBNs is intractable in general [50, 181]. In fact, for
DBNs with many variables, even representing the belief state is intractable, since with
N variables, KN entries are needed to represent it. Approximate inference algorithms
rely on breaking up the belief state into a product of lower dimensional distributions.
The Boyen-Koller (BK) algorithm [181] propagates joint distributions on smaller clusters
of variables, whose product is a surrogate for the full belief state. The factored frontier
(FF) algorithm [50] uses a cruder representation of the belief state, by only maintaining
the marginal distribution of each node. The belief state is then approximated by the
product of individual marginals. The marginals at the previous time slice are mapped
directly to the ones at the next time slice, without reconstructing the full belief state.
Recently a parameterized version of FF called hybrid FF (HFF) was proposed [182].
The idea behind HFF is to maintain a limited number of spikes corresponding to entries
in the full belief state, resulting in improved accuracy.
Here we use the factored frontier algorithm (FF) since it is efficient for large pathway
models. This is crucial, since we will need to use inference repeatedly, under a large
number of conditions, when searching for treatments. We now describe the FF algorithm
in more detail.





the (marginal) probability of Sti assuming the value v, with v ∈ V . Given the marginal
distribution of species at the initial time point t = 0, the task is to infer the marginals at
the time points t = 1, 2, . . . , T . The approximate marginals FF computes are denoted as




















Recall that pii,j(S`) ∈ V denotes the value assigned to S` ∈ PA(Si) in the parent
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configuration pii,j , and the conditional probability parameters θ
t
i,j,k are obtained using
the method outlined in Section 5.3.
The set of marginals thus computed can be viewed to be an approximate, factored
representation of the joint system state and can be used to monitor the evolution of the
system state over time.
5.4.3 Treatment evaluation
Model checking is commonly used to verify inherent properties of a model. Here we
propose to use model checking as a method to monitor the behavior of a DBN model
under multiple conditions, and find ones with which a specified property is met. A
treatment condition can be characterized by clamping the marginal distribution of a
subset of nodes to an externally set value. For instance, we can model the effect of a
molecular inhibitor by clamping its target to a marginal taking a low value with high
probability. Alternatively, if the inhibitor itself is a node in the DBN, one can set its
marginal to one that assigns high probability to a high value.
More generally, assume that we can clamp a subset of species Z ⊂ S, and let Z =
{Z1, Z2, . . . , Zm}. The clamped species can be associated with their corresponding DBN
nodes in the obvious way. A treatment condition can be described by the set of externally
fixed marginals MZ := {mtZi}, 1 ≤ i ≤ m, 0 ≤ t ≤ T . There are technical restrictions






The effect of a treatment can be evaluated by performing inference on the DBN
with respect to MZ . In Section 5.4.1 we defined how D |= ϕ (that is, that the DBN D
meets the property ϕ) can be determined using the sequence of marginals for each time
point. We will denote the DBN model subject to the treatment condition MZ as DMZ .
Consequently, we will say that the DBN meets the property ϕ under the treatment
MZ if the marginals, when performing inference under MZ , meet ϕ. We denote this
as DMZ |= ϕ. This gives the conceptual basis of evaluating treatment conditions with
respect to dynamical properties on a DBN.
Example (continued from Section 5.3) Recall the example DBN model in Figure
5.1. Assume that we have inhibitors available for SOS or MEK (Z = {SOS,MEK}).
One treatment condition could involve inhibiting MEK alone (Z ′ = {MEK}). This
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can be achieved by clamping MEK to a low value with high probability, that is, MZ′ is
defined as setting m0MEK(0) := 1,m
0





t = 1, 2, . . . , T . It is then possible to verify if DMZ′ |= ϕ, where ϕ is a PBL property.
5.4.4 Treatment finding
Having the means to evaluate the effect of a given treatment, we can also pose the inverse
problem of finding a treatment with given properties. There will usually be several prop-
erties of interest ϕ1, ϕ2, . . . , ϕL which should be satisfied using a treatment condition.
Our goal will be to look for treatments that maximize the number of satisfied proper-
ties. Until now we have considered combinations of both ligand stimuli and molecular
inhibitors as possible treatment conditions. However, here it makes sense to focus only
on inhibitors, since stimulation by ligands is controlled by the cell’s environment, and
usually not part of a drug treatment regime. Further, we will assume that if a node is
clamped, its marginal is set to a pre-determined fixed value and the marginal entries
are not, themselves, subject to optimization. With these assumptions a treatment will
be fully characterized by Z ′ ⊆ Z, since the marginals MZ′ will be a fix function of Z ′.
Our goal will now be to




DMZ′ |= ϕi is maximized. (5.17)
In other words, we are searching for the subset of clamped nodes with which the
highest number of properties are satisfied. There are other constraints we can include
in the optimization problem. For instance, we can restrict the maximum number of
clamped nodes to a fixed value (e.g. require that |Z ′| = 2 to search for the best pair of
clamped nodes).
If the set of possible treatment conditions is low, an exhaustive search over the
subsets of Z will be possible. Otherwise we can use a global optimization method on
the discrete search space to find the best treatment. A treatment condition can be
encoded as a binary vector of length |Z|, where the ith component of the vector is 1 iff
Zi ∈ Z ′. Many discrete search methods exist that can solve a maximization problem
on such a vector, including tabu search [183] and genetic algorithms [57]. More recently
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a discrete version of the Hooke-Jeeves method was used to perform optimization on
pathway models [158] and can also be applied here.
5.5 Modeling signaling in liver cancer cell lines
In this section we apply our proposed method to model signaling in the progression of
liver cancer [184, 43]. We learn 4 DBN models corresponding to 4 cell types ranging from
healthy to late stage cancer cells. We use cross validation and additional experiments
to assess if our models can predict the dynamics of protein activity under previously
unseen perturbations.
Then we use our treatment evaluation formalism to specify characteristic properties
of healthy cells and search for combinations of small molecule drugs (kinase inhibitors)
with which the most number of properties can be satisfied on each of the diseased cell
line models. Our results are valuable for guiding further experimentation, and could
lead to a better understanding of changes in signaling during cancer progression and
possible treatments.
This experimental study was conducted in collaboration with the Department of Sys-
tems Biology, Harvard Medical School, where all wet-lab experiments were performed.
5.5.1 Experimental data
To identify differences in signaling associated with tumor progression, experiments were
conducted on four human liver cell types. Primary hepatocytes (HPH) are isolated
from human donors and represent healthy liver cells. HHL5 cells are representative
of immortalized but not overtly transformed cells [185]. HepG2 [186] and Focus [187]
cell lines are both derived from hepatocarcinomas but Focus cells represent a higher
pathological grade of cancer.
Measurements were conducted under multiple conditions. Cells were exposed to one
of 5 ligands, in the presence or absence of one of 5 small molecule kinase inhibitors.
Multiplex bead-based immuno-sandwich assays using Luminex technology (BioPlex as-
says; www.luminexcorp.com) were performed. This provided simultaneous quantitative
measurements on the levels of modification of 12 signaling proteins under a total of 30
conditions (plus controls). The ligands and inhibitors used, and the measured proteins
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Figure 5.2: Experimental data on primary liver cells (HPH), an immortalized cell line
(HHL5) and two transformed liver cancer cell lines (HepG2, Focus).
are listed in Table 5.2. Measurements of signaling activity were obtained 10, 30, 90 and
360 minutes after applying ligand stimulation. Previous studies have established the se-
lectivity and linearity of these measurements [43]. The phosphorylation events assayed
correspond to sites of activating modification and therefore serve as a surrogate for the
level of activity of the signaling protein.
Data was normalized to the [0, 1] range with respect to the no-treatment control and
the measurements at the initial time point, following the methodology of [42]. The data
organization and processing was carried out in the MATLAB toolbox DataRail, which
was developed for high-throughput data management and integration [188]. Figure
5.2 shows the full experimental data set visualized with DataRail. The data consists of
measurements on 4 cell types (plotted separately), across 5 ligand treatments (columns),
combined with no inhibitor (DMSO) or one of 5 small molecule drug inhibitors (sub-
columns). Each rectangle contains a filled time-course plot of measured activity for the




IGF-1 Insulin related growth factor
TGFα Transforming growth factor
TNFα Tumor necrosis factor
IL-1α Interleukin-1



















Table 5.2: Ligands, inhibitors and measured proteins used to collect experimental data
for the liver cancer study.
5.5.2 Prior knowledge network
A prior structure was first assembled from the GeneGo database containing a total of
29 nodes and 71 edges. The set of nodes includes 5 ligands, which only have outgoing
edges, 12 proteins, whose phosphorylation is measured, and 12 hidden (unmeasured)
nodes, out of which 4 can be inhibited in experiments using small molecule drugs (p38
is in the set of measured proteins but can also be inhibited). This prior structure is
shown in Figure 5.3 (a).
We reduce the prior structure to a prior knowledge network (PKN), as defined in
Section 5.3.1, by two transformation steps. First, we compress out hidden nodes as
follows. The prior structure is a directed graph in which two nodes are connected if
there is a sequence of directed edges (a path) between them. Starting from each ligand,
we find paths on which the internal nodes are hidden nodes, until the first measured
node is reached. We then add a direct edge from the ligand to this measured node.
The same is done starting from each measured node, which has at least one edge to an
unmeasured node. The signs on the new edges are set consistent with the signs along
the path they replace. For instance, a path with two negative edges will be replaced
by a positive edge, and a path with one negative and one positive edge with a negative
one. Thereby, all hidden nodes are removed, and their effect is represented through
the newly added edges. Second, we model inhibitors explicitly, as input nodes, with
outgoing edges to the targets of the species they inhibit, but with opposite sign. For
instance, MEKi (the inhibitor of MEK) will be modeled as an input node with outgoing
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Figure 5.3: Prior knowledge network for signaling in liver cancer. (a) Prior structure
extracted from databases. (b) Compressed PKN used as basis for DBN construction.
Green arrows show activation, and red arrows inhibition.
inhibitory edges to p38, ERK and GSKs (since MEK had outgoing activation edges to
p38, ERK and GSKs). Following this procedure, the resulting structure has 22 nodes,
including 5 ligands, 5 inhibitors and 12 measured species. The total number of edges is












































































































































































































































Learning the DBN parameters involves solving one LP problem for each of 12 measured
species at 4 time points. For the 12 proteins in the DBN we chose 3 discrete levels at 0, 0.5
and 1, and for the nodes representing ligands and inhibitors we set two levels at 0 and
1. We added 1 intermediate time point between each measurement time (the correlation
time Tcorr = 2 for this pathway). Thus, the total number of LP problems solved is 96.
For the 12 measured species in the pathway, the number of DBN parameters ranged
between 9 and 6912, and the number of LP constraints were between 72 and 41532 (for
p90RKS and p70S6K respectively). The time taken to learn the DBN was, on average
44.3 seconds for each cell line, on a 3.3GHz desktop computer. The LP problems were
solved using the CPLEX (www.ibm.com) solver. We note that the LP problems at each
time slice could also be solved in parallel, further speeding up learning.
5.5.4 Validation with test data
We first show that a DBN learned using our proposed approach has predictive abil-
ity. To do so, we performed cross validation as follows. Recall that the original data
contains combinations of a ligand (one out of 5) combined with either no inhibitor or a
single inhibitor (one out of 5). To imitate the existence of unmeasured combinations, we
masked data for all species at all time points for 5 such combinations. Each run of cross
validation uses a different set of masked cases. For instance, in the first run, the com-
binations INS+PI3Ki, IGF+MEKi, TNFα+MTORCi, TGFα+p38i and IL-1α+AKTi
were masked, and the pairings were rotated to generate the remaining 4 cross validation
runs. In each run, we used the remaining data as a training set, learned the correspond-
ing DBN model, and then used inference on the resulting model to predict the masked
data.
We chose the mean absolute deviation as a measure of prediction accuracy, motivated
by the fact that DBN parameters were learned from the training data using the same
distance measure. The mean absolute deviation in predicting the time course dynamics
by the cell type specific DBNs was 0.064 for HPH, 0.041 for HHL5, 0.097 for HepG2
and 0.085 for FOCUS. These error rates are all below 10% of the possible range of
predicted values, and are comparable to the magnitude of measurement noise in the
data set. We also compared these values to predictions against scrambled data (the
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Figure 5.5: Prediction accuracy (mean absolute deviation) with respect to masked data
for each species, under different ligand treatments. Values averaged across 5 cases, all
cell lines and time points.
Cell type DBN Scrambled Random
HPH 0.064 0.104 (p < 10−12) 0.446
HHL5 0.041 0.071 (p < 10−12) 0.474
HepG2 0.097 0.161 (p < 10−16) 0.439
Focus 0.085 0.176 (p < 10−30) 0.444
Table 5.3: Mean absolute deviation of estimates from the true data values for liver cell
lines. The p-value of t-tests between the DBN predictions and the predictions with
respect to scrambled data are also shown indicating the significance of the difference.
order of masked data values were randomly scrambled when comparing to predictions)
and random predictions (uniform random predictions in the [0, 1] interval). These results
are shown in Table 5.3.
The prediction accuracy broken down by ligand and measured protein is shown in
Figure 5.5. There is some variability across ligands and proteins, but in all cases the
mean absolute deviation is below 0.25, and in most cases below 0.1. We also compared
the accuracy of predictions by the time point of measurement (Figure 5.6, top). The
early dynamics (10 and 30 minutes) are generally harder to predict, and better accuracy
is seen in predicting the later dynamics (90 and 360 minutes).
Next we looked at the effect of the number of interpolation time points used. DBNs
were learned with 0 to 4 interpolation time points; the prediction accuracies are shown
in Figure 5.6 (bottom). There is only a slight increase in accuracy with an increasing
number of interpolation time points, but the time needed to learn the model grows
linearly with the number of interpolation times. Therefore the choice of 1 interpolation
time point (equal to the correlation time of the DBN) is a reasonable choice.
Finally, we compared whether posing the constrained optimization problem using
the L1 measure (linear programming, LP) or the L2 measure (quadratic programming,
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Figure 5.6: Prediction accuracy on cross validation data for data at different time points
(a) and when learning with different number of interpolation time points (b)
QP) affects prediction accuracy. Using QP is more computationally intensive than LP,
and therefore its use is only justified if it provides considerable improvements. The
results in Figure 5.7 show that there is little difference between using LP or QP in terms
of accuracy. In fact, the mean absolute deviation of predictions is better for only 1 out
of 4 cell types with QP. When using the root mean square error to assess prediction
accuracy (a measure more well suited for QP), there is only a very small change in the
accuracy of LP and QP. Learning DBN parameters using QP took, on average, 330.8s
for each cell line, making it around 7 times slower than the same procedure with LP.
We conclude that the more efficient and scalable LP is a good choice for posing the
constrained optimization problem used to learn DBN parameters.
5.5.5 Experimental validation
An important component of our work is predicting dynamics under combination of lig-
ands and inhibitors that have not appeared in the training data set. In the previous
section we assessed the performance of learned DBNs on predicting a masked portion of
the training set. In this section we make use of additional experimental data measuring
the effect of some further treatment combinations. These combinations are summa-
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Figure 5.7: Comparison of prediction accuracy when solving the optimization with the
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Figure 5.8: Structure of validation experiments on the HepG2 cell line. Ligand sets 1−7
are measured combined with inhibitor sets A–K. Bold ligand sets are only combined with
bold inhibitor sets. Other ligand sets are combined with all inhibitor sets.
rized in Figure 5.8. Excluding control measurements, this gives a total of 56 treatment
conditions, some examples being TNFα + PI3Ki + MEKi and INS + TGFα + p38i.
The validation experimental data is limited, namely, it is only available for the
HepG2 cell line, and at the single 30 minute time point. Further, the value of the
fluorescence measurements cannot reliably be compared to those in the original training
set. However, it is possible to determine whether a certain treatment combination
resulted or did not result in the activation of a protein. Therefore we used the validation
data in the following way. We normalized the validation data to the [0, 1] range, taking
into account control measurements, and then discretized it with the threshold set at 0.5
(with this choice, 23.5% of the data points were “active”). We used the cell type specific
DBN model learned using the original training data set for the HepG2 cell line (see data
in Figure 5.2). We simulated the DBN under all conditions appearing in the validation
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Figure 5.9: ROC curve of DBN predictions of protein phosphorylation under multiple
combinations of ligands and inhibitors.
data set using the FF algorithm and recovered the state of the DBN corresponding to
the 30 minute time point. The “activation” of a protein on the DBN was interpreted by
requiring that the probability of the protein S taking a low value is smaller than a given
threshold (P (S = 0) ≤ γ, γ ∈ (0, 1)). This provides a binary prediction of activity, with
which it is possible to calculate the true positive/negative and false positive/negative
rates of the predictions with respect to the validation data. We chose a range of different
thresholds between γ = 0.01 and 0.99 for the output of the DBN and drew a receiver
operating characteristic (ROC) curve of the false positive and true positive rates (Figure
5.9). The ROC curve shows that DBN predictions maintain low false positive rates while
reaching a high true positive rate, as the threshold is decreased.
5.5.6 Treatment evaluation
In the previous sections we showed that we can learn cell type specific DBN models
for the 4 cell types of interest, and that these models have the capability to predict
dynamics under treatment conditions not covered by training data.
In this section, we use the learned cell type specific models to evaluate treatment
conditions and find ones that achieve specified dynamics. Our method for treatment
evaluation and optimization introduced in Section 5.4 can be used with any specifications
of interest expressed as PBL formulas. Here we will specify formulas based on the
dynamics of protein phosphorylation in healthy cells (HPH). Our motivation in doing so
is to find combinations of inhibitors, which when applied on the transformed cell lines
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ID Ligand Property Formula
ϕ1 TNFα cJUN stays at a low to medium level ((TNFα, vH) ≥ 1)⇒ G((cJUN, vL) ≥ 0.6)
ϕ2 TGFα cJUN is activated and sustained ((TGFα, vH) ≥ 1) ⇒ F((cJUN, vH) ≥ 0.2
∧FG((cJUN, vL) ≤ 0.5))
ϕ3 IL-1α cJUN is activated and sustained ((IL-1α, vH) ≥ 1) ⇒ F((cJUN, vH) ≥ 0.2
∧FG((cJUN, vL) ≤ 0.5))
ϕ4 TGFα ERK is activated and sustained ((TGFα, vH) ≥ 1) ⇒ F((ERK, vH) ≥ 0.2
∧FG((ERK, vL) ≤ 0.5))
ϕ5 TGFα HSP27 is transiently activated ((TGFα, vH) ≥ 1) ⇒ F((HSP27, vL) ≤ 0.5
∧FG((HSP27, vL) ≥ 0.8))
ϕ6 INS GSK3s stays at a low level ((INS, vH) ≥ 1)⇒ G((GSK3s = vL) ≥ 0.8)
ϕ7 IGF GSK3s stays at a low level ((IGF, vH) ≥ 1)⇒ G((GSK3s = vL) ≥ 0.8)
ϕ8 TGFα GSK3s is transiently activated ((TGFα, vH) ≥ 1) ⇒ F((GSK3s, vM ) ≥ 0.25
∧FG((GSK3s, vL) ≥ 0.8))
ϕ9 TNFα CREB stays at a low level ((TNFα, vH) ≥ 1)⇒ G((CREB = vL) ≥ 0.8)
ϕ10 TGFα CREB is transiently activated ((TGFα, vH) ≥ 1) ⇒ F((CREB, vM ) ≥ 0.25
∧FG((CREB, vL) ≥ 0.8))
ϕ11 IL-1α CREB stays at a low level ((IL-1α, vH) ≥ 1)⇒ G((CREB = vL) ≥ 0.8)
ϕ12 TNFα p38 is transiently activated ((TNFα, vH) ≥ 1) ⇒ F((p38, vM ) ≥ 0.1
∧FG((p38, vL) ≥ 0.8))
ϕ13 IL-1α p38 is transiently activated ((IL-1α, vH) ≥ 1) ⇒ F((p38, vM ) ≥ 0.1
∧FG((p38, vL) ≥ 0.8))
ϕ14 INS AKTs activation is not sustained ((INS, vH) ≥ 1)⇒ FG((AKTs = vL) ≥ 0.9)
ϕ15 IGF AKTs activation is not sustained ((IGF, vH) ≥ 1)⇒ FG((AKTs = vL) ≥ 0.9)
ϕ16 INS p70S6K stays at a low level ((INS, vH) ≥ 1)⇒ G((p70S6K = vL) ≥ 0.9)
ϕ17 IGF p70S6K stays at a low level ((IGF, vH) ≥ 1)⇒ G((p70S6K = vL) ≥ 0.9)
ϕ18 TNFα p70S6K stays at a low level ((TNFα, vH) ≥ 1) ⇒ G((p70S6K = vL) ≥
0.9)
Table 5.4: Formalized properties of protein phosphorylation dynamics on healthy liver
cells.
(HHL5, HepG2, Focus), can modify some aspects of their dynamics to mimic those in
healthy cells. We constructed a set of 18 properties, which each describe the dynamics
of protein activity in HPH cells under some ligand stimulation. The properties we chose
correspond to settings in which the dynamics in HPH cells is significantly different from
other cell types. The list of properties is shown in Table 5.4.
First we verified that the properties ϕ1 to ϕ18 are satisfied on the DBN model of
healthy cells. We then used the models of the remaining 3 cell lines to make predictions.
In this study, the choice in treatments is limited to 5 inhibitors, and each possible
treatment condition is characterized by a subset of these inhibitors, which are applied
on the cells (giving a total of 32 possible conditions). Despite the relatively small number
of combinatorial treatments, experimentally evaluating these combinations with respect
to the 18 properties would require the collection of an additional set of data roughly 3
times the size of the original data set. However, using our DBN models, verifying these
128
properties under all possible conditions in all cell lines is tractable (it took, on average,
35 seconds for each cell line). Therefore, in what follows, we present results based on
an exhaustive evaluation of all possible inhibitor combinations.
We were interested in finding the combination of inhibitors with which the most
properties are satisfied, based on the number of inhibitors used. Table 5.5 summarizes
the best inhibitor combinations for each possible number of inhibitors. When no in-
hibitor is used, 3 properties are satisfied on the HHL5 cell line, 1 on HepG2 and 1 on
Focus. When a single inhibitor is used a larger number of properties can be satisfied (8,
4 and 6) for HHL5, HepG2 and Focus, respectively. In each case, adding one more in-
hibitor can significantly increase the effectiveness of the treatment, and in each case the
combination of PI3Ki and AKTi was found to be the best. This combination resulted
in 11, 8 and 10 satisfied properties on HHL5, HepG2 and Focus, respectively.
In some cases we found that multiple different combinations can achieve the same
number of satisfied properties. However, in general they will satisfy a different set of
the properties. This is illustrated in Figure 5.10, where the subset of combinations
corresponding to pairs of inhibitors (10 possible pairs) is shown. For each combination
shaded rectangles indicate that a given property is satisfied. Figures showing the set of
satisfied properties for all inhibitor combinations are given in Appendix C.
The PI3K/AKT/mTOR pathway can reduce apoptosis and promote proliferation,
and is overactive in many cancers [189]. Our results specifically implicate PI3K and
AKT as important targets, since inhibiting these kinases results in better resemblance
to properties of healthy cells. We showed that the inhibition of either PI3K or AKT
alone is less effective than their combined inhibition. Further, inhibiting PI3K and AKT
is more effective than either one combined with mTOR inhibition.
Another important difference between healthy and diseased cells (expressed in prop-
erty ϕ5) is that heat shock protein (HSP27) response is triggered in healthy cells in
response to stimulation by the growth factor TGFα, whereas the same activation is
missing in diseased cell lines. The loss of heat shock response has been implicated as an
important component of disease progression in liver cancer [190]. Our analysis shows
that the transient activation of HSP27 in response to TGFα cannot be recovered through
any combination of the studied kinase inhibitors. This implies that the lack of response
could be due to the loss of an interaction between ERK and HSP27 during disease
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HHL5
Number of inhibitors Best combinations Number of properties satisfied
0 – 3
1 PI3Ki or mTORci or AKTi 8
2 PI3Ki + AKTi 11
3 PI3Ki + AKTi + mTORci 11
4 PI3Ki + MEKi + mTORci + AKTi or 10
PI3Ki + MEKi + p38i + AKTi or
PI3Ki + mTORci + p38i + AKTi or
5 All 10
HepG2
Number of inhibitors Best combinations Number of properties satisfied
0 – 1
1 MEKi or PI3Ki 4
2 PI3Ki + AKTi 8
3 PI3Ki + MEKi + mTORci or 10
PI3Ki + mTORci + p38i or
MEKi + mTORci + AKTi
4 PI3Ki + MEKi + mTORci + p38i or 10
PI3Ki + MEKi + mTORci + AKTi or
PI3Ki + mTORci + p38i + AKTi or
MEKi + mTORci + p38i + AKTi
5 All 10
Focus
Number of inhibitors Best combinations Number of properties satisfied
0 – 1
1 PI3Ki 6
2 PI3Ki + AKTi 10
3 PI3Ki + AKTi + mTORci 11
4 PI3Ki + AKTi + mTORci + p38i 11
5 All 10
Table 5.5: The best combinations of kinase inhibitors, shown by the number of inhibitors
used, for each of 3 transformed liver cell lines.
progression, and inhibiting upstream kinases is unlikely to recover this interaction.
5.6 Summary
In this chapter we proposed a method for learning DBN models of pathway dynamics.
Our method relies on solving a series of constrained optimization problems using linear
programming to obtain the conditional probability parameters of the DBN. This way of
learning parameters is scalable since the size of each LP problem only depends on the
number of parents of a node, and not on the overall size of the model.
Next we showed that once the parameters of the DBN have been learned one can use
inference algorithms to predict dynamics under various previously unseen conditions.
This allows us to specify biologically relevant dynamical properties in a probabilistic
temporal logic and find treatment conditions under which the properties are satisfied.
We applied our method to learn the dynamics of protein phosphorylation in signaling
pathways of liver cancer cell lines. Validation experiments showed that we could reliably
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predict dynamics under previously unseen combinations of ligand stimulation and kinase
inhibition. We learned a DBN model for 4 cell lines ranging from healthy cells to late
stage cancer cells. Then we specified 18 characteristic dynamical properties of dynamics
in healthy cells and reported combinations of kinase inhibitors with which the diseased
cell lines could match most of these properties.
An assumption we have made is that a prior knowledge network (PKN) is given,
from which the DBN structure can be derived. Inferring model structure from limited
experimental data is highly challenging and is likely to produce ambiguous results with-
out strong prior constraints. A more realistic goal is to refine the structure derived from
the PKN by removing unnecessary edges (edges whose existence does not contribute to
explaining data). It turns out that our linear programming approach can be extended
in a straightforward manner to solve this problem. Namely, one can introduce binary
edge indicator variables, which are used to constrain parameters to be consistent with
the existence or non-existence of an edge. Introducing a penalty for the overall number
of parents of a node, a mixed integer linear programming (MILP) problem can be posed.
Preliminary results show that using this approach the structure can be simplified signif-
icantly, while retaining predictive capability. The set of edges kept or removed in each
cell type specific model can also reveal important differences between disease stages. We
plan to further explore this line of work to gain insights about liver cancer progression.
Finally, we have considered treatment conditions as a subset of inputs that are held
at a constant high level during the course of the experiment. In a sense we have explored
here only static treatments. This is reasonable in our case study on liver cancer since the
transient signaling response to stimuli is measured in a relatively short time frame (up
to 360 minutes). For longer time scales, a more sophisticated dynamic treatment regime
could be explored. Building models from experimental data representing signaling on
longer time scales, and considering dynamical treatment conditions could open up many
interesting possibilities. For instance, it would be possible to model the sequential
application of cancer drugs, at potentially varying doses. The appropriate framework to
find such treatments is likely to be control theory, and works including [191] and [192]
could serve as useful pointers in this line of work.
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Figure 5.10: Effects of inhibitor combinations on 3 liver cancer cell lines with respect
to characteristic dynamical properties of healthy cells (see Table 5.4). Shaded boxes
indicate a satisfied property, and numbers on the right edge indicate the total number




The focus of this thesis was on modeling the dynamics of biological pathways. Our
understanding of complex cellular processes including the cell cycle, programmed cell
death, and the response to environmental stimuli can benefit greatly from quantitative
computational models. However building such models based on prior domain knowledge
and experimental data is challenging. This is partly due to many sources of uncertainty
in the modeled biological system, the experimental data, and the modeling process. In
the work presented here we used probabilistic approaches to deal with this uncertainty.
Specifically, Chapters 3 and 4 addressed the problem of parameter uncertainty, which
induces uncertainty in model predictions. Here a probabilistic approach allowed us to
explicitly model and quantify the accuracy of predictions, taking into account prior
knowledge and experimental data. In Chapter 5 dynamic Bayesian networks enabled
us to model probabilistic relationships between species that do not physically interact
with each other. This accounts for the uncertainty induced by unmodeled intermediate
species and the stochasticity of dynamics. We now briefly review the main contributions
of each chapter and discuss directions for future work.
In Chapter 3 we proposed kernel-enhanced particle filters to perform parameter
inference on pathway models. Particle filters used before in this context suffer from
particle collapse resulting in inaccurate predictions under parameter uncertainty. We
showed that the basic particle filter extended with kernel steps can recover from particle
collapse and give much more accurate predictions with a lower sample size. Making
Bayesian computations more tractable could lead to the wider adoption of such tech-
niques on realistic pathway models. The rich set of probabilistic analysis techniques in
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a Bayesian framework will allow a faithful characterization of the uncertainty of models
and the predictions made with them.
Next, we proposed a method for verifying properties of pathway models under
Bayesian parameter uncertainty. This is important since certain dynamical proper-
ties can be robustly preserved even if parameter values are unconstrained, while other
properties may not hold due to uncertainty. In a Bayesian probabilistic framework the
posterior characterizes the distribution of possible model parameters according to their
support from prior knowledge and experimental data. Sampling independently from
the posterior is generally not possible, hence we proposed a Markov chain Monte Carlo
scheme to collect a sequence of dependent samples. These samples can be used to de-
cide with statistical guarantees whether the model meets a given temporal logic property
with at least a certain probability.
A common point in Chapters 3 and 4 is the characterization of pathway models
under Bayesian parameter uncertainty. It is increasingly recognized that predictions
made using pathway models are subject to large variability depending on the amount
and quality of experimental data [8, 118]. This uncertainty should be reflected in the
way pathway models are published and deposited in databases. One solution would be
to publish all experimental data with the model. However, this would still require sub-
sequent users to perform computationally intensive parameter inference. It is therefore
better to store and publish a representation of the parameter posterior distribution along
with the model. The technical challenges involved, including how the high-dimensional
posterior should be encoded efficiently and in a standardized format, are interesting
questions for future research.
It would be useful to attach to a model a list of key properties that it possesses. These
properties should be verifiable at all stages of model construction and dissemination
[193]. For example, in a model of extrinsically triggered apoptosis, a property of interest
could be “according to this model, cells die within 6 hours after treatment with 50ng/ml
TRAIL”. Temporal logics and model checking, as argued in Chapters 4 and 5, provide
a useful framework for formalizing such statements and verifying them in a biological
context. Attaching a set of such properties that hold with high probability, to models
with Bayesian uncertainty, would enable their reliable dissemination and reuse. The
framework presented in Chapter 4 could be the basis for such a solution, and this could
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bring a new paradigm in the way pathway models are shared and updated.
The goal of Chapter 5 was to learn the dynamics of signaling pathways using dynamic
Bayesian networks. We developed a framework on the DBN to find treatment conditions
under which the pathway shows specified, desirable dynamics. This is especially useful
when searching for combinatorial treatments, which is very expensive experimentally.
We applied our DBN learning method to model signaling in 4 cell types representing a
range of stages in the progression towards liver cancer. We were able to find promising
combinations of kinase inhibitors, using which some aspects of the dynamics of diseased
cells can be driven to mimic those of healthy cells.
The experimental data we used consists of joint measurements of the phosphorylation
of multiple proteins under a range of ligand stimuli and perturbations. Similar data sets
have recently been collected for several melanoma [194] and breast cancer [195] cell
lines. However, dynamical models that could predict the response of different cell lines
to treatments have not been built. It will be interesting to apply our DBN learning
method to these and other similar data sets. More generally, our method is a step in
the direction from descriptive towards dynamic and predictive models of disease specific
signaling behavior.
The concept of learning cell type specific models, as we have done using our DBNs,
opens up interesting possibilities in personalized treatments. If predictive models are
learned for several sub-types of a disease, one will be able to make model based predic-
tions of what treatment (or combination of treatments) is most likely to yield a desired
outcome in a specific setting. Quantitative dynamical models which can make reliable











B.1 Spectral gap of the Markov chain
In Section 4.5.1 we described how the spectral gap of the Markov chain can be estimated
in practice. Our Markov chains are defined on a general state space, and their transition
kernel is described by a linear operator. Here we give a more precise definition of the
















































































































































Figure A.1: Particles projected on the plane of k1 against k3 at each step of the filter for
the enzyme-substrate model. PF-BASIC cannot converge to the high-probability region
of parameter space, but PF-KGAUSS efficiently moves there by using kernel steps.
We call a Markov chain X1, X2, . . . on state space Ω with transition kernel P (x, dy)
reversible if there exists a probability measure pi on Ω satisfying the detailed balance
condition,
pi(dx)P (x, dy) = pi(dy)P (y, dx) for every x, y ∈ Ω. (B.1)
Define L2(pi) as the Hilbert space of complex valued measurable functions that are square
integrable with respect to pi, endowed with the inner product (f, g) =
∫
fg∗ dpi. P can
be then viewed as a linear operator on L2(pi), denoted by P , defined as
(P f)(x) := EP (x,·)(f),
and reversibility is equivalent to the self-adjointness of P . The operator P acts on
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Figure A.2: Fit to experimental data with 1000 particles with different particle filter
methods on the JAK-STAT pathway.






For a Markov chain with stationary distribution pi, we define the chain’s spectrum as
S2 := {λ ∈ C \ 0 : (λI − P )−1 does not exist as a bounded linear operator on L2(pi)}.
For reversible chains, S2 lies on the real line. We now define the spectral gap as follows.
Definition B.1. The spectral gap for reversible chains is defined as
γ := 1− sup{λ : λ ∈ S2, λ 6= 1} if eigenvalue 1 has multiplicity 1,
γ := 0 otherwise.
In the case of non-reversible chains, [196] defines the pseudo-spectral gap, and shows
that it has similar properties as the spectral gap has for reversible chains.
B.2 EARM1.3 model
Here we show the dynamics of species appearing in the specified temporal logic properties
in Section 4.6.2. The plots show the simulated trajectories with respect to the parameter
posterior. The shaded area shows the 90 percentile of all trajectories (the quantiles are
calculated at each time point) simulated with each parameter collected by the MCMC
procedure. The dashed lines show the 50 percentile (median) of all trajectories.








































































Figure B.1: Simulated trajectories (shaded area between 5 and 95 percentile) with
respect to the parameter posterior when using only EC-RP data (top), and both EC-

































































































Figure C.1: Predictions by the DBN on additional experiments for the HepG2 cell line.














































































































































Figure C.3: Effects of all inhibitor combinations on HHL5 cells with respect to charac-
teristic dynamical properties of healthy cells (see Table 5.4). Shaded boxes indicate a
satisfied property, and numbers on the right edge indicate the total number of satisfied
properties for the given combination.
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Figure C.4: Effects of all inhibitor combinations on HepG2 cells with respect to charac-
teristic dynamical properties of healthy cells (see Table 5.4). Shaded boxes indicate a
satisfied property, and numbers on the right edge indicate the total number of satisfied
properties for the given combination.
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Figure C.5: Effects of all inhibitor combinations on Focus cells with respect to charac-
teristic dynamical properties of healthy cells (see Table 5.4). Shaded boxes indicate a
satisfied property, and numbers on the right edge indicate the total number of satisfied
properties for the given combination.
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